mapped_trait_uri	mapped_trait	n_study
http://purl.obolibrary.org/obo/GO_0006306	DNA methylation	4
http://purl.obolibrary.org/obo/GO_0006950	response to stress	5
http://purl.obolibrary.org/obo/GO_0006954	inflammatory response	1
http://purl.obolibrary.org/obo/GO_0007568	aging	32
http://purl.obolibrary.org/obo/GO_0007605	sensory perception of sound	1
http://purl.obolibrary.org/obo/GO_0007608	sensory perception of smell	7
http://purl.obolibrary.org/obo/GO_0007610	behavior	3
http://purl.obolibrary.org/obo/GO_0009314	response to radiation	21
http://purl.obolibrary.org/obo/GO_0009615	response to virus	2
http://purl.obolibrary.org/obo/GO_0010226	response to lithium ion	12
http://purl.obolibrary.org/obo/GO_0014072	response to opiate	2
http://purl.obolibrary.org/obo/GO_0031427	response to methotrexate	6
http://purl.obolibrary.org/obo/GO_0031960	response to corticosteroid	18
http://purl.obolibrary.org/obo/GO_0033273	response to vitamin	2
http://purl.obolibrary.org/obo/GO_0034097	response to cytokine	2
http://purl.obolibrary.org/obo/GO_0035456	response to interferon beta	23
http://purl.obolibrary.org/obo/GO_0036270	response to diuretic	16
http://purl.obolibrary.org/obo/GO_0036271	response to methylphenidate	2
http://purl.obolibrary.org/obo/GO_0036272	response to gemcitabine	7
http://purl.obolibrary.org/obo/GO_0036273	response to statin	25
http://purl.obolibrary.org/obo/GO_0036274	response to lapatinib	2
http://purl.obolibrary.org/obo/GO_0036275	response to 5' fluorouracil	4
http://purl.obolibrary.org/obo/GO_0036276	response to antidepressant	30
http://purl.obolibrary.org/obo/GO_0036277	response to anticonvulsant	20
http://purl.obolibrary.org/obo/GO_0036287	response to iloperidone	2
http://purl.obolibrary.org/obo/GO_0036288	response to ximelagatran	1
http://purl.obolibrary.org/obo/GO_0042476	odontogenesis	3
http://purl.obolibrary.org/obo/GO_0042493	response to drug	10
http://purl.obolibrary.org/obo/GO_0043278	response to morphine	1
http://purl.obolibrary.org/obo/GO_0044691	tooth eruption	2
http://purl.obolibrary.org/obo/GO_0046677	response to antibiotic	1
http://purl.obolibrary.org/obo/GO_0050909	sensory perception of taste	7
http://purl.obolibrary.org/obo/GO_0050913	sensory perception of bitter taste	6
http://purl.obolibrary.org/obo/GO_0050916	sensory perception of sweet taste	8
http://purl.obolibrary.org/obo/GO_0051384	response to glucocorticoid	6
http://purl.obolibrary.org/obo/GO_0060279	positive regulation of ovulation	1
http://purl.obolibrary.org/obo/GO_0061476	response to anticoagulant	8
http://purl.obolibrary.org/obo/GO_0061477	response to aromatase inhibitor	7
http://purl.obolibrary.org/obo/GO_0061478	response to platelet aggregation inhibitor	1
http://purl.obolibrary.org/obo/GO_0061479	response to reverse transcriptase inhibitor	10
http://purl.obolibrary.org/obo/GO_0070527	platelet aggregation	5
http://purl.obolibrary.org/obo/GO_0072718	response to cisplatin	10
http://purl.obolibrary.org/obo/GO_0072758	response to topoisomerase inhibitor	5
http://purl.obolibrary.org/obo/GO_0097327	response to antineoplastic agent	40
http://purl.obolibrary.org/obo/GO_0097328	response to carboplatin	10
http://purl.obolibrary.org/obo/GO_0097329	response to antimetabolite	1
http://purl.obolibrary.org/obo/GO_0097332	response to antipsychotic drug	15
http://purl.obolibrary.org/obo/GO_0097333	response to olanzapine	2
http://purl.obolibrary.org/obo/GO_0097334	response to perphenazine	1
http://purl.obolibrary.org/obo/GO_0097335	response to quetiapine	1
http://purl.obolibrary.org/obo/GO_0097336	response to risperidone	2
http://purl.obolibrary.org/obo/GO_0097337	response to ziprasidone	1
http://purl.obolibrary.org/obo/GO_0097338	response to clozapine	5
http://purl.obolibrary.org/obo/GO_0097366	response to bronchodilator	17
http://purl.obolibrary.org/obo/GO_1901554	response to acetaminophen	1
http://purl.obolibrary.org/obo/GO_1901555	response to paclitaxel	25
http://purl.obolibrary.org/obo/GO_1901556	response to candesartan	2
http://purl.obolibrary.org/obo/GO_1901557	response to fenofibrate	18
http://purl.obolibrary.org/obo/GO_1901558	response to metformin	5
http://purl.obolibrary.org/obo/GO_1901559	response to ribavirin	1
http://purl.obolibrary.org/obo/GO_1901563	response to camptothecin	1
http://purl.obolibrary.org/obo/GO_1901905	response to tamsulosin	1
http://purl.obolibrary.org/obo/GO_1902518	response to cyclophosphamide	4
http://purl.obolibrary.org/obo/GO_1902519	response to docetaxel	6
http://purl.obolibrary.org/obo/GO_1902520	response to doxorubicin	3
http://purl.obolibrary.org/obo/GO_1902521	response to etoposide	2
http://purl.obolibrary.org/obo/GO_1902522	response to epirubicin	3
http://purl.obolibrary.org/obo/GO_1903491	response to simvastatin	6
http://purl.obolibrary.org/obo/GO_1903493	response to clopidogrel	6
http://purl.obolibrary.org/obo/GO_1905119	response to haloperidol	2
http://purl.obolibrary.org/obo/GO_1990054	response to temozolomide	2
http://purl.obolibrary.org/obo/HANCESTRO_0014	Hispanic or Latin American	1
http://purl.obolibrary.org/obo/HP_0000008	Abnormal morphology of female internal genitalia	6
http://purl.obolibrary.org/obo/HP_0000016	Urinary retention	1
http://purl.obolibrary.org/obo/HP_0000020	Urinary incontinence	9
http://purl.obolibrary.org/obo/HP_0000023	Inguinal hernia	13
http://purl.obolibrary.org/obo/HP_0000079	Abnormality of the urinary system	1
http://purl.obolibrary.org/obo/HP_0000093	Proteinuria	11
http://purl.obolibrary.org/obo/HP_0000103	Polyuria	2
http://purl.obolibrary.org/obo/HP_0000112	Nephropathy	2
http://purl.obolibrary.org/obo/HP_0000131	Uterine leiomyoma	10
http://purl.obolibrary.org/obo/HP_0000132	Menorrhagia	6
http://purl.obolibrary.org/obo/HP_0000138	Ovarian cyst	4
http://purl.obolibrary.org/obo/HP_0000155	Oral ulcer	4
http://purl.obolibrary.org/obo/HP_0000175	Cleft palate	27
http://purl.obolibrary.org/obo/HP_0000202	Oral cleft	9
http://purl.obolibrary.org/obo/HP_0000225	Gingival bleeding	4
http://purl.obolibrary.org/obo/HP_0000238	Hydrocephalus	2
http://purl.obolibrary.org/obo/HP_0000360	Tinnitus	30
http://purl.obolibrary.org/obo/HP_0000471	Gastrointestinal angiodysplasia	2
http://purl.obolibrary.org/obo/HP_0000483	Astigmatism	23
http://purl.obolibrary.org/obo/HP_0000486	Strabismus	7
http://purl.obolibrary.org/obo/HP_0000539	Abnormality of refraction	8
http://purl.obolibrary.org/obo/HP_0000540	Hypermetropia	3
http://purl.obolibrary.org/obo/HP_0000545	Myopia	22
http://purl.obolibrary.org/obo/HP_0000565	Esotropia	1
http://purl.obolibrary.org/obo/HP_0000639	Nystagmus	1
http://purl.obolibrary.org/obo/HP_0000651	Diplopia	2
http://purl.obolibrary.org/obo/HP_0000708	Behavioral abnormality	2
http://purl.obolibrary.org/obo/HP_0000726	Dementia	3
http://purl.obolibrary.org/obo/HP_0000737	Irritability	6
http://purl.obolibrary.org/obo/HP_0000738	Hallucinations	1
http://purl.obolibrary.org/obo/HP_0000790	Hematuria	6
http://purl.obolibrary.org/obo/HP_0000924	Abnormality of the skeletal system	10
http://purl.obolibrary.org/obo/HP_0000938	Osteopenia	4
http://purl.obolibrary.org/obo/HP_0000951	Abnormality of the skin	4
http://purl.obolibrary.org/obo/HP_0000952	Jaundice	6
http://purl.obolibrary.org/obo/HP_0000957	Cafe-au-lait spot	1
http://purl.obolibrary.org/obo/HP_0000964	Eczema	9
http://purl.obolibrary.org/obo/HP_0000975	Hyperhidrosis	5
http://purl.obolibrary.org/obo/HP_0000989	Pruritus	7
http://purl.obolibrary.org/obo/HP_0001007	Hirsutism	1
http://purl.obolibrary.org/obo/HP_0001082	Cholecystitis	6
http://purl.obolibrary.org/obo/HP_0001094	Iridocyclitis	2
http://purl.obolibrary.org/obo/HP_0001250	Seizure	6
http://purl.obolibrary.org/obo/HP_0001268	Mental deterioration	4
http://purl.obolibrary.org/obo/HP_0001269	Hemiparesis	2
http://purl.obolibrary.org/obo/HP_0001279	Syncope	2
http://purl.obolibrary.org/obo/HP_0001337	Tremor	2
http://purl.obolibrary.org/obo/HP_0001395	Hepatic fibrosis	4
http://purl.obolibrary.org/obo/HP_0001397	Hepatic steatosis	1
http://purl.obolibrary.org/obo/HP_0001399	Hepatic failure	2
http://purl.obolibrary.org/obo/HP_0001537	Umbilical hernia	6
http://purl.obolibrary.org/obo/HP_0001541	Ascites	2
http://purl.obolibrary.org/obo/HP_0001634	Mitral valve prolapse	3
http://purl.obolibrary.org/obo/HP_0001636	Tetralogy of Fallot	1
http://purl.obolibrary.org/obo/HP_0001647	Bicuspid aortic valve	3
http://purl.obolibrary.org/obo/HP_0001649	Tachycardia	2
http://purl.obolibrary.org/obo/HP_0001662	Bradycardia	2
http://purl.obolibrary.org/obo/HP_0001671	Abnormal cardiac septum morphology	2
http://purl.obolibrary.org/obo/HP_0001744	Splenomegaly	4
http://purl.obolibrary.org/obo/HP_0001760	Abnormal foot morphology	1
http://purl.obolibrary.org/obo/HP_0001822	Hallux valgus	5
http://purl.obolibrary.org/obo/HP_0001873	Thrombocytopenia	5
http://purl.obolibrary.org/obo/HP_0001891	Iron deficiency anemia	13
http://purl.obolibrary.org/obo/HP_0001892	Abnormal bleeding	6
http://purl.obolibrary.org/obo/HP_0001915	Aplastic anemia	4
http://purl.obolibrary.org/obo/HP_0001919	Acute kidney injury	4
http://purl.obolibrary.org/obo/HP_0001939	Abnormality of metabolism/homeostasis	4
http://purl.obolibrary.org/obo/HP_0001943	Hypoglycemia	2
http://purl.obolibrary.org/obo/HP_0001945	Fever	7
http://purl.obolibrary.org/obo/HP_0001962	Palpitations	2
http://purl.obolibrary.org/obo/HP_0001977	Abnormal thrombosis	3
http://purl.obolibrary.org/obo/HP_0002013	Vomiting	10
http://purl.obolibrary.org/obo/HP_0002014	Diarrhea	16
http://purl.obolibrary.org/obo/HP_0002015	Dysphagia	7
http://purl.obolibrary.org/obo/HP_0002018	Nausea	7
http://purl.obolibrary.org/obo/HP_0002019	Constipation	6
http://purl.obolibrary.org/obo/HP_0002027	Abdominal pain	36
http://purl.obolibrary.org/obo/HP_0002036	Hiatus hernia	5
http://purl.obolibrary.org/obo/HP_0002088	Abnormal lung morphology	2
http://purl.obolibrary.org/obo/HP_0002094	Dyspnea	6
http://purl.obolibrary.org/obo/HP_0002105	Hemoptysis	2
http://purl.obolibrary.org/obo/HP_0002108	Spontaneous pneumothorax	5
http://purl.obolibrary.org/obo/HP_0002140	Ischemic stroke	35
http://purl.obolibrary.org/obo/HP_0002141	Gait imbalance	1
http://purl.obolibrary.org/obo/HP_0002153	Hyperkalemia	2
http://purl.obolibrary.org/obo/HP_0002172	Postural instability	1
http://purl.obolibrary.org/obo/HP_0002240	Hepatomegaly	2
http://purl.obolibrary.org/obo/HP_0002248	Hematemesis	2
http://purl.obolibrary.org/obo/HP_0002253	Colonic diverticula	1
http://purl.obolibrary.org/obo/HP_0002315	Headache	12
http://purl.obolibrary.org/obo/HP_0002321	Vertigo	4
http://purl.obolibrary.org/obo/HP_0002373	Febrile seizure (within the age range of 3 months to 6 years)	2
http://purl.obolibrary.org/obo/HP_0002571	Achalasia	2
http://purl.obolibrary.org/obo/HP_0002573	Hematochezia	3
http://purl.obolibrary.org/obo/HP_0002619	Varicose veins	15
http://purl.obolibrary.org/obo/HP_0002793	Abnormal pattern of respiration	4
http://purl.obolibrary.org/obo/HP_0002829	Arthralgia	5
http://purl.obolibrary.org/obo/HP_0002900	Hypokalemia	3
http://purl.obolibrary.org/obo/HP_0002907	Microscopic hematuria	4
http://purl.obolibrary.org/obo/HP_0002916	Abnormality of chromosome segregation	4
http://purl.obolibrary.org/obo/HP_0002919	Ketonuria	3
http://purl.obolibrary.org/obo/HP_0003073	Hypoalbuminemia	1
http://purl.obolibrary.org/obo/HP_0003074	Hyperglycemia	2
http://purl.obolibrary.org/obo/HP_0003076	Glycosuria	6
http://purl.obolibrary.org/obo/HP_0003110	Abnormality of urine homeostasis	4
http://purl.obolibrary.org/obo/HP_0003115	Abnormal EKG	1
http://purl.obolibrary.org/obo/HP_0003119	Abnormal circulating lipid concentration	1
http://purl.obolibrary.org/obo/HP_0003124	Hypercholesterolemia	10
http://purl.obolibrary.org/obo/HP_0003146	Hypocholesterolemia	1
http://purl.obolibrary.org/obo/HP_0003270	Abdominal distention	20
http://purl.obolibrary.org/obo/HP_0003319	Abnormality of the cervical spine	4
http://purl.obolibrary.org/obo/HP_0003401	Paresthesia	2
http://purl.obolibrary.org/obo/HP_0003418	Back pain	16
http://purl.obolibrary.org/obo/HP_0003474	Somatic sensory dysfunction	1
http://purl.obolibrary.org/obo/HP_0004299	Hernia of the abdominal wall	4
http://purl.obolibrary.org/obo/HP_0004308	Ventricular arrhythmia	2
http://purl.obolibrary.org/obo/HP_0004398	Peptic ulcer	2
http://purl.obolibrary.org/obo/HP_0004418	Thrombophlebitis	4
http://purl.obolibrary.org/obo/HP_0004796	Gastrointestinal obstruction	2
http://purl.obolibrary.org/obo/HP_0005224	Rectal abscess	2
http://purl.obolibrary.org/obo/HP_0006695	Atrioventricular canal defect	1
http://purl.obolibrary.org/obo/HP_0008770	Obsessive-compulsive trait	1
http://purl.obolibrary.org/obo/HP_0009762	Facial wrinkling	6
http://purl.obolibrary.org/obo/HP_0009907	Attached earlobe	1
http://purl.obolibrary.org/obo/HP_0009926	Epiphora	2
http://purl.obolibrary.org/obo/HP_0010313	Breast hypertrophy	2
http://purl.obolibrary.org/obo/HP_0010609	Skin tags	2
http://purl.obolibrary.org/obo/HP_0010865	Oppositional defiant disorder	2
http://purl.obolibrary.org/obo/HP_0010886	Osteochondritis Dissecans	1
http://purl.obolibrary.org/obo/HP_0010992	Stress urinary incontinence	4
http://purl.obolibrary.org/obo/HP_0011014	Abnormal glucose homeostasis	2
http://purl.obolibrary.org/obo/HP_0011015	Abnormal blood glucose concentration	2
http://purl.obolibrary.org/obo/HP_0011025	Abnormal cardiovascular system physiology	4
http://purl.obolibrary.org/obo/HP_0011079	Impacted tooth	4
http://purl.obolibrary.org/obo/HP_0011105	Hypervolemia	2
http://purl.obolibrary.org/obo/HP_0011106	Hypovolemia	2
http://purl.obolibrary.org/obo/HP_0011141	Age-related cataract	10
http://purl.obolibrary.org/obo/HP_0011142	Age-related nuclear cataract	4
http://purl.obolibrary.org/obo/HP_0011368	Epidermal thickening	2
http://purl.obolibrary.org/obo/HP_0011458	Abdominal symptom	6
http://purl.obolibrary.org/obo/HP_0011706	Second degree atrioventricular block	2
http://purl.obolibrary.org/obo/HP_0011713	Left bundle branch block	2
http://purl.obolibrary.org/obo/HP_0011868	Sciatica	15
http://purl.obolibrary.org/obo/HP_0011950	Bronchiolitis	1
http://purl.obolibrary.org/obo/HP_0012042	Aspirin-induced asthma	2
http://purl.obolibrary.org/obo/HP_0012076	Borderline personality disorder	1
http://purl.obolibrary.org/obo/HP_0012115	Hepatitis	4
http://purl.obolibrary.org/obo/HP_0012199	Cluster headache	2
http://purl.obolibrary.org/obo/HP_0012219	Erythema nodosum	2
http://purl.obolibrary.org/obo/HP_0012235	Drug-induced agranulocytosis	10
http://purl.obolibrary.org/obo/HP_0012378	Fatigue	14
http://purl.obolibrary.org/obo/HP_0012388	Acute bronchitis	4
http://purl.obolibrary.org/obo/HP_0012390	Anal fissure	6
http://purl.obolibrary.org/obo/HP_0012514	Lower limb pain	24
http://purl.obolibrary.org/obo/HP_0012532	Chronic pain	4
http://purl.obolibrary.org/obo/HP_0012594	Moderate albuminuria	5
http://purl.obolibrary.org/obo/HP_0012735	Cough	6
http://purl.obolibrary.org/obo/HP_0012803	Anisometropia	6
http://purl.obolibrary.org/obo/HP_0020046	Accommodative esotropia	1
http://purl.obolibrary.org/obo/HP_0025004	Hallux rigidus	2
http://purl.obolibrary.org/obo/HP_0025031	Abnormality of the digestive system	1
http://purl.obolibrary.org/obo/HP_0025095	Sneeze	1
http://purl.obolibrary.org/obo/HP_0025258	Stiff neck	1
http://purl.obolibrary.org/obo/HP_0025267	Snoring	2
http://purl.obolibrary.org/obo/HP_0030016	Dyspareunia	2
http://purl.obolibrary.org/obo/HP_0030148	Heart murmur	5
http://purl.obolibrary.org/obo/HP_0030680	Abnormality of cardiovascular system morphology	1
http://purl.obolibrary.org/obo/HP_0030775	Modic type vertebral endplate changes	1
http://purl.obolibrary.org/obo/HP_0030833	Neck pain	1
http://purl.obolibrary.org/obo/HP_0030834	Shoulder pain	5
http://purl.obolibrary.org/obo/HP_0030838	Hip pain	4
http://purl.obolibrary.org/obo/HP_0030839	Knee pain	7
http://purl.obolibrary.org/obo/HP_0030914	Abnormal peristalsis	1
http://purl.obolibrary.org/obo/HP_0030972	Abnormal systemic blood pressure	6
http://purl.obolibrary.org/obo/HP_0031292	Cutaneous abscess	6
http://purl.obolibrary.org/obo/HP_0031456	Ectopic pregnancy	2
http://purl.obolibrary.org/obo/HP_0031685	Abnormal stool composition	32
http://purl.obolibrary.org/obo/HP_0031760	Non-accomodative esotropia	1
http://purl.obolibrary.org/obo/HP_0032016	Abnormal sputum	2
http://purl.obolibrary.org/obo/HP_0040187	Neonatal sepsis	1
http://purl.obolibrary.org/obo/HP_0100543	Cognitive impairment	14
http://purl.obolibrary.org/obo/HP_0100578	Lipoatrophy	1
http://purl.obolibrary.org/obo/HP_0100607	Dysmenorrhea	4
http://purl.obolibrary.org/obo/HP_0100608	Metrorrhagia	1
http://purl.obolibrary.org/obo/HP_0100716	Self-injurious behavior	12
http://purl.obolibrary.org/obo/HP_0100749	Chest pain	22
http://purl.obolibrary.org/obo/HP_0100806	Sepsis	12
http://purl.obolibrary.org/obo/HP_0200023	Priapism	1
http://purl.obolibrary.org/obo/MONDO_0000153	transposition of the great arteries	1
http://purl.obolibrary.org/obo/MONDO_0000159	bone marrow failure syndrome	2
http://purl.obolibrary.org/obo/MONDO_0000254	cutaneous mycosis	2
http://purl.obolibrary.org/obo/MONDO_0000620	breast benign neoplasm	4
http://purl.obolibrary.org/obo/MONDO_0000728	ptosis	2
http://purl.obolibrary.org/obo/MONDO_0000812	vertebral column disease	2
http://purl.obolibrary.org/obo/MONDO_0000870	childhood acute lymphoblastic leukemia	1
http://purl.obolibrary.org/obo/MONDO_0000916	intestinal infectious disease	2
http://purl.obolibrary.org/obo/MONDO_0001020	amblyopia	7
http://purl.obolibrary.org/obo/MONDO_0001208	acute respiratory failure	2
http://purl.obolibrary.org/obo/MONDO_0001285	endometriosis of pelvic peritoneum	2
http://purl.obolibrary.org/obo/MONDO_0001330	presbyopia	6
http://purl.obolibrary.org/obo/MONDO_0001370	pericardial effusion	2
http://purl.obolibrary.org/obo/MONDO_0001410	postmenopausal atrophic vaginitis	2
http://purl.obolibrary.org/obo/MONDO_0001437	pulmonary alveolar proteinosis	1
http://purl.obolibrary.org/obo/MONDO_0001458	ulnar nerve lesion	2
http://purl.obolibrary.org/obo/MONDO_0001475	neutropenia	8
http://purl.obolibrary.org/obo/MONDO_0001583	diabetic polyneuropathy	2
http://purl.obolibrary.org/obo/MONDO_0001658	nontoxic goiter	6
http://purl.obolibrary.org/obo/MONDO_0002009	major depressive disorder	12
http://purl.obolibrary.org/obo/MONDO_0002013	lymphangioma	2
http://purl.obolibrary.org/obo/MONDO_0002025	psychiatric disorder	2
http://purl.obolibrary.org/obo/MONDO_0002026	candidiasis	8
http://purl.obolibrary.org/obo/MONDO_0002033	cecum cancer	2
http://purl.obolibrary.org/obo/MONDO_0002046	alcohol abuse	4
http://purl.obolibrary.org/obo/MONDO_0002076	pneumothorax	4
http://purl.obolibrary.org/obo/MONDO_0002078	heart septal defect	1
http://purl.obolibrary.org/obo/MONDO_0002134	physiological sexual disorder	2
http://purl.obolibrary.org/obo/MONDO_0002175	degeneration of macula and posterior pole	2
http://purl.obolibrary.org/obo/MONDO_0002203	constipation disorder	4
http://purl.obolibrary.org/obo/MONDO_0002243	hemorrhagic disease	2
http://purl.obolibrary.org/obo/MONDO_0002258	pharyngitis	3
http://purl.obolibrary.org/obo/MONDO_0002334	hematopoietic and lymphoid system neoplasm	3
http://purl.obolibrary.org/obo/MONDO_0002358	laryngeal carcinoma	2
http://purl.obolibrary.org/obo/MONDO_0002367	kidney cancer	1
http://purl.obolibrary.org/obo/MONDO_0002406	dermatitis	1
http://purl.obolibrary.org/obo/MONDO_0002423	rectosigmoid junction neoplasm	2
http://purl.obolibrary.org/obo/MONDO_0002436	nasal disorder	3
http://purl.obolibrary.org/obo/MONDO_0002462	glomerulonephritis	4
http://purl.obolibrary.org/obo/MONDO_0002471	bursitis	2
http://purl.obolibrary.org/obo/MONDO_0002488	intraductal breast neoplasm	2
http://purl.obolibrary.org/obo/MONDO_0002491	substance abuse	7
http://purl.obolibrary.org/obo/MONDO_0002492	acute kidney failure	4
http://purl.obolibrary.org/obo/MONDO_0002494	substance-related disorder	12
http://purl.obolibrary.org/obo/MONDO_0002959	radiculopathy	2
http://purl.obolibrary.org/obo/MONDO_0003060	biliary tract cancer	3
http://purl.obolibrary.org/obo/MONDO_0003090	extrahepatic bile duct carcinoma	1
http://purl.obolibrary.org/obo/MONDO_0003783	lymphopenia	2
http://purl.obolibrary.org/obo/MONDO_0003937	spondylitis	4
http://purl.obolibrary.org/obo/MONDO_0004247	peptic ulcer disease	2
http://purl.obolibrary.org/obo/MONDO_0004567	ileus	4
http://purl.obolibrary.org/obo/MONDO_0004647	in situ carcinoma	2
http://purl.obolibrary.org/obo/MONDO_0004678	dermatophytosis	2
http://purl.obolibrary.org/obo/MONDO_0004790	fatty liver disease	2
http://purl.obolibrary.org/obo/MONDO_0004805	leukocyte disease	2
http://purl.obolibrary.org/obo/MONDO_0004822	bronchiectasis	10
http://purl.obolibrary.org/obo/MONDO_0004857	tendinitis	2
http://purl.obolibrary.org/obo/MONDO_0004880	bowel dysfunction	17
http://purl.obolibrary.org/obo/MONDO_0004891	hyperopia	7
http://purl.obolibrary.org/obo/MONDO_0007182	Machado-Joseph disease	1
http://purl.obolibrary.org/obo/MONDO_0007899	lichen sclerosus et atrophicus	2
http://purl.obolibrary.org/obo/MONDO_0008277	stomach polyp	2
http://purl.obolibrary.org/obo/MONDO_0008903	lung cancer	1
http://purl.obolibrary.org/obo/MONDO_0009410	Addison disease	1
http://purl.obolibrary.org/obo/MONDO_0010888	endometriosis of uterus	2
http://purl.obolibrary.org/obo/MONDO_0011962	endometrial cancer	4
http://purl.obolibrary.org/obo/MONDO_0012511	preterm premature rupture of the membranes	1
http://purl.obolibrary.org/obo/MONDO_0015474	cryptosporidiosis	1
http://purl.obolibrary.org/obo/MONDO_0016586	systemic mastocytosis	1
http://purl.obolibrary.org/obo/MONDO_0018469	pulmonary non-tuberculous mycobacterial infection	1
http://purl.obolibrary.org/obo/MONDO_0018906	follicular lymphoma	5
http://purl.obolibrary.org/obo/MONDO_0019472	extranodal nasal NK/T cell lymphoma	2
http://purl.obolibrary.org/obo/MONDO_0020010	infectious disease of the nervous system	1
http://purl.obolibrary.org/obo/MONDO_0021066	urinary system neoplasm	2
http://purl.obolibrary.org/obo/MONDO_0021084	vision disorder	1
http://purl.obolibrary.org/obo/MONDO_0021107	narcolepsy	1
http://purl.obolibrary.org/obo/MONDO_0021117	lung neoplasm	6
http://purl.obolibrary.org/obo/MONDO_0021205	disease of ear	1
http://purl.obolibrary.org/obo/MONDO_0021355	neoplasm of esophagus	8
http://purl.obolibrary.org/obo/MONDO_0021398	polyp of rectum	2
http://purl.obolibrary.org/obo/MONDO_0021400	polyp of colon	4
http://purl.obolibrary.org/obo/MONDO_0021416	polyp of gallbladder	2
http://purl.obolibrary.org/obo/MONDO_0021449	benign neoplasm of stomach	2
http://purl.obolibrary.org/obo/MONDO_0021698	alcohol-related disorders	2
http://purl.obolibrary.org/obo/MONDO_0022208	crystal arthropathy	2
http://purl.obolibrary.org/obo/MONDO_0024280	polyarticular arthritis	2
http://purl.obolibrary.org/obo/MONDO_0024290	enuresis	1
http://purl.obolibrary.org/obo/MONDO_0024339	lymph node neoplasm	12
http://purl.obolibrary.org/obo/MONDO_0024355	respiratory tract infectious disease	1
http://purl.obolibrary.org/obo/MONDO_0024623	otorhinolaryngologic disease	3
http://purl.obolibrary.org/obo/MONDO_0024625	disorder of lacrimal gland	2
http://purl.obolibrary.org/obo/MONDO_0024633	hypertensive renal disease	1
http://purl.obolibrary.org/obo/MONDO_0024647	urolithiasis	11
http://purl.obolibrary.org/obo/MONDO_0041052	postherpetic neuralgia	1
http://purl.obolibrary.org/obo/MONDO_0041086	mixed anxiety and depressive disorder	2
http://purl.obolibrary.org/obo/MONDO_0041161	endometrial hyperplasia	2
http://purl.obolibrary.org/obo/MONDO_0042487	uterine cervix carcinoma in situ	2
http://purl.obolibrary.org/obo/MONDO_0043424	digestive system infectious disease	1
http://purl.obolibrary.org/obo/MONDO_0043885	eye infectious disease	2
http://purl.obolibrary.org/obo/MONDO_0044887	central nervous system non-hodgkin lymphoma	1
http://purl.obolibrary.org/obo/MONDO_0044965	abdominal and pelvic region disorder	2
http://purl.obolibrary.org/obo/MONDO_0044983	benign lipomatous neoplasm	10
http://purl.obolibrary.org/obo/MONDO_0045002	vertebral disease	2
http://purl.obolibrary.org/obo/MONDO_0060766	anal polyp	2
http://purl.obolibrary.org/obo/MONDO_0100096	COVID-19	67
http://purl.obolibrary.org/obo/MP_0001914	hemorrhage	2
http://purl.obolibrary.org/obo/NCBITaxon_210	Helicobacter pylori	4
http://purl.obolibrary.org/obo/NCIT_C117245	decreased attention	1
http://purl.obolibrary.org/obo/NCIT_C74532	nervousness	2
http://purl.obolibrary.org/obo/NCIT_C95746	sleepiness	5
http://purl.obolibrary.org/obo/PATO_0000047	biological sex	2
http://purl.obolibrary.org/obo/PATO_0000461	normal	24
http://purl.obolibrary.org/obo/PATO_0001163	decreased concentration	4
http://purl.obolibrary.org/obo/PATO_0001422	dead	1
http://purl.obolibrary.org/obo/UBERON_0010996	articular cartilage of joint	4
http://www.ebi.ac.uk/efo/EFO_0000094	B-cell acute lymphoblastic leukemia	14
http://www.ebi.ac.uk/efo/EFO_0000095	chronic lymphocytic leukemia	17
http://www.ebi.ac.uk/efo/EFO_0000096	neoplasm of mature B-cells	4
http://www.ebi.ac.uk/efo/EFO_0000174	Ewing sarcoma	3
http://www.ebi.ac.uk/efo/EFO_0000178	gastric carcinoma	18
http://www.ebi.ac.uk/efo/EFO_0000180	HIV-1 infection	12
http://www.ebi.ac.uk/efo/EFO_0000181	head and neck squamous cell carcinoma	2
http://www.ebi.ac.uk/efo/EFO_0000182	hepatocellular carcinoma	18
http://www.ebi.ac.uk/efo/EFO_0000183	Hodgkins lymphoma	8
http://www.ebi.ac.uk/efo/EFO_0000195	metabolic syndrome	18
http://www.ebi.ac.uk/efo/EFO_0000196	metastatic prostate cancer	1
http://www.ebi.ac.uk/efo/EFO_0000198	myelodysplastic syndrome	4
http://www.ebi.ac.uk/efo/EFO_0000203	monoclonal gammopathy	6
http://www.ebi.ac.uk/efo/EFO_0000217	gastritis	17
http://www.ebi.ac.uk/efo/EFO_0000220	acute lymphoblastic leukemia	17
http://www.ebi.ac.uk/efo/EFO_0000222	acute myeloid leukemia	6
http://www.ebi.ac.uk/efo/EFO_0000249	Alzheimer's disease	122
http://www.ebi.ac.uk/efo/EFO_0000253	amyotrophic lateral sclerosis	33
http://www.ebi.ac.uk/efo/EFO_0000266	aortic stenosis	8
http://www.ebi.ac.uk/efo/EFO_0000270	asthma	117
http://www.ebi.ac.uk/efo/EFO_0000274	atopic eczema	19
http://www.ebi.ac.uk/efo/EFO_0000275	atrial fibrillation	37
http://www.ebi.ac.uk/efo/EFO_0000278	pancreatitis	10
http://www.ebi.ac.uk/efo/EFO_0000279	azoospermia	2
http://www.ebi.ac.uk/efo/EFO_0000280	Barrett's esophagus	21
http://www.ebi.ac.uk/efo/EFO_0000284	benign prostatic hyperplasia	15
http://www.ebi.ac.uk/efo/EFO_0000289	bipolar disorder	113
http://www.ebi.ac.uk/efo/EFO_0000292	bladder carcinoma	33
http://www.ebi.ac.uk/efo/EFO_0000294	bladder tumor	2
http://www.ebi.ac.uk/efo/EFO_0000305	breast carcinoma	119
http://www.ebi.ac.uk/efo/EFO_0000311	cancer	19
http://www.ebi.ac.uk/efo/EFO_0000313	carcinoma	2
http://www.ebi.ac.uk/efo/EFO_0000318	cardiomyopathy	7
http://www.ebi.ac.uk/efo/EFO_0000319	cardiovascular disease	31
http://www.ebi.ac.uk/efo/EFO_0000326	central nervous system cancer	13
http://www.ebi.ac.uk/efo/EFO_0000337	chronic gastritis	4
http://www.ebi.ac.uk/efo/EFO_0000339	chronic myelogenous leukemia	1
http://www.ebi.ac.uk/efo/EFO_0000341	chronic obstructive pulmonary disease	65
http://www.ebi.ac.uk/efo/EFO_0000342	chronic pancreatitis	2
http://www.ebi.ac.uk/efo/EFO_0000352	clinical history	22
http://www.ebi.ac.uk/efo/EFO_0000365	colorectal adenocarcinoma	1
http://www.ebi.ac.uk/efo/EFO_0000384	Crohn's disease	54
http://www.ebi.ac.uk/efo/EFO_0000389	cutaneous melanoma	8
http://www.ebi.ac.uk/efo/EFO_0000398	dermatomyositis	4
http://www.ebi.ac.uk/efo/EFO_0000400	diabetes mellitus	28
http://www.ebi.ac.uk/efo/EFO_0000401	diabetic nephropathy	40
http://www.ebi.ac.uk/efo/EFO_0000403	diffuse large B-cell lymphoma	10
http://www.ebi.ac.uk/efo/EFO_0000404	diffuse scleroderma	3
http://www.ebi.ac.uk/efo/EFO_0000405	digestive system disease	13
http://www.ebi.ac.uk/efo/EFO_0000407	dilated cardiomyopathy	9
http://www.ebi.ac.uk/efo/EFO_0000408	disease	930
http://www.ebi.ac.uk/efo/EFO_0000409	disease free survival	10
http://www.ebi.ac.uk/efo/EFO_0000464	emphysema	13
http://www.ebi.ac.uk/efo/EFO_0000465	endocarditis	2
http://www.ebi.ac.uk/efo/EFO_0000474	epilepsy	25
http://www.ebi.ac.uk/efo/EFO_0000478	esophageal adenocarcinoma	12
http://www.ebi.ac.uk/efo/EFO_0000482	event free survival time	8
http://www.ebi.ac.uk/efo/EFO_0000483	exercise	3
http://www.ebi.ac.uk/efo/EFO_0000493	family history	95
http://www.ebi.ac.uk/efo/EFO_0000501	follicular thyroid carcinoma	1
http://www.ebi.ac.uk/efo/EFO_0000503	gastric adenocarcinoma	1
http://www.ebi.ac.uk/efo/EFO_0000516	glaucoma	32
http://www.ebi.ac.uk/efo/EFO_0000519	glioblastoma multiforme	4
http://www.ebi.ac.uk/efo/EFO_0000537	hypertension	50
http://www.ebi.ac.uk/efo/EFO_0000538	hypertrophic cardiomyopathy	8
http://www.ebi.ac.uk/efo/EFO_0000540	immune system disease	3
http://www.ebi.ac.uk/efo/EFO_0000546	injury	282
http://www.ebi.ac.uk/efo/EFO_0000553	invasive lobular carcinoma	1
http://www.ebi.ac.uk/efo/EFO_0000555	irritable bowel syndrome	20
http://www.ebi.ac.uk/efo/EFO_0000557	juvenile dermatomyositis	1
http://www.ebi.ac.uk/efo/EFO_0000571	lung adenocarcinoma	20
http://www.ebi.ac.uk/efo/EFO_0000574	lymphoma	10
http://www.ebi.ac.uk/efo/EFO_0000584	infectious meningitis	4
http://www.ebi.ac.uk/efo/EFO_0000588	mesothelioma	1
http://www.ebi.ac.uk/efo/EFO_0000589	metabolic disease	4
http://www.ebi.ac.uk/efo/EFO_0000612	myocardial infarction	37
http://www.ebi.ac.uk/efo/EFO_0000614	narcolepsy with cataplexy	10
http://www.ebi.ac.uk/efo/EFO_0000616	neoplasm	18
http://www.ebi.ac.uk/efo/EFO_0000618	nervous system disease	8
http://www.ebi.ac.uk/efo/EFO_0000621	neuroblastoma	11
http://www.ebi.ac.uk/efo/EFO_0000625	nevus	4
http://www.ebi.ac.uk/efo/EFO_0000637	osteosarcoma	2
http://www.ebi.ac.uk/efo/EFO_0000638	overall survival	18
http://www.ebi.ac.uk/efo/EFO_0000641	papillary thyroid carcinoma	1
http://www.ebi.ac.uk/efo/EFO_0000649	periodontitis	30
http://www.ebi.ac.uk/efo/EFO_0000650	whooping cough	4
http://www.ebi.ac.uk/efo/EFO_0000660	polycystic ovary syndrome	15
http://www.ebi.ac.uk/efo/EFO_0000668	preeclampsia	14
http://www.ebi.ac.uk/efo/EFO_0000676	psoriasis	41
http://www.ebi.ac.uk/efo/EFO_0000677	mental or behavioural disorder	33
http://www.ebi.ac.uk/efo/EFO_0000681	renal cell carcinoma	10
http://www.ebi.ac.uk/efo/EFO_0000684	respiratory system disease	15
http://www.ebi.ac.uk/efo/EFO_0000685	rheumatoid arthritis	79
http://www.ebi.ac.uk/efo/EFO_0000689	sampling time	14
http://www.ebi.ac.uk/efo/EFO_0000692	schizophrenia	134
http://www.ebi.ac.uk/efo/EFO_0000699	Sjogren syndrome	11
http://www.ebi.ac.uk/efo/EFO_0000701	skin disease	30
http://www.ebi.ac.uk/efo/EFO_0000702	small cell lung carcinoma	2
http://www.ebi.ac.uk/efo/EFO_0000707	squamous cell carcinoma	10
http://www.ebi.ac.uk/efo/EFO_0000708	squamous cell lung carcinoma	8
http://www.ebi.ac.uk/efo/EFO_0000712	stroke	45
http://www.ebi.ac.uk/efo/EFO_0000713	subarachnoid hemorrhage	6
http://www.ebi.ac.uk/efo/EFO_0000714	survival time	52
http://www.ebi.ac.uk/efo/EFO_0000717	systemic scleroderma	16
http://www.ebi.ac.uk/efo/EFO_0000720	test result	26
http://www.ebi.ac.uk/efo/EFO_0000729	ulcerative colitis	50
http://www.ebi.ac.uk/efo/EFO_0000731	uterine fibroid	17
http://www.ebi.ac.uk/efo/EFO_0000734	vitamin B12 deficiency	4
http://www.ebi.ac.uk/efo/EFO_0000756	melanoma	29
http://www.ebi.ac.uk/efo/EFO_0000763	viral disease	13
http://www.ebi.ac.uk/efo/EFO_0000764	HIV infection	1
http://www.ebi.ac.uk/efo/EFO_0000765	AIDS	3
http://www.ebi.ac.uk/efo/EFO_0000768	idiopathic pulmonary fibrosis	5
http://www.ebi.ac.uk/efo/EFO_0000769	Epstein-Barr virus infection	2
http://www.ebi.ac.uk/efo/EFO_0000770	malignant pleural mesothelioma	1
http://www.ebi.ac.uk/efo/EFO_0000771	bacterial disease	23
http://www.ebi.ac.uk/efo/EFO_0000783	myositis	4
http://www.ebi.ac.uk/efo/EFO_0001054	leprosy	5
http://www.ebi.ac.uk/efo/EFO_0001059	cataract	32
http://www.ebi.ac.uk/efo/EFO_0001060	celiac disease	27
http://www.ebi.ac.uk/efo/EFO_0001061	cervical carcinoma	23
http://www.ebi.ac.uk/efo/EFO_0001062	cytomegalovirus infection	1
http://www.ebi.ac.uk/efo/EFO_0001065	endometriosis	30
http://www.ebi.ac.uk/efo/EFO_0001067	parasitic infection	2
http://www.ebi.ac.uk/efo/EFO_0001068	malaria	11
http://www.ebi.ac.uk/efo/EFO_0001071	lung carcinoma	53
http://www.ebi.ac.uk/efo/EFO_0001072	memory impairment	2
http://www.ebi.ac.uk/efo/EFO_0001073	obesity	37
http://www.ebi.ac.uk/efo/EFO_0001075	ovarian carcinoma	33
http://www.ebi.ac.uk/efo/EFO_0001124	GM11992	1
http://www.ebi.ac.uk/efo/EFO_0001357	sporadic amyotrophic lateral sclerosis	6
http://www.ebi.ac.uk/efo/EFO_0001358	post-traumatic stress disorder	16
http://www.ebi.ac.uk/efo/EFO_0001359	type I diabetes mellitus	46
http://www.ebi.ac.uk/efo/EFO_0001360	type II diabetes mellitus	182
http://www.ebi.ac.uk/efo/EFO_0001361	pulmonary arterial hypertension	3
http://www.ebi.ac.uk/efo/EFO_0001365	age-related macular degeneration	30
http://www.ebi.ac.uk/efo/EFO_0001378	multiple myeloma	23
http://www.ebi.ac.uk/efo/EFO_0001379	endocrine system disease	1
http://www.ebi.ac.uk/efo/EFO_0001382	puberty	1
http://www.ebi.ac.uk/efo/EFO_0001421	liver disease	19
http://www.ebi.ac.uk/efo/EFO_0001422	cirrhosis of liver	18
http://www.ebi.ac.uk/efo/EFO_0001425	ischemic cardiomyopathy	1
http://www.ebi.ac.uk/efo/EFO_0001645	coronary artery disease	91
http://www.ebi.ac.uk/efo/EFO_0001663	prostate carcinoma	77
http://www.ebi.ac.uk/efo/EFO_0001666	aortic aneurysm	4
http://www.ebi.ac.uk/efo/EFO_0001668	human papilloma virus infection	3
http://www.ebi.ac.uk/efo/EFO_0002422	benign neoplasm	52
http://www.ebi.ac.uk/efo/EFO_0002427	myeloid neoplasm	2
http://www.ebi.ac.uk/efo/EFO_0002496	actinic keratosis	2
http://www.ebi.ac.uk/efo/EFO_0002503	cardiac hypertrophy	3
http://www.ebi.ac.uk/efo/EFO_0002506	osteoarthritis	50
http://www.ebi.ac.uk/efo/EFO_0002508	Parkinson's disease	63
http://www.ebi.ac.uk/efo/EFO_0002517	pancreatic ductal adenocarcinoma	1
http://www.ebi.ac.uk/efo/EFO_0002546	abnormal glucose tolerance	2
http://www.ebi.ac.uk/efo/EFO_0002571	medical procedure	104
http://www.ebi.ac.uk/efo/EFO_0002608	AIDS dementia	1
http://www.ebi.ac.uk/efo/EFO_0002609	juvenile idiopathic arthritis	12
http://www.ebi.ac.uk/efo/EFO_0002610	cocaine dependence	5
http://www.ebi.ac.uk/efo/EFO_0002614	insulin resistance	16
http://www.ebi.ac.uk/efo/EFO_0002618	pancreatic carcinoma	31
http://www.ebi.ac.uk/efo/EFO_0002628	peripartum cardiomyopathy	1
http://www.ebi.ac.uk/efo/EFO_0002686	atopy	6
http://www.ebi.ac.uk/efo/EFO_0002689	antiphospholipid syndrome	1
http://www.ebi.ac.uk/efo/EFO_0002690	systemic lupus erythematosus	53
http://www.ebi.ac.uk/efo/EFO_0002751	benign	2
http://www.ebi.ac.uk/efo/EFO_0002892	thyroid carcinoma	12
http://www.ebi.ac.uk/efo/EFO_0002916	esophageal carcinoma	13
http://www.ebi.ac.uk/efo/EFO_0002919	uterine carcinoma	2
http://www.ebi.ac.uk/efo/EFO_0002950	pregnancy	2
http://www.ebi.ac.uk/efo/EFO_0002970	muscular disease	4
http://www.ebi.ac.uk/efo/EFO_0003014	breast fibrocystic disease	2
http://www.ebi.ac.uk/efo/EFO_0003015	aggressive behavior	6
http://www.ebi.ac.uk/efo/EFO_0003033	bacteriemia	2
http://www.ebi.ac.uk/efo/EFO_0003035	cellulitis	10
http://www.ebi.ac.uk/efo/EFO_0003047	hepatitis C virus infection	6
http://www.ebi.ac.uk/efo/EFO_0003060	non-small cell lung carcinoma	13
http://www.ebi.ac.uk/efo/EFO_0003063	polymyositis	4
http://www.ebi.ac.uk/efo/EFO_0003086	kidney disease	7
http://www.ebi.ac.uk/efo/EFO_0003095	non-alcoholic fatty liver disease	20
http://www.ebi.ac.uk/efo/EFO_0003096	Pick disease	1
http://www.ebi.ac.uk/efo/EFO_0003100	peripheral neuropathy	16
http://www.ebi.ac.uk/efo/EFO_0003102	osteomyelitis	6
http://www.ebi.ac.uk/efo/EFO_0003103	urinary tract infection	8
http://www.ebi.ac.uk/efo/EFO_0003106	pneumonia	27
http://www.ebi.ac.uk/efo/EFO_0003108	essential tremor	3
http://www.ebi.ac.uk/efo/EFO_0003144	heart failure	16
http://www.ebi.ac.uk/efo/EFO_0003756	autism spectrum disorder	33
http://www.ebi.ac.uk/efo/EFO_0003757	Asperger syndrome	2
http://www.ebi.ac.uk/efo/EFO_0003758	autism	10
http://www.ebi.ac.uk/efo/EFO_0003761	unipolar depression	163
http://www.ebi.ac.uk/efo/EFO_0003762	vitamin D deficiency	6
http://www.ebi.ac.uk/efo/EFO_0003763	cerebrovascular disorder	13
http://www.ebi.ac.uk/efo/EFO_0003764	transient ischemic attack	8
http://www.ebi.ac.uk/efo/EFO_0003765	sign or symptom	6
http://www.ebi.ac.uk/efo/EFO_0003767	inflammatory bowel disease	27
http://www.ebi.ac.uk/efo/EFO_0003768	nicotine dependence	24
http://www.ebi.ac.uk/efo/EFO_0003770	diabetic retinopathy	13
http://www.ebi.ac.uk/efo/EFO_0003774	hyperlipidemia	3
http://www.ebi.ac.uk/efo/EFO_0003777	heart disease	7
http://www.ebi.ac.uk/efo/EFO_0003778	psoriatic arthritis	11
http://www.ebi.ac.uk/efo/EFO_0003779	Hashimoto's thyroiditis	6
http://www.ebi.ac.uk/efo/EFO_0003780	Behcet's syndrome	14
http://www.ebi.ac.uk/efo/EFO_0003781	carotid artery disease	1
http://www.ebi.ac.uk/efo/EFO_0003784	skin pigmentation	19
http://www.ebi.ac.uk/efo/EFO_0003785	allergy	37
http://www.ebi.ac.uk/efo/EFO_0003818	lung disease	4
http://www.ebi.ac.uk/efo/EFO_0003819	dental caries	17
http://www.ebi.ac.uk/efo/EFO_0003821	migraine disorder	32
http://www.ebi.ac.uk/efo/EFO_0003827	pulmonary embolism	11
http://www.ebi.ac.uk/efo/EFO_0003829	alcohol dependence	43
http://www.ebi.ac.uk/efo/EFO_0003830	prostatitis	2
http://www.ebi.ac.uk/efo/EFO_0003832	gallbladder disease	7
http://www.ebi.ac.uk/efo/EFO_0003833	brain neoplasm	8
http://www.ebi.ac.uk/efo/EFO_0003834	cutaneous lupus erythematosus	1
http://www.ebi.ac.uk/efo/EFO_0003839	retinopathy	13
http://www.ebi.ac.uk/efo/EFO_0003843	pain	29
http://www.ebi.ac.uk/efo/EFO_0003863	urogenital neoplasm	4
http://www.ebi.ac.uk/efo/EFO_0003865	kidney neoplasm	6
http://www.ebi.ac.uk/efo/EFO_0003867	rhabdomyolysis	1
http://www.ebi.ac.uk/efo/EFO_0003868	mouth neoplasm	1
http://www.ebi.ac.uk/efo/EFO_0003869	breast neoplasm	24
http://www.ebi.ac.uk/efo/EFO_0003870	brain aneurysm	19
http://www.ebi.ac.uk/efo/EFO_0003875	peripheral vascular disease	8
http://www.ebi.ac.uk/efo/EFO_0003877	sleep apnea	6
http://www.ebi.ac.uk/efo/EFO_0003881	hysterectomy	2
http://www.ebi.ac.uk/efo/EFO_0003882	osteoporosis	24
http://www.ebi.ac.uk/efo/EFO_0003884	chronic kidney disease	63
http://www.ebi.ac.uk/efo/EFO_0003885	multiple sclerosis	56
http://www.ebi.ac.uk/efo/EFO_0003888	attention deficit hyperactivity disorder	67
http://www.ebi.ac.uk/efo/EFO_0003889	functional laterality	7
http://www.ebi.ac.uk/efo/EFO_0003890	drug dependence	13
http://www.ebi.ac.uk/efo/EFO_0003892	pulmonary function measurement	36
http://www.ebi.ac.uk/efo/EFO_0003893	ovarian neoplasm	4
http://www.ebi.ac.uk/efo/EFO_0003894	acne	7
http://www.ebi.ac.uk/efo/EFO_0003895	epistaxis	2
http://www.ebi.ac.uk/efo/EFO_0003896	left ventricular hypertrophy	1
http://www.ebi.ac.uk/efo/EFO_0003897	stomach neoplasm	2
http://www.ebi.ac.uk/efo/EFO_0003898	ankylosing spondylitis	25
http://www.ebi.ac.uk/efo/EFO_0003901	dysuria	2
http://www.ebi.ac.uk/efo/EFO_0003902	spinal fracture	8
http://www.ebi.ac.uk/efo/EFO_0003907	deep vein thrombosis	10
http://www.ebi.ac.uk/efo/EFO_0003912	ankle brachial index	10
http://www.ebi.ac.uk/efo/EFO_0003913	angina pectoris	21
http://www.ebi.ac.uk/efo/EFO_0003914	atherosclerosis	8
http://www.ebi.ac.uk/efo/EFO_0003917	premature birth	4
http://www.ebi.ac.uk/efo/EFO_0003918	obstructive sleep apnea	6
http://www.ebi.ac.uk/efo/EFO_0003919	risk factor	8
http://www.ebi.ac.uk/efo/EFO_0003922	menopause	2
http://www.ebi.ac.uk/efo/EFO_0003923	bone density	60
http://www.ebi.ac.uk/efo/EFO_0003924	hair color	18
http://www.ebi.ac.uk/efo/EFO_0003925	cognition	2
http://www.ebi.ac.uk/efo/EFO_0003926	neuropsychological test	4
http://www.ebi.ac.uk/efo/EFO_0003928	necrotizing enterocolitis	1
http://www.ebi.ac.uk/efo/EFO_0003931	bone fracture	73
http://www.ebi.ac.uk/efo/EFO_0003939	energy intake	9
http://www.ebi.ac.uk/efo/EFO_0003940	physical activity	19
http://www.ebi.ac.uk/efo/EFO_0003944	tibia fracture	8
http://www.ebi.ac.uk/efo/EFO_0003947	personality	1
http://www.ebi.ac.uk/efo/EFO_0003948	gastroesophageal reflux disease	20
http://www.ebi.ac.uk/efo/EFO_0003949	eye color	14
http://www.ebi.ac.uk/efo/EFO_0003956	seasonal allergic rhinitis	19
http://www.ebi.ac.uk/efo/EFO_0003958	sunburn	4
http://www.ebi.ac.uk/efo/EFO_0003959	cleft lip	35
http://www.ebi.ac.uk/efo/EFO_0003961	hormone replacement therapy	10
http://www.ebi.ac.uk/efo/EFO_0003963	freckles	5
http://www.ebi.ac.uk/efo/EFO_0003966	eye disease	26
http://www.ebi.ac.uk/efo/EFO_0004138	bundle branch block	2
http://www.ebi.ac.uk/efo/EFO_0004143	carpal tunnel syndrome	9
http://www.ebi.ac.uk/efo/EFO_0004145	myopathy	4
http://www.ebi.ac.uk/efo/EFO_0004149	neuropathy	5
http://www.ebi.ac.uk/efo/EFO_0004190	open-angle glaucoma	34
http://www.ebi.ac.uk/efo/EFO_0004191	androgenetic alopecia	6
http://www.ebi.ac.uk/efo/EFO_0004192	alopecia areata	4
http://www.ebi.ac.uk/efo/EFO_0004193	basal cell carcinoma	15
http://www.ebi.ac.uk/efo/EFO_0004194	IGA glomerulonephritis	8
http://www.ebi.ac.uk/efo/EFO_0004196	viral human hepatitis infection	4
http://www.ebi.ac.uk/efo/EFO_0004197	hepatitis B virus infection	9
http://www.ebi.ac.uk/efo/EFO_0004198	skin neoplasm	42
http://www.ebi.ac.uk/efo/EFO_0004207	pathological myopia	8
http://www.ebi.ac.uk/efo/EFO_0004208	Vitiligo	11
http://www.ebi.ac.uk/efo/EFO_0004209	hypospadias	2
http://www.ebi.ac.uk/efo/EFO_0004210	gallstones	10
http://www.ebi.ac.uk/efo/EFO_0004211	Hypertriglyceridemia	5
http://www.ebi.ac.uk/efo/EFO_0004212	Keloid	6
http://www.ebi.ac.uk/efo/EFO_0004213	otosclerosis	1
http://www.ebi.ac.uk/efo/EFO_0004214	Abdominal Aortic Aneurysm	11
http://www.ebi.ac.uk/efo/EFO_0004215	anorexia nervosa	20
http://www.ebi.ac.uk/efo/EFO_0004216	conduct disorder	6
http://www.ebi.ac.uk/efo/EFO_0004220	chronic hepatitis C virus infection	17
http://www.ebi.ac.uk/efo/EFO_0004224	Coronary Restenosis	1
http://www.ebi.ac.uk/efo/EFO_0004225	Coronary Vasospasm	1
http://www.ebi.ac.uk/efo/EFO_0004226	Creutzfeldt Jacob Disease	2
http://www.ebi.ac.uk/efo/EFO_0004227	Dengue Hemorrhagic Fever	1
http://www.ebi.ac.uk/efo/EFO_0004228	drug-induced liver injury	31
http://www.ebi.ac.uk/efo/EFO_0004229	Dupuytren Contracture	3
http://www.ebi.ac.uk/efo/EFO_0004230	endometrial neoplasm	6
http://www.ebi.ac.uk/efo/EFO_0004232	eosinophilic esophagitis	7
http://www.ebi.ac.uk/efo/EFO_0004233	leukopenia	10
http://www.ebi.ac.uk/efo/EFO_0004234	erectile dysfunction	9
http://www.ebi.ac.uk/efo/EFO_0004235	exfoliation syndrome	6
http://www.ebi.ac.uk/efo/EFO_0004236	focal segmental glomerulosclerosis	1
http://www.ebi.ac.uk/efo/EFO_0004237	Graves disease	13
http://www.ebi.ac.uk/efo/EFO_0004238	hearing loss	19
http://www.ebi.ac.uk/efo/EFO_0004239	chronic hepatitis B virus infection	11
http://www.ebi.ac.uk/efo/EFO_0004240	heroin dependence	3
http://www.ebi.ac.uk/efo/EFO_0004242	obsessive-compulsive disorder	21
http://www.ebi.ac.uk/efo/EFO_0004243	carcinoid tumor	1
http://www.ebi.ac.uk/efo/EFO_0004244	interstitial lung disease	15
http://www.ebi.ac.uk/efo/EFO_0004246	mucocutaneous lymph node syndrome	11
http://www.ebi.ac.uk/efo/EFO_0004247	mood disorder	16
http://www.ebi.ac.uk/efo/EFO_0004248	male infertility	1
http://www.ebi.ac.uk/efo/EFO_0004249	meningococcal infection	1
http://www.ebi.ac.uk/efo/EFO_0004251	myeloproliferative disorder	3
http://www.ebi.ac.uk/efo/EFO_0004252	nasopharyngeal neoplasm	8
http://www.ebi.ac.uk/efo/EFO_0004253	nephrolithiasis	7
http://www.ebi.ac.uk/efo/EFO_0004254	membranous glomerulonephritis	5
http://www.ebi.ac.uk/efo/EFO_0004255	nephrotic syndrome	13
http://www.ebi.ac.uk/efo/EFO_0004256	neuromyelitis optica	3
http://www.ebi.ac.uk/efo/EFO_0004257	neurotic disorder	7
http://www.ebi.ac.uk/efo/EFO_0004259	osteonecrosis	10
http://www.ebi.ac.uk/efo/EFO_0004260	bone disease	9
http://www.ebi.ac.uk/efo/EFO_0004261	osteitis deformans	2
http://www.ebi.ac.uk/efo/EFO_0004262	panic disorder	13
http://www.ebi.ac.uk/efo/EFO_0004263	partial epilepsy	5
http://www.ebi.ac.uk/efo/EFO_0004264	vascular disease	9
http://www.ebi.ac.uk/efo/EFO_0004265	peripheral arterial disease	13
http://www.ebi.ac.uk/efo/EFO_0004266	primary ovarian insufficiency	5
http://www.ebi.ac.uk/efo/EFO_0004267	biliary liver cirrhosis	4
http://www.ebi.ac.uk/efo/EFO_0004268	sclerosing cholangitis	12
http://www.ebi.ac.uk/efo/EFO_0004269	cardiac arrhythmia	23
http://www.ebi.ac.uk/efo/EFO_0004270	restless legs syndrome	10
http://www.ebi.ac.uk/efo/EFO_0004272	anemia (phenotype)	20
http://www.ebi.ac.uk/efo/EFO_0004273	scoliosis	8
http://www.ebi.ac.uk/efo/EFO_0004274	gout	33
http://www.ebi.ac.uk/efo/EFO_0004276	Stevens-Johnson syndrome	10
http://www.ebi.ac.uk/efo/EFO_0004277	brain infarction	5
http://www.ebi.ac.uk/efo/EFO_0004278	sudden cardiac arrest	7
http://www.ebi.ac.uk/efo/EFO_0004279	suntan	5
http://www.ebi.ac.uk/efo/EFO_0004280	movement disorder	4
http://www.ebi.ac.uk/efo/EFO_0004282	thoracic aortic aneurysm	5
http://www.ebi.ac.uk/efo/EFO_0004283	goiter	2
http://www.ebi.ac.uk/efo/EFO_0004284	upper aerodigestive tract neoplasm	2
http://www.ebi.ac.uk/efo/EFO_0004285	albuminuria	9
http://www.ebi.ac.uk/efo/EFO_0004286	venous thromboembolism	30
http://www.ebi.ac.uk/efo/EFO_0004287	ventricular fibrillation	1
http://www.ebi.ac.uk/efo/EFO_0004288	colonic neoplasm	6
http://www.ebi.ac.uk/efo/EFO_0004289	lymphoid leukemia	5
http://www.ebi.ac.uk/efo/EFO_0004291	braces	1
http://www.ebi.ac.uk/efo/EFO_0004294	left atrial function	4
http://www.ebi.ac.uk/efo/EFO_0004295	left ventricular function	2
http://www.ebi.ac.uk/efo/EFO_0004296	thyroid function	3
http://www.ebi.ac.uk/efo/EFO_0004297	clinical laboratory measurement	1
http://www.ebi.ac.uk/efo/EFO_0004298	cardiovascular measurement	7
http://www.ebi.ac.uk/efo/EFO_0004300	longevity	24
http://www.ebi.ac.uk/efo/EFO_0004301	blood viscosity	1
http://www.ebi.ac.uk/efo/EFO_0004302	anthropometric measurement	17
http://www.ebi.ac.uk/efo/EFO_0004304	blood sedimentation	3
http://www.ebi.ac.uk/efo/EFO_0004305	erythrocyte count	35
http://www.ebi.ac.uk/efo/EFO_0004306	erythrocyte indices	1
http://www.ebi.ac.uk/efo/EFO_0004307	glucose tolerance test	23
http://www.ebi.ac.uk/efo/EFO_0004308	leukocyte count	38
http://www.ebi.ac.uk/efo/EFO_0004309	platelet count	42
http://www.ebi.ac.uk/efo/EFO_0004310	partial thromboplastin time	4
http://www.ebi.ac.uk/efo/EFO_0004311	heart function measurement	9
http://www.ebi.ac.uk/efo/EFO_0004312	vital capacity	32
http://www.ebi.ac.uk/efo/EFO_0004313	maximal midexpiratory flow rate	2
http://www.ebi.ac.uk/efo/EFO_0004314	forced expiratory volume	51
http://www.ebi.ac.uk/efo/EFO_0004315	drinking behavior	3
http://www.ebi.ac.uk/efo/EFO_0004317	extraversion	2
http://www.ebi.ac.uk/efo/EFO_0004318	smoking behavior	26
http://www.ebi.ac.uk/efo/EFO_0004319	smoking cessation	12
http://www.ebi.ac.uk/efo/EFO_0004320	suicidal ideation	4
http://www.ebi.ac.uk/efo/EFO_0004321	attempted suicide	21
http://www.ebi.ac.uk/efo/EFO_0004323	mental process	1
http://www.ebi.ac.uk/efo/EFO_0004324	body weights and measures	14
http://www.ebi.ac.uk/efo/EFO_0004325	blood pressure	29
http://www.ebi.ac.uk/efo/EFO_0004326	heart rate	22
http://www.ebi.ac.uk/efo/EFO_0004327	electrocardiography	10
http://www.ebi.ac.uk/efo/EFO_0004328	exercise test	25
http://www.ebi.ac.uk/efo/EFO_0004329	alcohol drinking	30
http://www.ebi.ac.uk/efo/EFO_0004330	coffee consumption	8
http://www.ebi.ac.uk/efo/EFO_0004333	episodic memory	21
http://www.ebi.ac.uk/efo/EFO_0004335	short-term memory	6
http://www.ebi.ac.uk/efo/EFO_0004336	speech perception	1
http://www.ebi.ac.uk/efo/EFO_0004337	intelligence	31
http://www.ebi.ac.uk/efo/EFO_0004338	body weight	40
http://www.ebi.ac.uk/efo/EFO_0004339	body height	73
http://www.ebi.ac.uk/efo/EFO_0004340	body mass index	199
http://www.ebi.ac.uk/efo/EFO_0004341	body fat distribution	21
http://www.ebi.ac.uk/efo/EFO_0004342	waist circumference	34
http://www.ebi.ac.uk/efo/EFO_0004343	waist-hip ratio	45
http://www.ebi.ac.uk/efo/EFO_0004344	birth weight	31
http://www.ebi.ac.uk/efo/EFO_0004345	corneal topography	12
http://www.ebi.ac.uk/efo/EFO_0004346	neuroimaging measurement	3954
http://www.ebi.ac.uk/efo/EFO_0004348	hematocrit	39
http://www.ebi.ac.uk/efo/EFO_0004350	reasoning	4
http://www.ebi.ac.uk/efo/EFO_0004351	resting heart rate	9
http://www.ebi.ac.uk/efo/EFO_0004352	mortality	15
http://www.ebi.ac.uk/efo/EFO_0004354	circadian rhythm	11
http://www.ebi.ac.uk/efo/EFO_0004357	electroencephalogram measurement	15
http://www.ebi.ac.uk/efo/EFO_0004358	event-related brain oscillation	1
http://www.ebi.ac.uk/efo/EFO_0004362	psychomotor performance	1
http://www.ebi.ac.uk/efo/EFO_0004363	information processing speed	14
http://www.ebi.ac.uk/efo/EFO_0004365	personality trait	8
http://www.ebi.ac.uk/efo/EFO_0004458	C-reactive protein measurement	60
http://www.ebi.ac.uk/efo/EFO_0004459	ferritin measurement	10
http://www.ebi.ac.uk/efo/EFO_0004461	iron biomarker measurement	14
http://www.ebi.ac.uk/efo/EFO_0004462	PR interval	16
http://www.ebi.ac.uk/efo/EFO_0004463	angiotensin converting enzyme activity measurement	1
http://www.ebi.ac.uk/efo/EFO_0004464	brain measurement	300
http://www.ebi.ac.uk/efo/EFO_0004465	fasting blood glucose measurement	63
http://www.ebi.ac.uk/efo/EFO_0004466	fasting blood insulin measurement	39
http://www.ebi.ac.uk/efo/EFO_0004467	insulin measurement	27
http://www.ebi.ac.uk/efo/EFO_0004468	glucose measurement	29
http://www.ebi.ac.uk/efo/EFO_0004469	HOMA-B	6
http://www.ebi.ac.uk/efo/EFO_0004471	insulin sensitivity measurement	11
http://www.ebi.ac.uk/efo/EFO_0004501	HOMA-IR	8
http://www.ebi.ac.uk/efo/EFO_0004502	adiponectin measurement	23
http://www.ebi.ac.uk/efo/EFO_0004503	hematological measurement	6
http://www.ebi.ac.uk/efo/EFO_0004504	serum hepcidin measurement	2
http://www.ebi.ac.uk/efo/EFO_0004505	telomere length	17
http://www.ebi.ac.uk/efo/EFO_0004506	monocyte early outgrowth colony forming unit	1
http://www.ebi.ac.uk/efo/EFO_0004507	D dimer measurement	2
http://www.ebi.ac.uk/efo/EFO_0004508	spine bone size	3
http://www.ebi.ac.uk/efo/EFO_0004509	hemoglobin measurement	49
http://www.ebi.ac.uk/efo/EFO_0004510	HPV seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0004511	femoral neck bone geometry	6
http://www.ebi.ac.uk/efo/EFO_0004512	bone measurement	26
http://www.ebi.ac.uk/efo/EFO_0004514	bone quantitative ultrasound measurement	15
http://www.ebi.ac.uk/efo/EFO_0004515	muscle measurement	2
http://www.ebi.ac.uk/efo/EFO_0004516	bone fracture related measurement	1
http://www.ebi.ac.uk/efo/EFO_0004517	arterial stiffness measurement	9
http://www.ebi.ac.uk/efo/EFO_0004518	creatinine measurement	41
http://www.ebi.ac.uk/efo/EFO_0004520	ICAM-1 measurement	5
http://www.ebi.ac.uk/efo/EFO_0004522	adhesion molecule measurement	1
http://www.ebi.ac.uk/efo/EFO_0004526	mean corpuscular volume	45
http://www.ebi.ac.uk/efo/EFO_0004527	mean corpuscular hemoglobin	35
http://www.ebi.ac.uk/efo/EFO_0004528	mean corpuscular hemoglobin concentration	50
http://www.ebi.ac.uk/efo/EFO_0004529	lipid measurement	13
http://www.ebi.ac.uk/efo/EFO_0004530	triglyceride measurement	213
http://www.ebi.ac.uk/efo/EFO_0004531	urate measurement	35
http://www.ebi.ac.uk/efo/EFO_0004532	serum gamma-glutamyl transferase measurement	26
http://www.ebi.ac.uk/efo/EFO_0004533	alkaline phosphatase measurement	23
http://www.ebi.ac.uk/efo/EFO_0004534	creatine kinase measurement	7
http://www.ebi.ac.uk/efo/EFO_0004535	serum albumin measurement	18
http://www.ebi.ac.uk/efo/EFO_0004536	total blood protein measurement	11
http://www.ebi.ac.uk/efo/EFO_0004537	neonatal systemic lupus erythematosus	1
http://www.ebi.ac.uk/efo/EFO_0004540	chronic fatigue syndrome	8
http://www.ebi.ac.uk/efo/EFO_0004541	HbA1c measurement	40
http://www.ebi.ac.uk/efo/EFO_0004542	planned process	196
http://www.ebi.ac.uk/efo/EFO_0004550	amygdala reactivity measurement	2
http://www.ebi.ac.uk/efo/EFO_0004555	glycoprotein measurement	2
http://www.ebi.ac.uk/efo/EFO_0004556	antibody measurement	2
http://www.ebi.ac.uk/efo/EFO_0004562	cryptorchidism	1
http://www.ebi.ac.uk/efo/EFO_0004565	serum IgG measurement	6
http://www.ebi.ac.uk/efo/EFO_0004566	body weight gain	5
http://www.ebi.ac.uk/efo/EFO_0004567	antipsychotic drug related weight gain	6
http://www.ebi.ac.uk/efo/EFO_0004568	serum non-albumin protein measurement	3
http://www.ebi.ac.uk/efo/EFO_0004569	brain serotonin transporter measurement	2
http://www.ebi.ac.uk/efo/EFO_0004570	bilirubin measurement	43
http://www.ebi.ac.uk/efo/EFO_0004571	butyrylcholinesterase measurement	2
http://www.ebi.ac.uk/efo/EFO_0004572	C4BP measurement	1
http://www.ebi.ac.uk/efo/EFO_0004573	chemerin measurement	4
http://www.ebi.ac.uk/efo/EFO_0004574	total cholesterol measurement	79
http://www.ebi.ac.uk/efo/EFO_0004575	e-selectin measurement	5
http://www.ebi.ac.uk/efo/EFO_0004576	fetal hemoglobin measurement	6
http://www.ebi.ac.uk/efo/EFO_0004577	infant head circumference	3
http://www.ebi.ac.uk/efo/EFO_0004578	homocysteine measurement	11
http://www.ebi.ac.uk/efo/EFO_0004579	serum IgE measurement	10
http://www.ebi.ac.uk/efo/EFO_0004581	interleukin 18 measurement	6
http://www.ebi.ac.uk/efo/EFO_0004582	liver enzyme measurement	1
http://www.ebi.ac.uk/efo/EFO_0004584	mean platelet volume	28
http://www.ebi.ac.uk/efo/EFO_0004585	naphthyl-keratin adduct measurement	1
http://www.ebi.ac.uk/efo/EFO_0004587	lymphocyte count	35
http://www.ebi.ac.uk/efo/EFO_0004589	brachial circumference	1
http://www.ebi.ac.uk/efo/EFO_0004591	childhood onset asthma	25
http://www.ebi.ac.uk/efo/EFO_0004593	gestational diabetes	4
http://www.ebi.ac.uk/efo/EFO_0004595	HIV mother to child transmission	1
http://www.ebi.ac.uk/efo/EFO_0004596	diabetes mellitus type 2 associated cataract	1
http://www.ebi.ac.uk/efo/EFO_0004599	acute graft vs. host disease	4
http://www.ebi.ac.uk/efo/EFO_0004606	gallbladder neoplasm	3
http://www.ebi.ac.uk/efo/EFO_0004607	duodenal ulcer	9
http://www.ebi.ac.uk/efo/EFO_0004608	cystic fibrosis associated meconium ileus	2
http://www.ebi.ac.uk/efo/EFO_0004609	treatment refractory schizophrenia	2
http://www.ebi.ac.uk/efo/EFO_0004610	acute lung injury	1
http://www.ebi.ac.uk/efo/EFO_0004611	low density lipoprotein cholesterol measurement	140
http://www.ebi.ac.uk/efo/EFO_0004612	high density lipoprotein cholesterol measurement	166
http://www.ebi.ac.uk/efo/EFO_0004614	apolipoprotein A 1 measurement	14
http://www.ebi.ac.uk/efo/EFO_0004615	apolipoprotein B measurement	12
http://www.ebi.ac.uk/efo/EFO_0004616	osteoarthritis, knee	34
http://www.ebi.ac.uk/efo/EFO_0004617	cystatin C measurement	12
http://www.ebi.ac.uk/efo/EFO_0004618	vitamin K measurement	2
http://www.ebi.ac.uk/efo/EFO_0004619	factor VII measurement	4
http://www.ebi.ac.uk/efo/EFO_0004620	vitamin B12 measurement	7
http://www.ebi.ac.uk/efo/EFO_0004621	vitamin B6 measurement	15
http://www.ebi.ac.uk/efo/EFO_0004622	sphingolipid measurement	5
http://www.ebi.ac.uk/efo/EFO_0004623	fibrinogen measurement	16
http://www.ebi.ac.uk/efo/EFO_0004624	prostate specific antigen measurement	11
http://www.ebi.ac.uk/efo/EFO_0004625	progranulin measurement	3
http://www.ebi.ac.uk/efo/EFO_0004626	IGFBP-3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0004627	IGF-1 measurement	3
http://www.ebi.ac.uk/efo/EFO_0004628	insulin like growth factor measurement	5
http://www.ebi.ac.uk/efo/EFO_0004629	von Willebrand factor measurement	9
http://www.ebi.ac.uk/efo/EFO_0004630	factor VIII measurement	4
http://www.ebi.ac.uk/efo/EFO_0004631	vitamin D measurement	38
http://www.ebi.ac.uk/efo/EFO_0004632	nevus count	5
http://www.ebi.ac.uk/efo/EFO_0004633	protein C measurement	3
http://www.ebi.ac.uk/efo/EFO_0004634	coagulation factor measurement	13
http://www.ebi.ac.uk/efo/EFO_0004635	leptin receptor measurement	1
http://www.ebi.ac.uk/efo/EFO_0004639	phospholipid measurement	16
http://www.ebi.ac.uk/efo/EFO_0004640	haptoglobin measurement	5
http://www.ebi.ac.uk/efo/EFO_0004641	white matter integrity	7
http://www.ebi.ac.uk/efo/EFO_0004642	cortisol secretion measurement	2
http://www.ebi.ac.uk/efo/EFO_0004644	TPE interval measurement	4
http://www.ebi.ac.uk/efo/EFO_0004645	response to vaccine	30
http://www.ebi.ac.uk/efo/EFO_0004647	response to platinum based chemotherapy	18
http://www.ebi.ac.uk/efo/EFO_0004653	response to TNF antagonist	18
http://www.ebi.ac.uk/efo/EFO_0004670	beta-amyloid 1-42 measurement	12
http://www.ebi.ac.uk/efo/EFO_0004682	QT interval	23
http://www.ebi.ac.uk/efo/EFO_0004683	wet macular degeneration	7
http://www.ebi.ac.uk/efo/EFO_0004684	tumor necrosis factor-alpha measurement	6
http://www.ebi.ac.uk/efo/EFO_0004685	hip geometry	2
http://www.ebi.ac.uk/efo/EFO_0004694	factor XI measurement	2
http://www.ebi.ac.uk/efo/EFO_0004695	intraocular pressure measurement	27
http://www.ebi.ac.uk/efo/EFO_0004696	sex hormone-binding globulin measurement	22
http://www.ebi.ac.uk/efo/EFO_0004697	estradiol measurement	15
http://www.ebi.ac.uk/efo/EFO_0004698	insomnia	20
http://www.ebi.ac.uk/efo/EFO_0004699	gambling behaviour	1
http://www.ebi.ac.uk/efo/EFO_0004701	methamphetamine dependence	2
http://www.ebi.ac.uk/efo/EFO_0004703	age at menarche	22
http://www.ebi.ac.uk/efo/EFO_0004704	age at menopause	19
http://www.ebi.ac.uk/efo/EFO_0004705	hypothyroidism	19
http://www.ebi.ac.uk/efo/EFO_0004707	infantile hypertrophic pyloric stenosis	3
http://www.ebi.ac.uk/efo/EFO_0004708	nodular sclerosis Hodgkin lymphoma	2
http://www.ebi.ac.uk/efo/EFO_0004710	pelvic organ prolapse	10
http://www.ebi.ac.uk/efo/EFO_0004712	podoconiosis	2
http://www.ebi.ac.uk/efo/EFO_0004713	FEV/FEC ratio	30
http://www.ebi.ac.uk/efo/EFO_0004714	sexual dysfunction	2
http://www.ebi.ac.uk/efo/EFO_0004715	MRI defined brain infarct	3
http://www.ebi.ac.uk/efo/EFO_0004718	vascular dementia	4
http://www.ebi.ac.uk/efo/EFO_0004719	pemphigus vulgaris	4
http://www.ebi.ac.uk/efo/EFO_0004720	prion disease	4
http://www.ebi.ac.uk/efo/EFO_0004723	coronary artery calcification	11
http://www.ebi.ac.uk/efo/EFO_0004724	carotid-femoral pulse wave velocity	1
http://www.ebi.ac.uk/efo/EFO_0004725	metabolite measurement	306
http://www.ebi.ac.uk/efo/EFO_0004728	serum amyloid A protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0004729	vitamin measurement	2
http://www.ebi.ac.uk/efo/EFO_0004730	hormone measurement	7
http://www.ebi.ac.uk/efo/EFO_0004731	eye measurement	164
http://www.ebi.ac.uk/efo/EFO_0004732	lipoprotein measurement	6
http://www.ebi.ac.uk/efo/EFO_0004733	anti-cyclic citrullinated peptide antibody measurement	2
http://www.ebi.ac.uk/efo/EFO_0004735	serum alanine aminotransferase measurement	41
http://www.ebi.ac.uk/efo/EFO_0004736	aspartate aminotransferase measurement	32
http://www.ebi.ac.uk/efo/EFO_0004737	carotenoid measurement	2
http://www.ebi.ac.uk/efo/EFO_0004738	tocopherol measurement	1
http://www.ebi.ac.uk/efo/EFO_0004739	circulating cell free DNA measurement	1
http://www.ebi.ac.uk/efo/EFO_0004741	blood urea nitrogen measurement	10
http://www.ebi.ac.uk/efo/EFO_0004742	renal system measurement	10
http://www.ebi.ac.uk/efo/EFO_0004743	facial morphology	3
http://www.ebi.ac.uk/efo/EFO_0004744	matrix metalloproteinase measurement	4
http://www.ebi.ac.uk/efo/EFO_0004745	NT-proBNP measurement	2
http://www.ebi.ac.uk/efo/EFO_0004746	lipoprotein-associated phospholipase A(2) measurement	6
http://www.ebi.ac.uk/efo/EFO_0004747	protein measurement	19
http://www.ebi.ac.uk/efo/EFO_0004748	thyroid stimulating hormone measurement	11
http://www.ebi.ac.uk/efo/EFO_0004749	CCL2 measurement	9
http://www.ebi.ac.uk/efo/EFO_0004750	interleukin 10 measurement	6
http://www.ebi.ac.uk/efo/EFO_0004751	CCL4 measurement	3
http://www.ebi.ac.uk/efo/EFO_0004752	parathyroid hormone measurement	3
http://www.ebi.ac.uk/efo/EFO_0004753	interleukin 12 measurement	4
http://www.ebi.ac.uk/efo/EFO_0004754	interleukin 1 receptor antagonist measurement	6
http://www.ebi.ac.uk/efo/EFO_0004760	t-tau measurement	14
http://www.ebi.ac.uk/efo/EFO_0004761	uric acid measurement	40
http://www.ebi.ac.uk/efo/EFO_0004762	vascular endothelial growth factor measurement	9
http://www.ebi.ac.uk/efo/EFO_0004763	p-tau measurement	10
http://www.ebi.ac.uk/efo/EFO_0004764	adipose tissue measurement	5
http://www.ebi.ac.uk/efo/EFO_0004765	visceral adipose tissue measurement	34
http://www.ebi.ac.uk/efo/EFO_0004766	subcutaneous adipose tissue measurement	16
http://www.ebi.ac.uk/efo/EFO_0004767	visceral:subcutaneous adipose tissue ratio	13
http://www.ebi.ac.uk/efo/EFO_0004768	follicle stimulating hormone measurement	5
http://www.ebi.ac.uk/efo/EFO_0004769	anti-Mullerian hormone measurement	1
http://www.ebi.ac.uk/efo/EFO_0004770	ovarian reserve	1
http://www.ebi.ac.uk/efo/EFO_0004771	visual cortical surface area measurement	2
http://www.ebi.ac.uk/efo/EFO_0004772	early onset hypertension	2
http://www.ebi.ac.uk/efo/EFO_0004775	toxic epidermal necrolysis	7
http://www.ebi.ac.uk/efo/EFO_0004776	alcohol and nicotine codependence	3
http://www.ebi.ac.uk/efo/EFO_0004777	alcohol withdrawal	3
http://www.ebi.ac.uk/efo/EFO_0004778	self rated health	5
http://www.ebi.ac.uk/efo/EFO_0004779	CHAOS measure	1
http://www.ebi.ac.uk/efo/EFO_0004782	behavior or behavioral disorder measurement	17
http://www.ebi.ac.uk/efo/EFO_0004783	TEMPS-A questionnaire	5
http://www.ebi.ac.uk/efo/EFO_0004784	self reported educational attainment	26
http://www.ebi.ac.uk/efo/EFO_0004785	South Texas Assessment of Neurocognition	1
http://www.ebi.ac.uk/efo/EFO_0004789	atrial natriuretic factor measurement	1
http://www.ebi.ac.uk/efo/EFO_0004790	CD40 ligand measurement	4
http://www.ebi.ac.uk/efo/EFO_0004791	tissue plasminogen activator measurement	3
http://www.ebi.ac.uk/efo/EFO_0004792	plasminogen activator inhibitor 1 measurement	7
http://www.ebi.ac.uk/efo/EFO_0004795	skin sensitivity to sun	3
http://www.ebi.ac.uk/efo/EFO_0004799	cholelithiasis	8
http://www.ebi.ac.uk/efo/EFO_0004800	frontal theta oscillation measurement	1
http://www.ebi.ac.uk/efo/EFO_0004802	family size	1
http://www.ebi.ac.uk/efo/EFO_0004803	male fertility	1
http://www.ebi.ac.uk/efo/EFO_0004804	birth rate	1
http://www.ebi.ac.uk/efo/EFO_0004805	formal thought disorder	1
http://www.ebi.ac.uk/efo/EFO_0004806	asbestos exposure measurement	2
http://www.ebi.ac.uk/efo/EFO_0004808	L lactate dehydrogenase measurement	4
http://www.ebi.ac.uk/efo/EFO_0004810	interleukin-6 measurement	23
http://www.ebi.ac.uk/efo/EFO_0004811	interleukin-8 measurement	4
http://www.ebi.ac.uk/efo/EFO_0004812	interleukin-1 beta measurement	4
http://www.ebi.ac.uk/efo/EFO_0004818	transforming growth factor beta measurement	2
http://www.ebi.ac.uk/efo/EFO_0004819	resistin measurement	5
http://www.ebi.ac.uk/efo/EFO_0004820	sex ratio	2
http://www.ebi.ac.uk/efo/EFO_0004825	temperament and character inventory	1
http://www.ebi.ac.uk/efo/EFO_0004826	anti-neutrophil antibody associated vasculitis	4
http://www.ebi.ac.uk/efo/EFO_0004827	economic and social preference	7
http://www.ebi.ac.uk/efo/EFO_0004828	genetic variation	2
http://www.ebi.ac.uk/efo/EFO_0004829	response to irinotecan	2
http://www.ebi.ac.uk/efo/EFO_0004830	caudate nucleus volume	5
http://www.ebi.ac.uk/efo/EFO_0004831	RR interval	3
http://www.ebi.ac.uk/efo/EFO_0004832	optic disc size measurement	9
http://www.ebi.ac.uk/efo/EFO_0004833	neutrophil count	31
http://www.ebi.ac.uk/efo/EFO_0004838	calcium measurement	20
http://www.ebi.ac.uk/efo/EFO_0004839	CD4:CD8 lymphocyte ratio	1
http://www.ebi.ac.uk/efo/EFO_0004840	cortical thickness	13
http://www.ebi.ac.uk/efo/EFO_0004841	digit length ratio	5
http://www.ebi.ac.uk/efo/EFO_0004842	eosinophil count	30
http://www.ebi.ac.uk/efo/EFO_0004843	vitamin B measurement	2
http://www.ebi.ac.uk/efo/EFO_0004844	hip bone size	5
http://www.ebi.ac.uk/efo/EFO_0004845	magnesium measurement	8
http://www.ebi.ac.uk/efo/EFO_0004846	serotonin measurement	1
http://www.ebi.ac.uk/efo/EFO_0004847	age at onset	72
http://www.ebi.ac.uk/efo/EFO_0004857	vitamin A measurement	1
http://www.ebi.ac.uk/efo/EFO_0004860	common carotid intimal medial thickness	5
http://www.ebi.ac.uk/efo/EFO_0004861	phosphorus measurement	2
http://www.ebi.ac.uk/efo/EFO_0004862	phytosterol measurement	1
http://www.ebi.ac.uk/efo/EFO_0004863	recombination rate	4
http://www.ebi.ac.uk/efo/EFO_0004864	renal sinus adipose tissue measurement	1
http://www.ebi.ac.uk/efo/EFO_0004865	thyroid volume	2
http://www.ebi.ac.uk/efo/EFO_0004866	autoantibody measurement	5
http://www.ebi.ac.uk/efo/EFO_0004867	vitamin E measurement	1
http://www.ebi.ac.uk/efo/EFO_0004868	volumetric brain MRI	2
http://www.ebi.ac.uk/efo/EFO_0004869	YKL40 measurement	2
http://www.ebi.ac.uk/efo/EFO_0004870	sleep measurement	12
http://www.ebi.ac.uk/efo/EFO_0004872	inflammatory biomarker measurement	4
http://www.ebi.ac.uk/efo/EFO_0004873	cytokine measurement	9
http://www.ebi.ac.uk/efo/EFO_0004874	memory performance	29
http://www.ebi.ac.uk/efo/EFO_0004875	mathematical ability	10
http://www.ebi.ac.uk/efo/EFO_0004880	urinary arsenic measurement	2
http://www.ebi.ac.uk/efo/EFO_0004881	asparaginase hypersensitivity	10
http://www.ebi.ac.uk/efo/EFO_0004884	breast size	3
http://www.ebi.ac.uk/efo/EFO_0004885	early cardiac repolarization measurement	2
http://www.ebi.ac.uk/efo/EFO_0004886	intracranial volume measurement	6
http://www.ebi.ac.uk/efo/EFO_0004887	maximal oxygen uptake measurement	5
http://www.ebi.ac.uk/efo/EFO_0004888	post operative nausea and vomiting	2
http://www.ebi.ac.uk/efo/EFO_0004889	postoperative ventricular dysfunction	1
http://www.ebi.ac.uk/efo/EFO_0004892	Sasang constitutional medicine	1
http://www.ebi.ac.uk/efo/EFO_0004893	testicular dysgenesis syndrome	1
http://www.ebi.ac.uk/efo/EFO_0004895	Tourette syndrome	12
http://www.ebi.ac.uk/efo/EFO_0004908	testosterone measurement	28
http://www.ebi.ac.uk/efo/EFO_0004909	dihydrotestosterone measurement	1
http://www.ebi.ac.uk/efo/EFO_0004910	CYP3A4 activity	1
http://www.ebi.ac.uk/efo/EFO_0004911	familial hypercholesterolemia	1
http://www.ebi.ac.uk/efo/EFO_0004912	serum IgA measurement	5
http://www.ebi.ac.uk/efo/EFO_0004913	lentiform nucleus measurement	3
http://www.ebi.ac.uk/efo/EFO_0004914	facial neural processing	1
http://www.ebi.ac.uk/efo/EFO_0004915	vaspin measurement	1
http://www.ebi.ac.uk/efo/EFO_0004918	age at diagnosis	18
http://www.ebi.ac.uk/efo/EFO_0004920	progression free survival	11
http://www.ebi.ac.uk/efo/EFO_0004952	disease recurrence	8
http://www.ebi.ac.uk/efo/EFO_0004953	date of diagnosis	1
http://www.ebi.ac.uk/efo/EFO_0004955	Breslow thickness	2
http://www.ebi.ac.uk/efo/EFO_0004979	comprehensive strength index	1
http://www.ebi.ac.uk/efo/EFO_0004980	appendicular lean mass	6
http://www.ebi.ac.uk/efo/EFO_0004983	complement C3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0004984	complement C4 measurement	2
http://www.ebi.ac.uk/efo/EFO_0004985	platelet reactivity measurement	8
http://www.ebi.ac.uk/efo/EFO_0004991	Myasthenia gravis	5
http://www.ebi.ac.uk/efo/EFO_0004992	Otitis media	5
http://www.ebi.ac.uk/efo/EFO_0004993	serum IgM measurement	4
http://www.ebi.ac.uk/efo/EFO_0004994	lumbar disc degeneration	9
http://www.ebi.ac.uk/efo/EFO_0004995	lean body mass	69
http://www.ebi.ac.uk/efo/EFO_0004997	type 2 diabetes nephropathy	4
http://www.ebi.ac.uk/efo/EFO_0004998	carbohydrate measurement	1
http://www.ebi.ac.uk/efo/EFO_0004999	N-glycan measurement	3
http://www.ebi.ac.uk/efo/EFO_0005000	leptin measurement	21
http://www.ebi.ac.uk/efo/EFO_0005001	phenylalanine measurement	3
http://www.ebi.ac.uk/efo/EFO_0005002	lysine measurement	4
http://www.ebi.ac.uk/efo/EFO_0005035	hippocampal volume	18
http://www.ebi.ac.uk/efo/EFO_0005036	platelet measurement	1
http://www.ebi.ac.uk/efo/EFO_0005037	aortic root size	3
http://www.ebi.ac.uk/efo/EFO_0005038	hair morphology	3
http://www.ebi.ac.uk/efo/EFO_0005039	hippocampal atrophy	4
http://www.ebi.ac.uk/efo/EFO_0005043	cardiac troponin T measurement	4
http://www.ebi.ac.uk/efo/EFO_0005045	visceral Leishmaniasis	2
http://www.ebi.ac.uk/efo/EFO_0005046	cutaneous Leishmaniasis	1
http://www.ebi.ac.uk/efo/EFO_0005047	erythrocyte measurement	2
http://www.ebi.ac.uk/efo/EFO_0005053	internal carotid intimal medial thickness	1
http://www.ebi.ac.uk/efo/EFO_0005054	QRS complex	5
http://www.ebi.ac.uk/efo/EFO_0005055	QRS duration	15
http://www.ebi.ac.uk/efo/EFO_0005056	age at death	2
http://www.ebi.ac.uk/efo/EFO_0005057	myoglobin measurement	1
http://www.ebi.ac.uk/efo/EFO_0005058	tyrosine measurement	6
http://www.ebi.ac.uk/efo/EFO_0005059	acylcarnitine measurement	2
http://www.ebi.ac.uk/efo/EFO_0005080	CC16 measurement	2
http://www.ebi.ac.uk/efo/EFO_0005081	surfactant protein D measurement	1
http://www.ebi.ac.uk/efo/EFO_0005088	testicular carcinoma	11
http://www.ebi.ac.uk/efo/EFO_0005089	whole-brain volume	2
http://www.ebi.ac.uk/efo/EFO_0005090	basophil count	23
http://www.ebi.ac.uk/efo/EFO_0005091	monocyte count	29
http://www.ebi.ac.uk/efo/EFO_0005092	entorhinal cortical volume	3
http://www.ebi.ac.uk/efo/EFO_0005093	hip circumference	12
http://www.ebi.ac.uk/efo/EFO_0005094	P wave duration	3
http://www.ebi.ac.uk/efo/EFO_0005095	PR segment	2
http://www.ebi.ac.uk/efo/EFO_0005105	lipid or lipoprotein measurement	1
http://www.ebi.ac.uk/efo/EFO_0005106	body composition measurement	1
http://www.ebi.ac.uk/efo/EFO_0005108	arm span	1
http://www.ebi.ac.uk/efo/EFO_0005109	energy expenditure	1
http://www.ebi.ac.uk/efo/EFO_0005110	fatty acid measurement	93
http://www.ebi.ac.uk/efo/EFO_0005111	folic acid measurement	3
http://www.ebi.ac.uk/efo/EFO_0005112	gestational age	12
http://www.ebi.ac.uk/efo/EFO_0005114	head circumference	1
http://www.ebi.ac.uk/efo/EFO_0005115	metabolic rate measurement	1
http://www.ebi.ac.uk/efo/EFO_0005116	urinary metabolite measurement	9
http://www.ebi.ac.uk/efo/EFO_0005117	CCL5 measurement	2
http://www.ebi.ac.uk/efo/EFO_0005118	IGFBP-1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0005119	antioxidant measurement	2
http://www.ebi.ac.uk/efo/EFO_0005126	arylesterase enzyme measurement	1
http://www.ebi.ac.uk/efo/EFO_0005127	cancer biomarker measurement	2
http://www.ebi.ac.uk/efo/EFO_0005128	albumin:globulin ratio measurement	2
http://www.ebi.ac.uk/efo/EFO_0005129	hepatitis C induced liver cirrhosis	1
http://www.ebi.ac.uk/efo/EFO_0005130	thyroxine measurement	7
http://www.ebi.ac.uk/efo/EFO_0005131	HVA measurement	4
http://www.ebi.ac.uk/efo/EFO_0005132	5-HIAA measurement	4
http://www.ebi.ac.uk/efo/EFO_0005133	MHPG measurement	3
http://www.ebi.ac.uk/efo/EFO_0005134	amino acid measurement	9
http://www.ebi.ac.uk/efo/EFO_0005137	conduction system disorder	2
http://www.ebi.ac.uk/efo/EFO_0005139	serum ceruloplasmin measurement	1
http://www.ebi.ac.uk/efo/EFO_0005140	autoimmune disease	8
http://www.ebi.ac.uk/efo/EFO_0005187	C-peptide measurement	7
http://www.ebi.ac.uk/efo/EFO_0005188	CCL11 measurement	2
http://www.ebi.ac.uk/efo/EFO_0005192	red blood cell distribution width	24
http://www.ebi.ac.uk/efo/EFO_0005193	serum IgG glycosylation measurement	6
http://www.ebi.ac.uk/efo/EFO_0005194	amyloid-beta measurement	12
http://www.ebi.ac.uk/efo/EFO_0005195	response to cholinesterase inhibitor	1
http://www.ebi.ac.uk/efo/EFO_0005196	vasoactive peptide measurement	1
http://www.ebi.ac.uk/efo/EFO_0005197	beta-2 microglobulin measurement	1
http://www.ebi.ac.uk/efo/EFO_0005199	renal transplant outcome measurement	15
http://www.ebi.ac.uk/efo/EFO_0005200	antiphospholipid antibody measurement	2
http://www.ebi.ac.uk/efo/EFO_0005201	height growth measurement	3
http://www.ebi.ac.uk/efo/EFO_0005202	response to hydrochlorothiazide	6
http://www.ebi.ac.uk/efo/EFO_0005203	eating disorder	5
http://www.ebi.ac.uk/efo/EFO_0005204	bulimia nervosa	1
http://www.ebi.ac.uk/efo/EFO_0005205	response to dabigatran etexilate	1
http://www.ebi.ac.uk/efo/EFO_0005206	oligoclonal band measurement	2
http://www.ebi.ac.uk/efo/EFO_0005207	congenital heart disease	4
http://www.ebi.ac.uk/efo/EFO_0005208	glomerular filtration rate	48
http://www.ebi.ac.uk/efo/EFO_0005210	brain connectivity measurement	5
http://www.ebi.ac.uk/efo/EFO_0005211	aspirin hydrolysis measurement	1
http://www.ebi.ac.uk/efo/EFO_0005213	central corneal thickness	10
http://www.ebi.ac.uk/efo/EFO_0005220	pulmonary neuroendocrine tumor	1
http://www.ebi.ac.uk/efo/EFO_0005221	cholangiocarcinoma	4
http://www.ebi.ac.uk/efo/EFO_0005229	reading	3
http://www.ebi.ac.uk/efo/EFO_0005230	anxiety	16
http://www.ebi.ac.uk/efo/EFO_0005239	aortic valve calcification	3
http://www.ebi.ac.uk/efo/EFO_0005240	rhegmatogenous retinal detachment	2
http://www.ebi.ac.uk/efo/EFO_0005241	employment status	1
http://www.ebi.ac.uk/efo/EFO_0005242	methamphetamine-induced psychosis	1
http://www.ebi.ac.uk/efo/EFO_0005243	myeloperoxidase measurement	3
http://www.ebi.ac.uk/efo/EFO_0005245	body weight loss	4
http://www.ebi.ac.uk/efo/EFO_0005246	hypersomnia	3
http://www.ebi.ac.uk/efo/EFO_0005247	anti-Helicobacter pylori serum IgG measurement	2
http://www.ebi.ac.uk/efo/EFO_0005250	occupation-related stress disorder	1
http://www.ebi.ac.uk/efo/EFO_0005251	hypotension	5
http://www.ebi.ac.uk/efo/EFO_0005252	orthostatic hypotension	3
http://www.ebi.ac.uk/efo/EFO_0005257	response to anthracycline-based chemotherapy	10
http://www.ebi.ac.uk/efo/EFO_0005260	response to antimicrotubule agent	5
http://www.ebi.ac.uk/efo/EFO_0005262	mitral annular calcification	1
http://www.ebi.ac.uk/efo/EFO_0005266	serum selenium measurement	2
http://www.ebi.ac.uk/efo/EFO_0005267	serum copper measurement	2
http://www.ebi.ac.uk/efo/EFO_0005268	serum zinc measurement	2
http://www.ebi.ac.uk/efo/EFO_0005269	congenital heart malformation	1
http://www.ebi.ac.uk/efo/EFO_0005271	sleep duration	36
http://www.ebi.ac.uk/efo/EFO_0005272	sleep quality	5
http://www.ebi.ac.uk/efo/EFO_0005273	sleep depth	1
http://www.ebi.ac.uk/efo/EFO_0005274	sleep time	1
http://www.ebi.ac.uk/efo/EFO_0005275	dihydroxy docosatrienoic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0005276	hydroxy-leucine measurement	1
http://www.ebi.ac.uk/efo/EFO_0005278	cardiovascular disease biomarker measurement	2
http://www.ebi.ac.uk/efo/EFO_0005279	temporomandibular joint disorder	3
http://www.ebi.ac.uk/efo/EFO_0005280	sleep latency	3
http://www.ebi.ac.uk/efo/EFO_0005295	migraine with aura	6
http://www.ebi.ac.uk/efo/EFO_0005296	migraine without aura	7
http://www.ebi.ac.uk/efo/EFO_0005297	Granulomatosis with Polyangiitis	2
http://www.ebi.ac.uk/efo/EFO_0005298	allergic sensitization measurement	2
http://www.ebi.ac.uk/efo/EFO_0005299	non-word reading	2
http://www.ebi.ac.uk/efo/EFO_0005300	word reading	2
http://www.ebi.ac.uk/efo/EFO_0005301	reading and spelling ability	13
http://www.ebi.ac.uk/efo/EFO_0005306	ventricular tachycardia	2
http://www.ebi.ac.uk/efo/EFO_0005307	torsades de pointes	1
http://www.ebi.ac.uk/efo/EFO_0005318	axial length measurement	5
http://www.ebi.ac.uk/efo/EFO_0005319	contact dermatitis	8
http://www.ebi.ac.uk/efo/EFO_0005320	contact dermatitis due to nickel	1
http://www.ebi.ac.uk/efo/EFO_0005321	molar-incisor hypomineralization	1
http://www.ebi.ac.uk/efo/EFO_0005322	callous-unemotional behaviour	1
http://www.ebi.ac.uk/efo/EFO_0005323	post-operative sign or symptom	1
http://www.ebi.ac.uk/efo/EFO_0005324	post-operative sensory disturbance	1
http://www.ebi.ac.uk/efo/EFO_0005325	response to angiotensin-converting enzyme inhibitor	9
http://www.ebi.ac.uk/efo/EFO_0005400	chemotherapy-induced alopecia	7
http://www.ebi.ac.uk/efo/EFO_0005401	response to high sodium diet	2
http://www.ebi.ac.uk/efo/EFO_0005402	response to low sodium diet	1
http://www.ebi.ac.uk/efo/EFO_0005403	response to dietary potassium supplementation	1
http://www.ebi.ac.uk/efo/EFO_0005404	response to cold pressor test	1
http://www.ebi.ac.uk/efo/EFO_0005405	response to antihypertensive drug	4
http://www.ebi.ac.uk/efo/EFO_0005406	colorectal adenoma	4
http://www.ebi.ac.uk/efo/EFO_0005407	psychosis	6
http://www.ebi.ac.uk/efo/EFO_0005408	pyroglutamine measurement	2
http://www.ebi.ac.uk/efo/EFO_0005409	fat body mass	58
http://www.ebi.ac.uk/efo/EFO_0005410	tooth agenesis	7
http://www.ebi.ac.uk/efo/EFO_0005411	schizoaffective disorder	2
http://www.ebi.ac.uk/efo/EFO_0005412	functional impairment measurement	1
http://www.ebi.ac.uk/efo/EFO_0005413	joint damage measurement	11
http://www.ebi.ac.uk/efo/EFO_0005414	airway hyperresponsiveness	1
http://www.ebi.ac.uk/efo/EFO_0005415	serum alpha-1-antitrypsin measurement	2
http://www.ebi.ac.uk/efo/EFO_0005416	serum ST2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0005417	response to mTOR inhibitor	2
http://www.ebi.ac.uk/efo/EFO_0005418	serum dimethylarginine measurement	3
http://www.ebi.ac.uk/efo/EFO_0005419	contrast sensitivity measurement	1
http://www.ebi.ac.uk/efo/EFO_0005420	grey matter volume measurement	4
http://www.ebi.ac.uk/efo/EFO_0005421	serum homoarginine measurement	1
http://www.ebi.ac.uk/efo/EFO_0005422	skin aging	1
http://www.ebi.ac.uk/efo/EFO_0005423	adolescent idiopathic scoliosis	11
http://www.ebi.ac.uk/efo/EFO_0005424	dyslexia	4
http://www.ebi.ac.uk/efo/EFO_0005425	language impairment	5
http://www.ebi.ac.uk/efo/EFO_0005426	autism spectrum disorder symptom	10
http://www.ebi.ac.uk/efo/EFO_0005427	social communication impairment	2
http://www.ebi.ac.uk/efo/EFO_0005429	borderline personality disorder symptom	1
http://www.ebi.ac.uk/efo/EFO_0005430	nicotine use	2
http://www.ebi.ac.uk/efo/EFO_0005431	illegal drug consumption	2
http://www.ebi.ac.uk/efo/EFO_0005432	non-substance related disinhibited behaviour	2
http://www.ebi.ac.uk/efo/EFO_0005512	estrogen receptor status	3
http://www.ebi.ac.uk/efo/EFO_0005514	HER2 status	1
http://www.ebi.ac.uk/efo/EFO_0005524	large artery stroke	15
http://www.ebi.ac.uk/efo/EFO_0005526	response to alcohol	5
http://www.ebi.ac.uk/efo/EFO_0005527	ejection fraction measurement	2
http://www.ebi.ac.uk/efo/EFO_0005528	parasitemia measurement	1
http://www.ebi.ac.uk/efo/EFO_0005529	Chagas cardiomyopathy	2
http://www.ebi.ac.uk/efo/EFO_0005530	Trypanosoma cruzi seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0005532	angioedema	4
http://www.ebi.ac.uk/efo/EFO_0005533	response to non-steroidal anti-inflammatory	4
http://www.ebi.ac.uk/efo/EFO_0005534	delayed encephalopathy after acute carbon monoxide poisoning	1
http://www.ebi.ac.uk/efo/EFO_0005536	nitric oxide exhalation measurement	4
http://www.ebi.ac.uk/efo/EFO_0005537	triple-negative breast cancer	3
http://www.ebi.ac.uk/efo/EFO_0005538	thrombin generation potential measurement	11
http://www.ebi.ac.uk/efo/EFO_0005539	adrenal gland disease	2
http://www.ebi.ac.uk/efo/EFO_0005543	glioma	18
http://www.ebi.ac.uk/efo/EFO_0005549	diphtheria	2
http://www.ebi.ac.uk/efo/EFO_0005570	oral cavity cancer	5
http://www.ebi.ac.uk/efo/EFO_0005576	pernicious anemia	6
http://www.ebi.ac.uk/efo/EFO_0005577	pharynx cancer	2
http://www.ebi.ac.uk/efo/EFO_0005585	shigellosis	1
http://www.ebi.ac.uk/efo/EFO_0005611	opioid dependence	9
http://www.ebi.ac.uk/efo/EFO_0005624	ileocolitis	1
http://www.ebi.ac.uk/efo/EFO_0005627	perianal Crohn's disease	1
http://www.ebi.ac.uk/efo/EFO_0005653	serum metabolite measurement	12
http://www.ebi.ac.uk/efo/EFO_0005654	velocity of sound measurement	7
http://www.ebi.ac.uk/efo/EFO_0005655	response to cytosine arabinoside	2
http://www.ebi.ac.uk/efo/EFO_0005657	response to protease inhibitor	2
http://www.ebi.ac.uk/efo/EFO_0005658	response to selective serotonin reuptake inhibitor	25
http://www.ebi.ac.uk/efo/EFO_0005659	plasma beta-amyloid 1-40 measurement	2
http://www.ebi.ac.uk/efo/EFO_0005660	plasma beta-amyloid 1-42 measurement	2
http://www.ebi.ac.uk/efo/EFO_0005661	Child Behaviour Checklist assessment	1
http://www.ebi.ac.uk/efo/EFO_0005663	urinary uromodulin measurement	1
http://www.ebi.ac.uk/efo/EFO_0005664	blood metabolite measurement	20
http://www.ebi.ac.uk/efo/EFO_0005665	white matter hyperintensity measurement	18
http://www.ebi.ac.uk/efo/EFO_0005666	thyroid peroxidase antibody measurement	9
http://www.ebi.ac.uk/efo/EFO_0005667	urinary albumin excretion rate	1
http://www.ebi.ac.uk/efo/EFO_0005668	anterior chamber depth measurement	1
http://www.ebi.ac.uk/efo/EFO_0005669	intracerebral hemorrhage	13
http://www.ebi.ac.uk/efo/EFO_0005670	smoking initiation	15
http://www.ebi.ac.uk/efo/EFO_0005671	smoking behaviour measurement	73
http://www.ebi.ac.uk/efo/EFO_0005672	acute coronary syndrome	1
http://www.ebi.ac.uk/efo/EFO_0005673	chronic mucus hypersecretion	3
http://www.ebi.ac.uk/efo/EFO_0005674	white matter microstructure measurement	15
http://www.ebi.ac.uk/efo/EFO_0005675	vitamin D-binding protein measurement	2
http://www.ebi.ac.uk/efo/EFO_0005676	Autoimmune Hepatitis	4
http://www.ebi.ac.uk/efo/EFO_0005677	puberty onset measurement	8
http://www.ebi.ac.uk/efo/EFO_0005678	hippocampal sclerosis of aging	2
http://www.ebi.ac.uk/efo/EFO_0005680	omega-6 polyunsaturated fatty acid measurement	10
http://www.ebi.ac.uk/efo/EFO_0005681	Staphylococcus aureus infection	2
http://www.ebi.ac.uk/efo/EFO_0005682	oxygen saturation measurement	2
http://www.ebi.ac.uk/efo/EFO_0005686	receptive language perception	4
http://www.ebi.ac.uk/efo/EFO_0005687	fibromyalgia	9
http://www.ebi.ac.uk/efo/EFO_0005689	non-high density lipoprotein cholesterol measurement	3
http://www.ebi.ac.uk/efo/EFO_0005690	musical aptitude	1
http://www.ebi.ac.uk/efo/EFO_0005691	plasma trimethylamine N-oxide measurement	2
http://www.ebi.ac.uk/efo/EFO_0005741	infectious disease	7
http://www.ebi.ac.uk/efo/EFO_0005757	vaginal inflammation	2
http://www.ebi.ac.uk/efo/EFO_0005760	serum carcinoembryonic antigen measurement	2
http://www.ebi.ac.uk/efo/EFO_0005761	lupus nephritis	2
http://www.ebi.ac.uk/efo/EFO_0005762	neuropathic pain	4
http://www.ebi.ac.uk/efo/EFO_0005763	pulse pressure measurement	37
http://www.ebi.ac.uk/efo/EFO_0005766	skin fluorescence measurement	2
http://www.ebi.ac.uk/efo/EFO_0005767	rheumatoid factor measurement	2
http://www.ebi.ac.uk/efo/EFO_0005768	response to rate control therapy	1
http://www.ebi.ac.uk/efo/EFO_0005769	calcium metabolic disease	2
http://www.ebi.ac.uk/efo/EFO_0005772	neurodegenerative disease	2
http://www.ebi.ac.uk/efo/EFO_0005773	retinal detachment	16
http://www.ebi.ac.uk/efo/EFO_0005774	brain disease	2
http://www.ebi.ac.uk/efo/EFO_0005782	age-related hearing impairment	11
http://www.ebi.ac.uk/efo/EFO_0005802	cartilage disease	2
http://www.ebi.ac.uk/efo/EFO_0005803	hematologic disease	2
http://www.ebi.ac.uk/efo/EFO_0005842	colorectal cancer	79
http://www.ebi.ac.uk/efo/EFO_0005843	cortisol measurement	7
http://www.ebi.ac.uk/efo/EFO_0005844	response to dietary antigen	1
http://www.ebi.ac.uk/efo/EFO_0005845	hemoglobin A2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0005846	cryoglobulinemia	1
http://www.ebi.ac.uk/efo/EFO_0005849	serum lipase activity measurement	2
http://www.ebi.ac.uk/efo/EFO_0005850	emphysema pattern measurement	2
http://www.ebi.ac.uk/efo/EFO_0005851	height-adjusted body mass index	1
http://www.ebi.ac.uk/efo/EFO_0005852	Heschl's gyrus morphology measurement	1
http://www.ebi.ac.uk/efo/EFO_0005853	response to silica exposure	1
http://www.ebi.ac.uk/efo/EFO_0005854	allergic rhinitis	15
http://www.ebi.ac.uk/efo/EFO_0005855	narcolepsy without cataplexy	4
http://www.ebi.ac.uk/efo/EFO_0005856	arthritis	7
http://www.ebi.ac.uk/efo/EFO_0005890	osteoarthritis biomarker measurement	1
http://www.ebi.ac.uk/efo/EFO_0005895	ossification of the posterior longitudinal ligament of the spine	1
http://www.ebi.ac.uk/efo/EFO_0005917	generalised epilepsy	1
http://www.ebi.ac.uk/efo/EFO_0005918	osteoprotegerin measurement	4
http://www.ebi.ac.uk/efo/EFO_0005919	recombination measurement	1
http://www.ebi.ac.uk/efo/EFO_0005921	FEV change measurement	9
http://www.ebi.ac.uk/efo/EFO_0005922	esophageal squamous cell carcinoma	1
http://www.ebi.ac.uk/efo/EFO_0005924	binge eating	6
http://www.ebi.ac.uk/efo/EFO_0005935	overweight body mass index status	4
http://www.ebi.ac.uk/efo/EFO_0005936	underweight body mass index status	3
http://www.ebi.ac.uk/efo/EFO_0005937	longitudinal BMI measurement	18
http://www.ebi.ac.uk/efo/EFO_0005938	congenital left-sided heart lesions	6
http://www.ebi.ac.uk/efo/EFO_0005939	parental genotype effect measurement	36
http://www.ebi.ac.uk/efo/EFO_0005940	psychotic symptoms	9
http://www.ebi.ac.uk/efo/EFO_0005941	mammographic density measurement	7
http://www.ebi.ac.uk/efo/EFO_0005942	chemotherapy-induced hypertension	1
http://www.ebi.ac.uk/efo/EFO_0005943	response to bevacizumab	6
http://www.ebi.ac.uk/efo/EFO_0005944	cumulative dose response to bevacizumab	1
http://www.ebi.ac.uk/efo/EFO_0005949	antinuclear antibody measurement	3
http://www.ebi.ac.uk/efo/EFO_0005951	sexual dimorphism	2
http://www.ebi.ac.uk/efo/EFO_0005952	non-Hodgkins lymphoma	10
http://www.ebi.ac.uk/efo/EFO_0006309	plasma plasminogen measurement	2
http://www.ebi.ac.uk/efo/EFO_0006312	mitochondrial DNA measurement	11
http://www.ebi.ac.uk/efo/EFO_0006313	chemotherapy-induced oral mucositis	1
http://www.ebi.ac.uk/efo/EFO_0006314	response to high-dose melphalan	1
http://www.ebi.ac.uk/efo/EFO_0006315	thiopurine immunosuppressant-induced pancreatitis	1
http://www.ebi.ac.uk/efo/EFO_0006316	infant expressive language ability	1
http://www.ebi.ac.uk/efo/EFO_0006317	response to thiopurine	20
http://www.ebi.ac.uk/efo/EFO_0006319	HIV viral set point measurement	2
http://www.ebi.ac.uk/efo/EFO_0006325	response to serotonin-norephinephrine reuptake inhibitor	1
http://www.ebi.ac.uk/efo/EFO_0006326	response to bupropion	3
http://www.ebi.ac.uk/efo/EFO_0006328	response to venlafaxine	6
http://www.ebi.ac.uk/efo/EFO_0006329	response to citalopram	8
http://www.ebi.ac.uk/efo/EFO_0006331	selenium measurement	4
http://www.ebi.ac.uk/efo/EFO_0006332	serum iron measurement	7
http://www.ebi.ac.uk/efo/EFO_0006333	transferrin saturation measurement	4
http://www.ebi.ac.uk/efo/EFO_0006334	total iron binding capacity	5
http://www.ebi.ac.uk/efo/EFO_0006335	systolic blood pressure	109
http://www.ebi.ac.uk/efo/EFO_0006336	diastolic blood pressure	102
http://www.ebi.ac.uk/efo/EFO_0006337	response to allopurinol	3
http://www.ebi.ac.uk/efo/EFO_0006338	pit and fissure surface dental caries	2
http://www.ebi.ac.uk/efo/EFO_0006339	smooth surface dental caries	2
http://www.ebi.ac.uk/efo/EFO_0006340	mean arterial pressure	16
http://www.ebi.ac.uk/efo/EFO_0006341	transferrin measurement	4
http://www.ebi.ac.uk/efo/EFO_0006342	aggressive periodontitis	4
http://www.ebi.ac.uk/efo/EFO_0006344	medication adherence behavior	5
http://www.ebi.ac.uk/efo/EFO_0006345	response to phenytoin	3
http://www.ebi.ac.uk/efo/EFO_0006346	severe cutaneous adverse reaction	3
http://www.ebi.ac.uk/efo/EFO_0006347	pulmonary artery enlargement	2
http://www.ebi.ac.uk/efo/EFO_0006352	laryngeal squamous cell carcinoma	2
http://www.ebi.ac.uk/efo/EFO_0006462	ovarian mucinous adenocarcinoma	2
http://www.ebi.ac.uk/efo/EFO_0006501	carotid plaque build	9
http://www.ebi.ac.uk/efo/EFO_0006502	mammographic density percentage	2
http://www.ebi.ac.uk/efo/EFO_0006503	dense area measurement	1
http://www.ebi.ac.uk/efo/EFO_0006504	non-dense area measurement	1
http://www.ebi.ac.uk/efo/EFO_0006505	chronic bronchitis	9
http://www.ebi.ac.uk/efo/EFO_0006506	hepatic lipid content measurement	2
http://www.ebi.ac.uk/efo/EFO_0006507	nicotine glucuronidation measurement	1
http://www.ebi.ac.uk/efo/EFO_0006508	cotinine glucuronidation measurement	1
http://www.ebi.ac.uk/efo/EFO_0006510	Herpes Zoster	12
http://www.ebi.ac.uk/efo/EFO_0006511	Kashin-Beck disease	3
http://www.ebi.ac.uk/efo/EFO_0006512	angiographic measurement	1
http://www.ebi.ac.uk/efo/EFO_0006513	hereditary hemochromatosis type 1	1
http://www.ebi.ac.uk/efo/EFO_0006514	Alzheimer's disease biomarker measurement	2
http://www.ebi.ac.uk/efo/EFO_0006515	angiotensin-converting enzyme measurement	1
http://www.ebi.ac.uk/efo/EFO_0006516	superior frontal gyrus grey matter volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0006517	interferon alpha measurement	1
http://www.ebi.ac.uk/efo/EFO_0006518	response to losartan	1
http://www.ebi.ac.uk/efo/EFO_0006519	MMR-related febrile seizures	1
http://www.ebi.ac.uk/efo/EFO_0006520	carbon monoxide exhalation measurement	2
http://www.ebi.ac.uk/efo/EFO_0006521	calcium intake measurement	1
http://www.ebi.ac.uk/efo/EFO_0006522	asymmetrical dimethylarginine measurement	2
http://www.ebi.ac.uk/efo/EFO_0006523	symmetrical dimethylarginine measurement	2
http://www.ebi.ac.uk/efo/EFO_0006524	L-arginine measurement	3
http://www.ebi.ac.uk/efo/EFO_0006525	cigarettes per day measurement	19
http://www.ebi.ac.uk/efo/EFO_0006526	pack-years measurement	6
http://www.ebi.ac.uk/efo/EFO_0006527	smoking status measurement	75
http://www.ebi.ac.uk/efo/EFO_0006781	coffee consumption measurement	7
http://www.ebi.ac.uk/efo/EFO_0006782	cups of coffee per day measurement	6
http://www.ebi.ac.uk/efo/EFO_0006783	psychosocial stress measurement	9
http://www.ebi.ac.uk/efo/EFO_0006784	body height at birth	2
http://www.ebi.ac.uk/efo/EFO_0006785	infant body height	1
http://www.ebi.ac.uk/efo/EFO_0006788	anxiety disorder	18
http://www.ebi.ac.uk/efo/EFO_0006789	typhoid fever	3
http://www.ebi.ac.uk/efo/EFO_0006790	cerebral amyloid angiopathy	11
http://www.ebi.ac.uk/efo/EFO_0006791	vascular brain injury	1
http://www.ebi.ac.uk/efo/EFO_0006792	Lewy body dementia	6
http://www.ebi.ac.uk/efo/EFO_0006793	left inferior lateral ventricle volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0006794	cerebrospinal fluid biomarker measurement	7
http://www.ebi.ac.uk/efo/EFO_0006795	serum VEGFR2 concentration measurement	1
http://www.ebi.ac.uk/efo/EFO_0006796	very long-chain saturated fatty acid measurement	3
http://www.ebi.ac.uk/efo/EFO_0006797	neurofibrillary tangles measurement	9
http://www.ebi.ac.uk/efo/EFO_0006798	neuritic plaque measurement	9
http://www.ebi.ac.uk/efo/EFO_0006799	Lewy body dementia measurement	1
http://www.ebi.ac.uk/efo/EFO_0006800	vascular brain injury measurement	1
http://www.ebi.ac.uk/efo/EFO_0006801	Alzheimer's disease neuropathologic change	1
http://www.ebi.ac.uk/efo/EFO_0006802	response to red blood cell transfusion	2
http://www.ebi.ac.uk/efo/EFO_0006804	alloimmunization	2
http://www.ebi.ac.uk/efo/EFO_0006805	word list delayed recall measurement	1
http://www.ebi.ac.uk/efo/EFO_0006807	linoleic acid measurement	4
http://www.ebi.ac.uk/efo/EFO_0006808	arachidonic acid measurement	2
http://www.ebi.ac.uk/efo/EFO_0006809	docosapentaenoic acid measurement	4
http://www.ebi.ac.uk/efo/EFO_0006810	oleic acid measurement	2
http://www.ebi.ac.uk/efo/EFO_0006811	linolenic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0006812	autoimmune thyroid disease	7
http://www.ebi.ac.uk/efo/EFO_0006816	response to heparin	2
http://www.ebi.ac.uk/efo/EFO_0006817	yang deficiency	1
http://www.ebi.ac.uk/efo/EFO_0006818	stricture	3
http://www.ebi.ac.uk/efo/EFO_0006819	mild disease course	1
http://www.ebi.ac.uk/efo/EFO_0006820	complicated disease course	1
http://www.ebi.ac.uk/efo/EFO_0006821	trans fatty acid measurement	4
http://www.ebi.ac.uk/efo/EFO_0006828	plasma renin activity measurement	2
http://www.ebi.ac.uk/efo/EFO_0006829	GFR change measurement	2
http://www.ebi.ac.uk/efo/EFO_0006830	insulin metabolic clearance rate measurement	1
http://www.ebi.ac.uk/efo/EFO_0006831	acute insulin response measurement	4
http://www.ebi.ac.uk/efo/EFO_0006832	disposition index measurement	5
http://www.ebi.ac.uk/efo/EFO_0006833	glucose effectiveness measurement	1
http://www.ebi.ac.uk/efo/EFO_0006834	septic shock	5
http://www.ebi.ac.uk/efo/EFO_0006835	pyoderma gangrenosum	1
http://www.ebi.ac.uk/efo/EFO_0006836	rapid kidney function decline	1
http://www.ebi.ac.uk/efo/EFO_0006842	diabetes mellitus biomarker	3
http://www.ebi.ac.uk/efo/EFO_0006845	liver disease biomarker	3
http://www.ebi.ac.uk/efo/EFO_0006859	head and neck malignant neoplasia	5
http://www.ebi.ac.uk/efo/EFO_0006861	male breast carcinoma	2
http://www.ebi.ac.uk/efo/EFO_0006862	Meniere disease	8
http://www.ebi.ac.uk/efo/EFO_0006864	breastfeeding duration	1
http://www.ebi.ac.uk/efo/EFO_0006865	urgency urinary incontinence	3
http://www.ebi.ac.uk/efo/EFO_0006866	electrodermal activity measurement	5
http://www.ebi.ac.uk/efo/EFO_0006867	skin conductance level	1
http://www.ebi.ac.uk/efo/EFO_0006868	skin conductance response amplitude	1
http://www.ebi.ac.uk/efo/EFO_0006869	skin conductance response frequency	1
http://www.ebi.ac.uk/efo/EFO_0006870	alpha wave measurement	2
http://www.ebi.ac.uk/efo/EFO_0006871	beta wave measurement	3
http://www.ebi.ac.uk/efo/EFO_0006872	delta wave measurement	2
http://www.ebi.ac.uk/efo/EFO_0006873	theta wave measurement	3
http://www.ebi.ac.uk/efo/EFO_0006874	antisaccade response measurement	4
http://www.ebi.ac.uk/efo/EFO_0006875	acoustic startle blink response measurement	4
http://www.ebi.ac.uk/efo/EFO_0006876	seasonality measurement	4
http://www.ebi.ac.uk/efo/EFO_0006882	suicide behaviour measurement	21
http://www.ebi.ac.uk/efo/EFO_0006883	alpha peak frequency measurement	1
http://www.ebi.ac.uk/efo/EFO_0006896	glucose homeostasis measurement	1
http://www.ebi.ac.uk/efo/EFO_0006897	airway responsiveness measurement	1
http://www.ebi.ac.uk/efo/EFO_0006898	airway wall thickness measurement	1
http://www.ebi.ac.uk/efo/EFO_0006899	PCSK9 protein measurement	2
http://www.ebi.ac.uk/efo/EFO_0006900	endothelial growth factor measurement	1
http://www.ebi.ac.uk/efo/EFO_0006901	angiopoietin-2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0006902	angiopoietin-2 receptor measurement	1
http://www.ebi.ac.uk/efo/EFO_0006903	hepatocyte growth factor measurement	5
http://www.ebi.ac.uk/efo/EFO_0006904	response to efavirenz	3
http://www.ebi.ac.uk/efo/EFO_0006905	response to abacavir	1
http://www.ebi.ac.uk/efo/EFO_0006906	virologic response measurement	2
http://www.ebi.ac.uk/efo/EFO_0006913	prefrontal cortex cytoarchtiectural measurement	1
http://www.ebi.ac.uk/efo/EFO_0006916	response to dalcetrapib	1
http://www.ebi.ac.uk/efo/EFO_0006917	spontaneous preterm birth	12
http://www.ebi.ac.uk/efo/EFO_0006918	female fertility	3
http://www.ebi.ac.uk/efo/EFO_0006919	cardiovascular event measurement	14
http://www.ebi.ac.uk/efo/EFO_0006920	BNP measurement	2
http://www.ebi.ac.uk/efo/EFO_0006921	birth measurement	12
http://www.ebi.ac.uk/efo/EFO_0006922	delivery measurement	1
http://www.ebi.ac.uk/efo/EFO_0006923	fertility measurement	18
http://www.ebi.ac.uk/efo/EFO_0006924	household air pollution measurement	1
http://www.ebi.ac.uk/efo/EFO_0006925	lipoprotein A measurement	17
http://www.ebi.ac.uk/efo/EFO_0006927	severe aplastic anemia	1
http://www.ebi.ac.uk/efo/EFO_0006928	motion sickness	1
http://www.ebi.ac.uk/efo/EFO_0006929	IgG index	1
http://www.ebi.ac.uk/efo/EFO_0006930	brain volume measurement	14
http://www.ebi.ac.uk/efo/EFO_0006931	nucleus accumbens volume	5
http://www.ebi.ac.uk/efo/EFO_0006932	putamen volume	6
http://www.ebi.ac.uk/efo/EFO_0006933	pallidum volume	5
http://www.ebi.ac.uk/efo/EFO_0006934	amygdala volume	5
http://www.ebi.ac.uk/efo/EFO_0006935	thalamus volume	12
http://www.ebi.ac.uk/efo/EFO_0006936	optic disc measurement	1
http://www.ebi.ac.uk/efo/EFO_0006937	optic disc area measurement	6
http://www.ebi.ac.uk/efo/EFO_0006939	cup-to-disc ratio measurement	7
http://www.ebi.ac.uk/efo/EFO_0006940	optic cup area measurement	6
http://www.ebi.ac.uk/efo/EFO_0006941	grip strength measurement	18
http://www.ebi.ac.uk/efo/EFO_0006942	facial pigmentation measurement	6
http://www.ebi.ac.uk/efo/EFO_0006943	blood pressure change measurement	2
http://www.ebi.ac.uk/efo/EFO_0006944	systolic blood pressure change measurement	16
http://www.ebi.ac.uk/efo/EFO_0006945	diastolic blood pressure change measurement	15
http://www.ebi.ac.uk/efo/EFO_0006946	behavioural disinhibition measurement	15
http://www.ebi.ac.uk/efo/EFO_0006947	red wine liking measurement	1
http://www.ebi.ac.uk/efo/EFO_0006948	white wine liking measurement	1
http://www.ebi.ac.uk/efo/EFO_0006950	response to vincristine	2
http://www.ebi.ac.uk/efo/EFO_0006951	ototoxicity	3
http://www.ebi.ac.uk/efo/EFO_0006952	cytotoxicity measurement	11
http://www.ebi.ac.uk/efo/EFO_0006953	family history of lung cancer	4
http://www.ebi.ac.uk/efo/EFO_0006954	response to triamcinolone acetonide	1
http://www.ebi.ac.uk/efo/EFO_0006955	ADAMTS13 activity measurement	1
http://www.ebi.ac.uk/efo/EFO_0006956	intraocular pressure change measurement	1
http://www.ebi.ac.uk/efo/EFO_0006957	X12063 measurement	1
http://www.ebi.ac.uk/efo/EFO_0006958	mannose measurement	1
http://www.ebi.ac.uk/efo/EFO_0006959	gene methylation measurement	2
http://www.ebi.ac.uk/efo/EFO_0006988	endophenotype	1
http://www.ebi.ac.uk/efo/EFO_0006992	response to biological dust exposure	1
http://www.ebi.ac.uk/efo/EFO_0006993	response to mineral dust exposure	1
http://www.ebi.ac.uk/efo/EFO_0006994	response to gases and fumes exposure	1
http://www.ebi.ac.uk/efo/EFO_0006995	response to diisocyanate	1
http://www.ebi.ac.uk/efo/EFO_0006996	response to homoharringtonine	1
http://www.ebi.ac.uk/efo/EFO_0006997	response to cold medicine	2
http://www.ebi.ac.uk/efo/EFO_0006998	response to stavudine	1
http://www.ebi.ac.uk/efo/EFO_0006999	cancer aggressiveness measurement	2
http://www.ebi.ac.uk/efo/EFO_0007000	Gleason score measurement	1
http://www.ebi.ac.uk/efo/EFO_0007001	dehydroepiandrosterone sulphate measurement	3
http://www.ebi.ac.uk/efo/EFO_0007002	luteinizing hormone measurement	4
http://www.ebi.ac.uk/efo/EFO_0007003	prolactin measurement	1
http://www.ebi.ac.uk/efo/EFO_0007004	progesterone measurement	1
http://www.ebi.ac.uk/efo/EFO_0007006	depressive symptom measurement	73
http://www.ebi.ac.uk/efo/EFO_0007007	ticagrelor measurement	1
http://www.ebi.ac.uk/efo/EFO_0007009	skin pigmentation measurement	18
http://www.ebi.ac.uk/efo/EFO_0007010	drug use measurement	4
http://www.ebi.ac.uk/efo/EFO_0007011	SSRI use measurement	1
http://www.ebi.ac.uk/efo/EFO_0007012	NSAID use measurement	1
http://www.ebi.ac.uk/efo/EFO_0007013	aspirin use measurement	4
http://www.ebi.ac.uk/efo/EFO_0007014	3-hydroxypropylmercapturic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007015	3-hydroxy-1-methylpropylmercapturic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007016	food allergy measurement	7
http://www.ebi.ac.uk/efo/EFO_0007017	peanut allergy measurement	6
http://www.ebi.ac.uk/efo/EFO_0007018	egg allergy measurement	4
http://www.ebi.ac.uk/efo/EFO_0007019	milk allergy measurement	4
http://www.ebi.ac.uk/efo/EFO_0007020	AR-C124910XX measurement	1
http://www.ebi.ac.uk/efo/EFO_0007021	Lewy body measurement	1
http://www.ebi.ac.uk/efo/EFO_0007034	seropositivity measurement	15
http://www.ebi.ac.uk/efo/EFO_0007036	herpes virus seropositivity	7
http://www.ebi.ac.uk/efo/EFO_0007037	cytomegalovirus seropositivity	6
http://www.ebi.ac.uk/efo/EFO_0007038	Influenza A seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0007040	blood lead measurement	7
http://www.ebi.ac.uk/efo/EFO_0007041	obese body mass index status	2
http://www.ebi.ac.uk/efo/EFO_0007042	polychlorinated biphenyls measurement	3
http://www.ebi.ac.uk/efo/EFO_0007043	response to transplant	1
http://www.ebi.ac.uk/efo/EFO_0007044	response to allogeneic hematopoietic stem cell transplant	1
http://www.ebi.ac.uk/efo/EFO_0007046	executive function	1
http://www.ebi.ac.uk/efo/EFO_0007047	Toxoplasma gondii seropositivity	4
http://www.ebi.ac.uk/efo/EFO_0007048	human herpesvirus 6 seropositivity	3
http://www.ebi.ac.uk/efo/EFO_0007050	HSV1 seropositivity	3
http://www.ebi.ac.uk/efo/EFO_0007051	vein graft stenosis	1
http://www.ebi.ac.uk/efo/EFO_0007052	antisocial behaviour measurement	6
http://www.ebi.ac.uk/efo/EFO_0007053	myelosuppression	2
http://www.ebi.ac.uk/efo/EFO_0007054	microsatellite instability measurement	1
http://www.ebi.ac.uk/efo/EFO_0007056	clinical treatment	558
http://www.ebi.ac.uk/efo/EFO_0007068	ulcer of lower limb	2
http://www.ebi.ac.uk/efo/EFO_0007117	carotid artery intima media thickness	8
http://www.ebi.ac.uk/efo/EFO_0007118	sitting height ratio	1
http://www.ebi.ac.uk/efo/EFO_0007119	Sasang constitutional medicine type	4
http://www.ebi.ac.uk/efo/EFO_0007120	Tae-Yang	1
http://www.ebi.ac.uk/efo/EFO_0007121	So-Yang	1
http://www.ebi.ac.uk/efo/EFO_0007122	Tae-Eum	1
http://www.ebi.ac.uk/efo/EFO_0007123	So-Eum	1
http://www.ebi.ac.uk/efo/EFO_0007124	salivary gland lesion	1
http://www.ebi.ac.uk/efo/EFO_0007125	lachrymal gland lesion	1
http://www.ebi.ac.uk/efo/EFO_0007135	adult-onset Still's disease	1
http://www.ebi.ac.uk/efo/EFO_0007144	amebiasis	1
http://www.ebi.ac.uk/efo/EFO_0007148	aortic valve insufficiency	2
http://www.ebi.ac.uk/efo/EFO_0007149	appendicitis	15
http://www.ebi.ac.uk/efo/EFO_0007160	autoimmune thrombocytopenic purpura	3
http://www.ebi.ac.uk/efo/EFO_0007167	Bell's palsy	5
http://www.ebi.ac.uk/efo/EFO_0007184	bronchopneumonia	2
http://www.ebi.ac.uk/efo/EFO_0007187	bullous pemphigoid	1
http://www.ebi.ac.uk/efo/EFO_0007191	cannabis dependence	5
http://www.ebi.ac.uk/efo/EFO_0007204	chickenpox	4
http://www.ebi.ac.uk/efo/EFO_0007208	Churg-Strauss syndrome	3
http://www.ebi.ac.uk/efo/EFO_0007214	common cold	2
http://www.ebi.ac.uk/efo/EFO_0007229	cryptococcosis	1
http://www.ebi.ac.uk/efo/EFO_0007262	epilepsy with generalized tonic-clonic seizures	1
http://www.ebi.ac.uk/efo/EFO_0007292	Guillain-Barre syndrome	1
http://www.ebi.ac.uk/efo/EFO_0007294	hand, foot and mouth disease, illness severity status	1
http://www.ebi.ac.uk/efo/EFO_0007305	hepatitis A virus infection	2
http://www.ebi.ac.uk/efo/EFO_0007309	Herpesviridae infectious disease	2
http://www.ebi.ac.uk/efo/EFO_0007315	hordeolum	2
http://www.ebi.ac.uk/efo/EFO_0007321	hypopharynx cancer	1
http://www.ebi.ac.uk/efo/EFO_0007326	infectious mononucleosis	4
http://www.ebi.ac.uk/efo/EFO_0007328	influenza	1
http://www.ebi.ac.uk/efo/EFO_0007351	lymphangitis	10
http://www.ebi.ac.uk/efo/EFO_0007361	maxillary sinusitis	2
http://www.ebi.ac.uk/efo/EFO_0007363	meibomian cyst	4
http://www.ebi.ac.uk/efo/EFO_0007383	Mumps virus infectious disease	4
http://www.ebi.ac.uk/efo/EFO_0007386	Mycobacterium avium complex disease	1
http://www.ebi.ac.uk/efo/EFO_0007427	pericarditis	2
http://www.ebi.ac.uk/efo/EFO_0007429	peritonsillar abscess	2
http://www.ebi.ac.uk/efo/EFO_0007453	postpartum depression	2
http://www.ebi.ac.uk/efo/EFO_0007477	scarlet fever	4
http://www.ebi.ac.uk/efo/EFO_0007486	sinusitis	9
http://www.ebi.ac.uk/efo/EFO_0007490	spinal stenosis	11
http://www.ebi.ac.uk/efo/EFO_0007493	spondylolisthesis	4
http://www.ebi.ac.uk/efo/EFO_0007503	suppurative otitis media	4
http://www.ebi.ac.uk/efo/EFO_0007510	tinea	2
http://www.ebi.ac.uk/efo/EFO_0007527	tropical spastic paraparesis	1
http://www.ebi.ac.uk/efo/EFO_0007532	uterine corpus cancer	4
http://www.ebi.ac.uk/efo/EFO_0007536	vesicoureteral reflux	3
http://www.ebi.ac.uk/efo/EFO_0007537	vestibular neuronitis	1
http://www.ebi.ac.uk/efo/EFO_0007543	vulvovaginal candidiasis	2
http://www.ebi.ac.uk/efo/EFO_0007575	blood aluminium measurement	1
http://www.ebi.ac.uk/efo/EFO_0007576	blood cadmium measurement	1
http://www.ebi.ac.uk/efo/EFO_0007577	blood cobalt measurement	1
http://www.ebi.ac.uk/efo/EFO_0007578	blood copper measurement	1
http://www.ebi.ac.uk/efo/EFO_0007579	blood chromium measurement	1
http://www.ebi.ac.uk/efo/EFO_0007580	blood mercury measurement	1
http://www.ebi.ac.uk/efo/EFO_0007581	blood manganese measurement	1
http://www.ebi.ac.uk/efo/EFO_0007582	blood molybdenum measurement	1
http://www.ebi.ac.uk/efo/EFO_0007583	blood nickel measurement	1
http://www.ebi.ac.uk/efo/EFO_0007584	blood zinc measurement	1
http://www.ebi.ac.uk/efo/EFO_0007585	Cannabis use	13
http://www.ebi.ac.uk/efo/EFO_0007586	Cannabis use initiation	1
http://www.ebi.ac.uk/efo/EFO_0007591	bone mineral accretion measurement	1
http://www.ebi.ac.uk/efo/EFO_0007592	response to bleomycin	1
http://www.ebi.ac.uk/efo/EFO_0007593	chromatid break measurement	1
http://www.ebi.ac.uk/efo/EFO_0007612	response to montelukast	1
http://www.ebi.ac.uk/efo/EFO_0007613	response to endocrine therapy	4
http://www.ebi.ac.uk/efo/EFO_0007614	asthma exacerbation measurement	6
http://www.ebi.ac.uk/efo/EFO_0007615	thrombus formation measurement	1
http://www.ebi.ac.uk/efo/EFO_0007616	hearing measurement	34
http://www.ebi.ac.uk/efo/EFO_0007617	pure tone hearing measurement	4
http://www.ebi.ac.uk/efo/EFO_0007618	hearing threshold measurement	14
http://www.ebi.ac.uk/efo/EFO_0007619	suicide ideation measurement	3
http://www.ebi.ac.uk/efo/EFO_0007620	volumetric bone mineral density	6
http://www.ebi.ac.uk/efo/EFO_0007621	bone mineral content measurement	20
http://www.ebi.ac.uk/efo/EFO_0007622	sRAGE measurement	1
http://www.ebi.ac.uk/efo/EFO_0007623	suicide behaviour	1
http://www.ebi.ac.uk/efo/EFO_0007624	suicide	3
http://www.ebi.ac.uk/efo/EFO_0007626	emphysema imaging measurement	3
http://www.ebi.ac.uk/efo/EFO_0007627	airway imaging measurement	4
http://www.ebi.ac.uk/efo/EFO_0007628	gas trapping measurement	1
http://www.ebi.ac.uk/efo/EFO_0007629	hemoglobin A1 measurement	7
http://www.ebi.ac.uk/efo/EFO_0007630	glycerophospholipid measurement	93
http://www.ebi.ac.uk/efo/EFO_0007631	hexose measurement	2
http://www.ebi.ac.uk/efo/EFO_0007633	response to thioamide	2
http://www.ebi.ac.uk/efo/EFO_0007634	major depressive episode	4
http://www.ebi.ac.uk/efo/EFO_0007635	concentration dose ratio	4
http://www.ebi.ac.uk/efo/EFO_0007636	attention function measurement	4
http://www.ebi.ac.uk/efo/EFO_0007638	Yu-Zhi constitution type	1
http://www.ebi.ac.uk/efo/EFO_0007639	minimal erythema dose	1
http://www.ebi.ac.uk/efo/EFO_0007645	longitudinal alcohol consumption measurement	7
http://www.ebi.ac.uk/efo/EFO_0007646	amyloid plaque accumulation rate	1
http://www.ebi.ac.uk/efo/EFO_0007647	response to vancomycin	3
http://www.ebi.ac.uk/efo/EFO_0007648	vancomycin trough measurement	1
http://www.ebi.ac.uk/efo/EFO_0007649	renal elimination rate measurement	1
http://www.ebi.ac.uk/efo/EFO_0007650	soluble interleukin-2 receptor subunit alpha measurement	1
http://www.ebi.ac.uk/efo/EFO_0007651	urinary S-phenylmercapturic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007653	clinical ideal cardiovascular health	1
http://www.ebi.ac.uk/efo/EFO_0007654	clinical and behavioural ideal cardiovascular health	1
http://www.ebi.ac.uk/efo/EFO_0007656	plasma clusterin measurement	1
http://www.ebi.ac.uk/efo/EFO_0007657	cerebrospinal fluid clusterin measurement	3
http://www.ebi.ac.uk/efo/EFO_0007658	carrier status	4
http://www.ebi.ac.uk/efo/EFO_0007659	APOE carrier status	2
http://www.ebi.ac.uk/efo/EFO_0007660	neuroticism measurement	26
http://www.ebi.ac.uk/efo/EFO_0007661	response to lamotrigine	4
http://www.ebi.ac.uk/efo/EFO_0007662	response to triptolide	1
http://www.ebi.ac.uk/efo/EFO_0007663	childhood aggressive behaviour measurement	9
http://www.ebi.ac.uk/efo/EFO_0007664	outer ear morphology trait	3
http://www.ebi.ac.uk/efo/EFO_0007665	ear protrusion	1
http://www.ebi.ac.uk/efo/EFO_0007666	lobe size	1
http://www.ebi.ac.uk/efo/EFO_0007667	lobe attachment	3
http://www.ebi.ac.uk/efo/EFO_0007668	tragus size	1
http://www.ebi.ac.uk/efo/EFO_0007669	antitragus size	1
http://www.ebi.ac.uk/efo/EFO_0007670	helix rolling	1
http://www.ebi.ac.uk/efo/EFO_0007671	folding of antihelix	1
http://www.ebi.ac.uk/efo/EFO_0007672	crus helix expression	1
http://www.ebi.ac.uk/efo/EFO_0007673	superior crus of antihelix expression	1
http://www.ebi.ac.uk/efo/EFO_0007674	Darwin's tubercule	1
http://www.ebi.ac.uk/efo/EFO_0007675	metastasis measurement	4
http://www.ebi.ac.uk/efo/EFO_0007676	response to zileuton	1
http://www.ebi.ac.uk/efo/EFO_0007677	LDL peak particle diameter measurement	1
http://www.ebi.ac.uk/efo/EFO_0007678	total fat intake measurement	1
http://www.ebi.ac.uk/efo/EFO_0007679	oppositional defiant disorder measurement	2
http://www.ebi.ac.uk/efo/EFO_0007680	gait measurement	6
http://www.ebi.ac.uk/efo/EFO_0007681	triglyceride change measurement	9
http://www.ebi.ac.uk/efo/EFO_0007682	response to cetuximab	4
http://www.ebi.ac.uk/efo/EFO_0007683	response to CAPOX-B	2
http://www.ebi.ac.uk/efo/EFO_0007684	response to high fat food intake	1
http://www.ebi.ac.uk/efo/EFO_0007685	trichloroethylene-induced hypersensitivity	1
http://www.ebi.ac.uk/efo/EFO_0007699	eye movement measurement	12
http://www.ebi.ac.uk/efo/EFO_0007700	exploratory eye movement measurement	5
http://www.ebi.ac.uk/efo/EFO_0007701	spine bone mineral density	19
http://www.ebi.ac.uk/efo/EFO_0007702	hip bone mineral density	14
http://www.ebi.ac.uk/efo/EFO_0007704	depressive episode measurement	16
http://www.ebi.ac.uk/efo/EFO_0007705	manic episode measurement	27
http://www.ebi.ac.uk/efo/EFO_0007706	manic or hypomanic episode	1
http://www.ebi.ac.uk/efo/EFO_0007707	cerebral amyloid deposition measurement	8
http://www.ebi.ac.uk/efo/EFO_0007708	t-tau:beta-amyloid 1-42 ratio measurement	5
http://www.ebi.ac.uk/efo/EFO_0007709	p-tau:beta-amyloid 1-42 ratio measurement	2
http://www.ebi.ac.uk/efo/EFO_0007710	cognitive decline measurement	15
http://www.ebi.ac.uk/efo/EFO_0007718	carotid artery stiffness measurement	1
http://www.ebi.ac.uk/efo/EFO_0007719	carotid artery external diameter measurement	1
http://www.ebi.ac.uk/efo/EFO_0007720	carotid artery internal diameter measurement	1
http://www.ebi.ac.uk/efo/EFO_0007721	carotid artery central pulse pressure measurement	1
http://www.ebi.ac.uk/efo/EFO_0007722	carotid artery wall cross sectional area measurement	1
http://www.ebi.ac.uk/efo/EFO_0007723	carotid artery mean blood pressure measurement	1
http://www.ebi.ac.uk/efo/EFO_0007724	carotid artery circumferential wall stress measurement	1
http://www.ebi.ac.uk/efo/EFO_0007737	BMI-adjusted adiponectin measurement	3
http://www.ebi.ac.uk/efo/EFO_0007738	cingulate cortex measurement	7
http://www.ebi.ac.uk/efo/EFO_0007739	left superior temporal gyrus thickness measurement	1
http://www.ebi.ac.uk/efo/EFO_0007740	S wave amplitude	1
http://www.ebi.ac.uk/efo/EFO_0007741	R wave amplitude	1
http://www.ebi.ac.uk/efo/EFO_0007742	QRS amplitude	4
http://www.ebi.ac.uk/efo/EFO_0007743	influenza A severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0007745	lactate measurement	3
http://www.ebi.ac.uk/efo/EFO_0007746	white matter lesion progression measurement	2
http://www.ebi.ac.uk/efo/EFO_0007747	postburn hypertrophic scarring severity measurement	3
http://www.ebi.ac.uk/efo/EFO_0007753	seasonal gut microbiome measurement	3
http://www.ebi.ac.uk/efo/EFO_0007754	response to immunochemotherapy	1
http://www.ebi.ac.uk/efo/EFO_0007755	atopic march	7
http://www.ebi.ac.uk/efo/EFO_0007757	persistent Staphylococcus aureus carrier status	1
http://www.ebi.ac.uk/efo/EFO_0007758	intermittent Staphylococcus aureus carrier status	1
http://www.ebi.ac.uk/efo/EFO_0007759	alpha-linolenic acid measurement	2
http://www.ebi.ac.uk/efo/EFO_0007760	eicosapentaenoic acid measurement	2
http://www.ebi.ac.uk/efo/EFO_0007761	docosahexaenoic acid measurement	6
http://www.ebi.ac.uk/efo/EFO_0007762	gamma-linolenic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007763	dihomo-gamma-linolenic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007764	delta-5 desaturase measurement	2
http://www.ebi.ac.uk/efo/EFO_0007765	delta-6 desaturase measurement	2
http://www.ebi.ac.uk/efo/EFO_0007766	response to beta blocker	13
http://www.ebi.ac.uk/efo/EFO_0007767	response to calcium channel blocker	4
http://www.ebi.ac.uk/efo/EFO_0007768	response to exercise	4
http://www.ebi.ac.uk/efo/EFO_0007769	thoracic-to-hip circumference ratio measurement	1
http://www.ebi.ac.uk/efo/EFO_0007770	post-operative fentanyl consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0007771	pathologic complete response measurement	3
http://www.ebi.ac.uk/efo/EFO_0007772	calcaneal bone quantitative ultrasound measurement	2
http://www.ebi.ac.uk/efo/EFO_0007773	cutaneous psoriasis measurement	2
http://www.ebi.ac.uk/efo/EFO_0007774	thrombomodulin measurement	8
http://www.ebi.ac.uk/efo/EFO_0007775	thrombin-antithrombin complex measurement	1
http://www.ebi.ac.uk/efo/EFO_0007776	prothrombin fragments F1+2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0007777	base metabolic rate measurement	6
http://www.ebi.ac.uk/efo/EFO_0007778	urinary albumin to creatinine ratio	15
http://www.ebi.ac.uk/efo/EFO_0007779	response to pazopanib	1
http://www.ebi.ac.uk/efo/EFO_0007780	periodontal measurement	10
http://www.ebi.ac.uk/efo/EFO_0007781	stressful life event measurement	18
http://www.ebi.ac.uk/efo/EFO_0007783	mosaic loss of chromosome Y measurement	4
http://www.ebi.ac.uk/efo/EFO_0007784	functional decline measurement	2
http://www.ebi.ac.uk/efo/EFO_0007785	femoral neck bone mineral density	18
http://www.ebi.ac.uk/efo/EFO_0007786	menstrual cycle measurement	4
http://www.ebi.ac.uk/efo/EFO_0007787	plasma betaine measurement	1
http://www.ebi.ac.uk/efo/EFO_0007788	BMI-adjusted waist-hip ratio	55
http://www.ebi.ac.uk/efo/EFO_0007789	BMI-adjusted waist circumference	23
http://www.ebi.ac.uk/efo/EFO_0007790	Epstein Barr virus nuclear antigen 1 IgG measurement	5
http://www.ebi.ac.uk/efo/EFO_0007791	rheumatoid factor seropositivity measurement	2
http://www.ebi.ac.uk/efo/EFO_0007792	antipsychotic drug use measurement	1
http://www.ebi.ac.uk/efo/EFO_0007793	BMI-adjusted leptin measurement	13
http://www.ebi.ac.uk/efo/EFO_0007794	nicotine metabolite ratio	5
http://www.ebi.ac.uk/efo/EFO_0007795	anxiety disorder measurement	4
http://www.ebi.ac.uk/efo/EFO_0007796	parental longevity	33
http://www.ebi.ac.uk/efo/EFO_0007797	language measurement	6
http://www.ebi.ac.uk/efo/EFO_0007798	linguistic error measurement	1
http://www.ebi.ac.uk/efo/EFO_0007799	syntactic complexity measurement	1
http://www.ebi.ac.uk/efo/EFO_0007800	body fat percentage	30
http://www.ebi.ac.uk/efo/EFO_0007801	lycopene measurement	1
http://www.ebi.ac.uk/efo/EFO_0007802	obsessive-compulsive symptom measurement	6
http://www.ebi.ac.uk/efo/EFO_0007803	emotional symptom measurement	154
http://www.ebi.ac.uk/efo/EFO_0007804	LDL cholesterol change measurement	10
http://www.ebi.ac.uk/efo/EFO_0007805	HDL cholesterol change measurement	9
http://www.ebi.ac.uk/efo/EFO_0007806	total cholesterol change measurement	4
http://www.ebi.ac.uk/efo/EFO_0007807	erythrocyte cadmium measurement	2
http://www.ebi.ac.uk/efo/EFO_0007808	response to bortezomib	2
http://www.ebi.ac.uk/efo/EFO_0007809	response to flupirtine	1
http://www.ebi.ac.uk/efo/EFO_0007810	Plasmodium falciparum antigen IgG1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0007811	Plasmodium falciparum antigen IgG3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0007812	Plasmodium falciparum antigen IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0007813	cotinine measurement	6
http://www.ebi.ac.uk/efo/EFO_0007814	refractive error measurement	10
http://www.ebi.ac.uk/efo/EFO_0007815	response to dabrafenib	1
http://www.ebi.ac.uk/efo/EFO_0007816	response to trametinib	2
http://www.ebi.ac.uk/efo/EFO_0007817	sleep apnea measurement	5
http://www.ebi.ac.uk/efo/EFO_0007818	athletic endurance measurement	3
http://www.ebi.ac.uk/efo/EFO_0007819	advanced glycation end-product measurement	1
http://www.ebi.ac.uk/efo/EFO_0007820	cognitive behavioural therapy	5
http://www.ebi.ac.uk/efo/EFO_0007821	hair morphology measurement	4
http://www.ebi.ac.uk/efo/EFO_0007822	hair colour measurement	21
http://www.ebi.ac.uk/efo/EFO_0007823	facial hair thickness measurement	5
http://www.ebi.ac.uk/efo/EFO_0007824	hair shape measurement	2
http://www.ebi.ac.uk/efo/EFO_0007825	balding measurement	14
http://www.ebi.ac.uk/efo/EFO_0007826	aggressive behaviour measurement	1
http://www.ebi.ac.uk/efo/EFO_0007827	nighttime rest measurement	1
http://www.ebi.ac.uk/efo/EFO_0007828	daytime rest measurement	5
http://www.ebi.ac.uk/efo/EFO_0007829	eating behaviour	2
http://www.ebi.ac.uk/efo/EFO_0007830	food addiction measurement	1
http://www.ebi.ac.uk/efo/EFO_0007835	alcohol dependence measurement	13
http://www.ebi.ac.uk/efo/EFO_0007836	coenzyme Q10 measurement	1
http://www.ebi.ac.uk/efo/EFO_0007837	anti-citrullinated protein antibody seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0007838	response to anti-thyroid drug	2
http://www.ebi.ac.uk/efo/EFO_0007840	pesticide exposure measurement	1
http://www.ebi.ac.uk/efo/EFO_0007841	facial morphology measurement	388
http://www.ebi.ac.uk/efo/EFO_0007842	chin morphology measurement	14
http://www.ebi.ac.uk/efo/EFO_0007843	nose morphology measurement	277
http://www.ebi.ac.uk/efo/EFO_0007844	forehead morphology measurement	12
http://www.ebi.ac.uk/efo/EFO_0007845	lip morphology measurement	63
http://www.ebi.ac.uk/efo/EFO_0007847	cheekbone morphology measurement	19
http://www.ebi.ac.uk/efo/EFO_0007848	apolipoprotein A-IV measurement	1
http://www.ebi.ac.uk/efo/EFO_0007849	functional brain measurement	23
http://www.ebi.ac.uk/efo/EFO_0007850	solar lentigines measurement	1
http://www.ebi.ac.uk/efo/EFO_0007851	seroconversion	1
http://www.ebi.ac.uk/efo/EFO_0007852	thiopurine methyltransferase activity measurement	2
http://www.ebi.ac.uk/efo/EFO_0007853	response to mercaptopurine	5
http://www.ebi.ac.uk/efo/EFO_0007854	knee peak torque measurement	1
http://www.ebi.ac.uk/efo/EFO_0007855	facial width measurement	2
http://www.ebi.ac.uk/efo/EFO_0007856	facial height measurement	3
http://www.ebi.ac.uk/efo/EFO_0007857	facial depth measurement	1
http://www.ebi.ac.uk/efo/EFO_0007858	eye morphology measurement	24
http://www.ebi.ac.uk/efo/EFO_0007859	response to interferon	6
http://www.ebi.ac.uk/efo/EFO_0007860	ADHD symptom measurement	4
http://www.ebi.ac.uk/efo/EFO_0007863	hand, foot and mouth disease, illness severity status	1
http://www.ebi.ac.uk/efo/EFO_0007864	sulfate measurement	2
http://www.ebi.ac.uk/efo/EFO_0007865	loneliness measurement	10
http://www.ebi.ac.uk/efo/EFO_0007866	response to rifampicin	2
http://www.ebi.ac.uk/efo/EFO_0007867	response to gefitinib	1
http://www.ebi.ac.uk/efo/EFO_0007868	response to erlotinib	2
http://www.ebi.ac.uk/efo/EFO_0007869	wellbeing measurement	154
http://www.ebi.ac.uk/efo/EFO_0007870	response to norepinephrine-dopamine reuptake inhibitor	1
http://www.ebi.ac.uk/efo/EFO_0007871	response to escitalopram	8
http://www.ebi.ac.uk/efo/EFO_0007872	caffeine metabolite measurement	6
http://www.ebi.ac.uk/efo/EFO_0007873	cartilage thickness measurement	1
http://www.ebi.ac.uk/efo/EFO_0007874	gut microbiome measurement	696
http://www.ebi.ac.uk/efo/EFO_0007875	excessive daytime sleepiness measurement	8
http://www.ebi.ac.uk/efo/EFO_0007876	insomnia measurement	9
http://www.ebi.ac.uk/efo/EFO_0007877	risky sexual behaviour measurement	4
http://www.ebi.ac.uk/efo/EFO_0007878	alcohol consumption measurement	58
http://www.ebi.ac.uk/efo/EFO_0007879	petaloid toenail	1
http://www.ebi.ac.uk/efo/EFO_0007880	response to dendritic cell-based immunotherapy	1
http://www.ebi.ac.uk/efo/EFO_0007881	job-related exhaustion measurement	1
http://www.ebi.ac.uk/efo/EFO_0007883	taxonomic microbiome measurement	1
http://www.ebi.ac.uk/efo/EFO_0007885	JT interval	2
http://www.ebi.ac.uk/efo/EFO_0007886	DDT metabolite measurement	2
http://www.ebi.ac.uk/efo/EFO_0007887	autosomal dominant compelling helio-ophthalmic outburst syndrome	3
http://www.ebi.ac.uk/efo/EFO_0007888	age at voice drop	7
http://www.ebi.ac.uk/efo/EFO_0007889	dysmenorrheic pain measurement	3
http://www.ebi.ac.uk/efo/EFO_0007890	pericardial adipose tissue measurement	7
http://www.ebi.ac.uk/efo/EFO_0007891	skin barrier function measurement	1
http://www.ebi.ac.uk/efo/EFO_0007892	donor genotype effect measurement	10
http://www.ebi.ac.uk/efo/EFO_0007893	alpha-carotene measurement	1
http://www.ebi.ac.uk/efo/EFO_0007894	beta-carotene measurement	1
http://www.ebi.ac.uk/efo/EFO_0007895	lutein measurement	1
http://www.ebi.ac.uk/efo/EFO_0007896	zeaxanthin measurement	1
http://www.ebi.ac.uk/efo/EFO_0007897	cryptoxanthin measurement	1
http://www.ebi.ac.uk/efo/EFO_0007898	alpha-tocopherol measurement	1
http://www.ebi.ac.uk/efo/EFO_0007899	gamma-tocopherol measurement	1
http://www.ebi.ac.uk/efo/EFO_0007900	retinol measurement	1
http://www.ebi.ac.uk/efo/EFO_0007901	hepcidin:ferritin ratio	1
http://www.ebi.ac.uk/efo/EFO_0007902	hepcidin:transferrin saturation ratio	1
http://www.ebi.ac.uk/efo/EFO_0007903	magnesium:calcium ratio	1
http://www.ebi.ac.uk/efo/EFO_0007904	susceptibility to childhood ear infection measurement	3
http://www.ebi.ac.uk/efo/EFO_0007905	joint hypermobility measurement	1
http://www.ebi.ac.uk/efo/EFO_0007906	synophrys measurement	1
http://www.ebi.ac.uk/efo/EFO_0007907	methadone dose measurement	2
http://www.ebi.ac.uk/efo/EFO_0007908	traffic air pollution measurement	6
http://www.ebi.ac.uk/efo/EFO_0007909	CHGA cleavage product measurement	1
http://www.ebi.ac.uk/efo/EFO_0007910	CHGB cleavage product measurement	1
http://www.ebi.ac.uk/efo/EFO_0007911	personality trait measurement	1
http://www.ebi.ac.uk/efo/EFO_0007912	conscientiousness measurement	3
http://www.ebi.ac.uk/efo/EFO_0007913	extraversion measurement	2
http://www.ebi.ac.uk/efo/EFO_0007914	openness measurement	4
http://www.ebi.ac.uk/efo/EFO_0007915	agreeableness measurement	2
http://www.ebi.ac.uk/efo/EFO_0007916	response to tricyclic antidepressant	2
http://www.ebi.ac.uk/efo/EFO_0007917	response to tetracyclic antidepressant	2
http://www.ebi.ac.uk/efo/EFO_0007918	response to anti-tuberculosis drug	5
http://www.ebi.ac.uk/efo/EFO_0007919	response to diclofenac	1
http://www.ebi.ac.uk/efo/EFO_0007920	response to fluoroquinolones	1
http://www.ebi.ac.uk/efo/EFO_0007921	response to nitrofurantoin	1
http://www.ebi.ac.uk/efo/EFO_0007922	response to sulfonylurea	3
http://www.ebi.ac.uk/efo/EFO_0007923	response to terbinafine	1
http://www.ebi.ac.uk/efo/EFO_0007924	tonsillectomy risk measurement	3
http://www.ebi.ac.uk/efo/EFO_0007925	response to paliperidone	5
http://www.ebi.ac.uk/efo/EFO_0007927	schizophrenia symptom severity measurement	5
http://www.ebi.ac.uk/efo/EFO_0007928	ventricular rate measurement	2
http://www.ebi.ac.uk/efo/EFO_0007929	triglyceride:HDL cholesterol ratio	1
http://www.ebi.ac.uk/efo/EFO_0007930	LDL cholesterol:HDL cholesterol ratio	1
http://www.ebi.ac.uk/efo/EFO_0007931	non-HDL cholesterol:HDL cholesterol ratio	1
http://www.ebi.ac.uk/efo/EFO_0007932	multiple keratinocyte carcinoma susceptibility measurement	1
http://www.ebi.ac.uk/efo/EFO_0007933	radius bone mineral density	4
http://www.ebi.ac.uk/efo/EFO_0007934	creatinine clearance measurement	6
http://www.ebi.ac.uk/efo/EFO_0007935	urinary uric acid to creatinine ratio	1
http://www.ebi.ac.uk/efo/EFO_0007936	disease prognosis measurement	4
http://www.ebi.ac.uk/efo/EFO_0007937	blood protein measurement	1069
http://www.ebi.ac.uk/efo/EFO_0007938	coronary atherosclerosis measurement	4
http://www.ebi.ac.uk/efo/EFO_0007939	respiratory symptom measurement	15
http://www.ebi.ac.uk/efo/EFO_0007940	chronic venous insufficiency	1
http://www.ebi.ac.uk/efo/EFO_0007941	LDH-related sciatica symptom severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0007942	hip osteoarthritis symptom severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0007943	response to platinum-based neoadjuvant chemotherapy	1
http://www.ebi.ac.uk/efo/EFO_0007944	allergen exposure measurement	2
http://www.ebi.ac.uk/efo/EFO_0007945	agoraphobia symptom measurement	1
http://www.ebi.ac.uk/efo/EFO_0007946	tiredness measurement	1
http://www.ebi.ac.uk/efo/EFO_0007947	serum galactose-deficient IgA1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0007948	HIV-associated neurocognitive disorder	4
http://www.ebi.ac.uk/efo/EFO_0007949	acute-on-chronic liver failure	1
http://www.ebi.ac.uk/efo/EFO_0007955	mouth morphology measurement	6
http://www.ebi.ac.uk/efo/EFO_0007956	monocyte:lymphocyte ratio	1
http://www.ebi.ac.uk/efo/EFO_0007957	urinary 1,3-butadiene measurement	1
http://www.ebi.ac.uk/efo/EFO_0007959	fetal genotype effect measurement	15
http://www.ebi.ac.uk/efo/EFO_0007960	organochlorine pesticide measurement	2
http://www.ebi.ac.uk/efo/EFO_0007961	polybrominated biphenyl measurement	2
http://www.ebi.ac.uk/efo/EFO_0007962	polybrominated diphenyl ether measurement	2
http://www.ebi.ac.uk/efo/EFO_0007963	abnormal paneth cell measurement	1
http://www.ebi.ac.uk/efo/EFO_0007964	gestational serum measurement	8
http://www.ebi.ac.uk/efo/EFO_0007965	response to combination chemotherapy	5
http://www.ebi.ac.uk/efo/EFO_0007966	clopidogrel metabolite measurement	1
http://www.ebi.ac.uk/efo/EFO_0007967	blood osmolality measurement	1
http://www.ebi.ac.uk/efo/EFO_0007968	tissue factor pathway inhibitor measurement	1
http://www.ebi.ac.uk/efo/EFO_0007969	cognitive inhibition measurement	3
http://www.ebi.ac.uk/efo/EFO_0007970	estrone measurement	5
http://www.ebi.ac.uk/efo/EFO_0007971	estrone conjugate measurement	3
http://www.ebi.ac.uk/efo/EFO_0007972	androstenedione measurement	3
http://www.ebi.ac.uk/efo/EFO_0007973	palmitoleic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007974	vaccenic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007975	gondoic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007976	erucic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007977	nervonic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0007978	red blood cell density measurement	7
http://www.ebi.ac.uk/efo/EFO_0007979	childhood trauma measurement	8
http://www.ebi.ac.uk/efo/EFO_0007980	cerebral blood flow measurement	1
http://www.ebi.ac.uk/efo/EFO_0007981	response to thiazide	4
http://www.ebi.ac.uk/efo/EFO_0007982	mild neurocognitive disorder	2
http://www.ebi.ac.uk/efo/EFO_0007983	asymptomatic neurocognitive impairment	2
http://www.ebi.ac.uk/efo/EFO_0007984	platelet component distribution width	6
http://www.ebi.ac.uk/efo/EFO_0007985	platelet crit	4
http://www.ebi.ac.uk/efo/EFO_0007986	reticulocyte count	14
http://www.ebi.ac.uk/efo/EFO_0007987	granulocyte count	4
http://www.ebi.ac.uk/efo/EFO_0007988	myeloid white cell count	8
http://www.ebi.ac.uk/efo/EFO_0007989	monocyte percentage of leukocytes	4
http://www.ebi.ac.uk/efo/EFO_0007990	neutrophil percentage of leukocytes	4
http://www.ebi.ac.uk/efo/EFO_0007991	eosinophil percentage of leukocytes	4
http://www.ebi.ac.uk/efo/EFO_0007992	basophil percentage of leukocytes	4
http://www.ebi.ac.uk/efo/EFO_0007993	lymphocyte percentage of leukocytes	4
http://www.ebi.ac.uk/efo/EFO_0007994	neutrophil percentage of granulocytes	1
http://www.ebi.ac.uk/efo/EFO_0007995	basophil percentage of granulocytes	1
http://www.ebi.ac.uk/efo/EFO_0007996	eosinophil percentage of granulocytes	1
http://www.ebi.ac.uk/efo/EFO_0007997	granulocyte percentage of myeloid white cells	1
http://www.ebi.ac.uk/efo/EFO_0007998	cognitive impairment measurement	3
http://www.ebi.ac.uk/efo/EFO_0007999	lower body strength measurement	1
http://www.ebi.ac.uk/efo/EFO_0008000	peak insulin response measurement	3
http://www.ebi.ac.uk/efo/EFO_0008001	insulin secretion measurement	3
http://www.ebi.ac.uk/efo/EFO_0008002	physical activity measurement	118
http://www.ebi.ac.uk/efo/EFO_0008003	heart rate variability measurement	6
http://www.ebi.ac.uk/efo/EFO_0008004	resting metabolic rate measurement	1
http://www.ebi.ac.uk/efo/EFO_0008005	energy expenditure measurement	2
http://www.ebi.ac.uk/efo/EFO_0008006	skin aging measurement	4
http://www.ebi.ac.uk/efo/EFO_0008007	age at assessment	16
http://www.ebi.ac.uk/efo/EFO_0008008	lower urinary tract symptom	4
http://www.ebi.ac.uk/efo/EFO_0008009	1,5 anhydroglucitol measurement	2
http://www.ebi.ac.uk/efo/EFO_0008011	a disintegrin and metalloproteinase with thrombospondin motifs 13	1
http://www.ebi.ac.uk/efo/EFO_0008016	Agouti-related protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0008024	angiostatin measurement	1
http://www.ebi.ac.uk/efo/EFO_0008035	beta-nerve growth factor measurement	3
http://www.ebi.ac.uk/efo/EFO_0008036	BMI-adjusted fasting blood glucose measurement	3
http://www.ebi.ac.uk/efo/EFO_0008037	BMI-adjusted fasting blood insulin measurement	2
http://www.ebi.ac.uk/efo/EFO_0008038	BMI-adjusted hip bone size	1
http://www.ebi.ac.uk/efo/EFO_0008039	BMI-adjusted hip circumference	8
http://www.ebi.ac.uk/efo/EFO_0008051	C-C motif chemokine 3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008054	C-C motif chemokine 7 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008056	C-X-C motif chemokine 10 measurement	3
http://www.ebi.ac.uk/efo/EFO_0008059	C-X-C motif chemokine 6 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008069	carboxypeptidase B2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008082	chemokine (C-C motif) ligand 27 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008083	chemokine (C-X-C motif) ligand 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008087	coagulation factor V measurement	3
http://www.ebi.ac.uk/efo/EFO_0008090	complement C1r subcomponent measurement	1
http://www.ebi.ac.uk/efo/EFO_0008091	complement C1s subcomponent measurement	1
http://www.ebi.ac.uk/efo/EFO_0008094	complement component C8 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008096	complement factor B measurement	1
http://www.ebi.ac.uk/efo/EFO_0008097	complement factor H measurement	3
http://www.ebi.ac.uk/efo/EFO_0008098	complement factor H-related protein 5 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008103	cystatin-D measurement	1
http://www.ebi.ac.uk/efo/EFO_0008111	diet measurement	32
http://www.ebi.ac.uk/efo/EFO_0008122	eotaxin measurement	1
http://www.ebi.ac.uk/efo/EFO_0008130	fibroblast growth factor basic measurement	3
http://www.ebi.ac.uk/efo/EFO_0008137	galectin-3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008142	granulocyte colony-stimulating factor measurement	3
http://www.ebi.ac.uk/efo/EFO_0008146	growth-regulated alpha protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0008165	interferon gamma measurement	4
http://www.ebi.ac.uk/efo/EFO_0008167	interleukin 1 Receptor accessory protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0008168	interleukin 1 receptor-like 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008169	interleukin 1 receptor-like 2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008170	interleukin 12 receptor subunit beta-1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008171	interleukin 13 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008172	interleukin 15 receptor subunit alpha measurement	1
http://www.ebi.ac.uk/efo/EFO_0008173	interleukin 16 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008174	interleukin 17 measurement	4
http://www.ebi.ac.uk/efo/EFO_0008175	interleukin 17 receptor A measurement	1
http://www.ebi.ac.uk/efo/EFO_0008176	interleukin 17 receptor B measurement	1
http://www.ebi.ac.uk/efo/EFO_0008178	interleukin 18 receptor 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008184	interleukin 4 measurement	4
http://www.ebi.ac.uk/efo/EFO_0008185	interleukin 5 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008187	interleukin 6 receptor subunit alpha measurement	3
http://www.ebi.ac.uk/efo/EFO_0008188	interleukin 6 receptor subunit beta measurement	1
http://www.ebi.ac.uk/efo/EFO_0008189	interleukin 7 measurement	2
http://www.ebi.ac.uk/efo/EFO_0008190	interleukin 7 receptor subunit alpha measurement	1
http://www.ebi.ac.uk/efo/EFO_0008191	interleukin 8 measurement	3
http://www.ebi.ac.uk/efo/EFO_0008192	interleukin 9 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008202	L-Selectin measurement	1
http://www.ebi.ac.uk/efo/EFO_0008203	lactadherin measurement	1
http://www.ebi.ac.uk/efo/EFO_0008204	left ventricular diastolic function measurement	18
http://www.ebi.ac.uk/efo/EFO_0008205	left ventricular structural measurement	16
http://www.ebi.ac.uk/efo/EFO_0008206	left ventricular systolic function measurement	8
http://www.ebi.ac.uk/efo/EFO_0008217	macrophage colony stimulating factor measurement	2
http://www.ebi.ac.uk/efo/EFO_0008218	macrophage inflammatory protein 1a measurement	1
http://www.ebi.ac.uk/efo/EFO_0008219	macrophage inflammatory protein 1b measurement	1
http://www.ebi.ac.uk/efo/EFO_0008221	macrophage migration inhibitory factor measurement	1
http://www.ebi.ac.uk/efo/EFO_0008226	MAP kinase-activated protein kinase 3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008229	melanoma-derived growth regulatory protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0008230	mental development measurement	2
http://www.ebi.ac.uk/efo/EFO_0008233	MHC class I polypeptide-related sequence A measurement	1
http://www.ebi.ac.uk/efo/EFO_0008235	monocyte chemotactic protein 3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008236	monokine induced by gamma interferon measurement	1
http://www.ebi.ac.uk/efo/EFO_0008237	motor development measurement	2
http://www.ebi.ac.uk/efo/EFO_0008241	NAD-dependent protein deacetylase sirtuin-2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008242	NADPH--cytochrome P450 reductase measurement	1
http://www.ebi.ac.uk/efo/EFO_0008254	P-Selectin measurement	1
http://www.ebi.ac.uk/efo/EFO_0008255	particulate matter air pollution measurement	3
http://www.ebi.ac.uk/efo/EFO_0008259	phospholipase A2, membrane associated measurement	1
http://www.ebi.ac.uk/efo/EFO_0008264	platelet-derived growth factor BB measurement	4
http://www.ebi.ac.uk/efo/EFO_0008282	serum amyloid A-1 protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0008287	SLAM family member 7 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008290	spondin-1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008291	stem Cell Factor measurement	3
http://www.ebi.ac.uk/efo/EFO_0008292	stem Cell Growth Factor beta measurement	1
http://www.ebi.ac.uk/efo/EFO_0008293	stromal cell-derived factor 1 alpha measurement	3
http://www.ebi.ac.uk/efo/EFO_0008300	TNF-related apoptosis-inducing ligand measurement	2
http://www.ebi.ac.uk/efo/EFO_0008307	tuberculin skin test reactivity measurement	2
http://www.ebi.ac.uk/efo/EFO_0008308	tumor necrosis factor beta measurement	2
http://www.ebi.ac.uk/efo/EFO_0008316	vaso-occlusive pain measurement	1
http://www.ebi.ac.uk/efo/EFO_0008317	very low density lipoprotein cholesterol measurement	22
http://www.ebi.ac.uk/efo/EFO_0008318	vitamin K-dependent protein C measurement	1
http://www.ebi.ac.uk/efo/EFO_0008320	white matter volume measurement	2
http://www.ebi.ac.uk/efo/EFO_0008322	decreased susceptibility to bacterial infection	4
http://www.ebi.ac.uk/efo/EFO_0008324	response to sulfasalazine	4
http://www.ebi.ac.uk/efo/EFO_0008325	response to sotalol	7
http://www.ebi.ac.uk/efo/EFO_0008328	chronotype measurement	22
http://www.ebi.ac.uk/efo/EFO_0008329	facial emotion recognition measurement	8
http://www.ebi.ac.uk/efo/EFO_0008330	fear of pain measurement	1
http://www.ebi.ac.uk/efo/EFO_0008331	interleukin 2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008332	interleukin 2 receptor antagonist measurement	1
http://www.ebi.ac.uk/efo/EFO_0008333	T wave amplitude	4
http://www.ebi.ac.uk/efo/EFO_0008334	TpTe measurement	4
http://www.ebi.ac.uk/efo/EFO_0008335	ventricular repolarisation duration measurement	4
http://www.ebi.ac.uk/efo/EFO_0008336	disease progression measurement	27
http://www.ebi.ac.uk/efo/EFO_0008337	psychosis predisposition measurement	11
http://www.ebi.ac.uk/efo/EFO_0008338	fear of severe pain measurement	1
http://www.ebi.ac.uk/efo/EFO_0008339	fear of medical pain measurement	1
http://www.ebi.ac.uk/efo/EFO_0008340	fear of minor pain measurement	1
http://www.ebi.ac.uk/efo/EFO_0008341	snoring measurement	9
http://www.ebi.ac.uk/efo/EFO_0008342	parental emotion expression measurmement	2
http://www.ebi.ac.uk/efo/EFO_0008343	sex interaction measurement	47
http://www.ebi.ac.uk/efo/EFO_0008344	response to placebo	8
http://www.ebi.ac.uk/efo/EFO_0008345	response to duloxetine	3
http://www.ebi.ac.uk/efo/EFO_0008346	family history of upper gastrointestinal cancer	1
http://www.ebi.ac.uk/efo/EFO_0008347	response to trastuzumab	3
http://www.ebi.ac.uk/efo/EFO_0008348	response to ranibizumab	4
http://www.ebi.ac.uk/efo/EFO_0008349	thiazide-induced hyponatremia	1
http://www.ebi.ac.uk/efo/EFO_0008353	cellular adhesion molecule measurement	1
http://www.ebi.ac.uk/efo/EFO_0008354	cognitive function measurement	304
http://www.ebi.ac.uk/efo/EFO_0008355	dietary heme iron intake measurement	1
http://www.ebi.ac.uk/efo/EFO_0008358	dorsolateral prefrontal cortex functional measurement	1
http://www.ebi.ac.uk/efo/EFO_0008360	environmental exposure measurement	3
http://www.ebi.ac.uk/efo/EFO_0008361	environmental tobacco smoke exposure measurement	3
http://www.ebi.ac.uk/efo/EFO_0008362	farm exposure measurement	1
http://www.ebi.ac.uk/efo/EFO_0008364	generational effect measurement	1
http://www.ebi.ac.uk/efo/EFO_0008365	heart amyloid deposition measurement	2
http://www.ebi.ac.uk/efo/EFO_0008366	IgG isotype profile measurement	5
http://www.ebi.ac.uk/efo/EFO_0008367	infant cerebrospinal fluid volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0008368	infant grey matter volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0008369	infant intracranial volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0008370	infant white matter volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0008371	kidney amyloid deposition measurement	2
http://www.ebi.ac.uk/efo/EFO_0008372	laterality measurement	1
http://www.ebi.ac.uk/efo/EFO_0008373	left ventricular ejection fraction measurement	7
http://www.ebi.ac.uk/efo/EFO_0008374	liver amyloid deposition measurement	1
http://www.ebi.ac.uk/efo/EFO_0008375	macula measurement	2
http://www.ebi.ac.uk/efo/EFO_0008377	mosquito bite reaction itch intensity measurement	3
http://www.ebi.ac.uk/efo/EFO_0008378	mosquito bite reaction size measurement	3
http://www.ebi.ac.uk/efo/EFO_0008379	P wave terminal force measurement	1
http://www.ebi.ac.uk/efo/EFO_0008380	perceived unattractiveness to mosquitos measurement	1
http://www.ebi.ac.uk/efo/EFO_0008381	total cortical area measurement	2
http://www.ebi.ac.uk/efo/EFO_0008382	TP53 mutation status	1
http://www.ebi.ac.uk/efo/EFO_0008383	treatment outcome measurement	1
http://www.ebi.ac.uk/efo/EFO_0008384	tumor necrosis factor receptor II measurement	2
http://www.ebi.ac.uk/efo/EFO_0008385	visual acuity measurement	15
http://www.ebi.ac.uk/efo/EFO_0008386	body odor measurement	1
http://www.ebi.ac.uk/efo/EFO_0008387	caudate nucleus measurement	2
http://www.ebi.ac.uk/efo/EFO_0008388	gamma wave measurement	1
http://www.ebi.ac.uk/efo/EFO_0008389	putamen measurement	2
http://www.ebi.ac.uk/efo/EFO_0008390	prothrombin time measurement	4
http://www.ebi.ac.uk/efo/EFO_0008391	erythropoetin measurement	2
http://www.ebi.ac.uk/efo/EFO_0008392	triiodothyronine measurement	3
http://www.ebi.ac.uk/efo/EFO_0008393	reaction time measurement	4
http://www.ebi.ac.uk/efo/EFO_0008394	verbal-numerical reasoning measurement	2
http://www.ebi.ac.uk/efo/EFO_0008395	response to darapladib	9
http://www.ebi.ac.uk/efo/EFO_0008396	response to reward	2
http://www.ebi.ac.uk/efo/EFO_0008397	response to disappointment	2
http://www.ebi.ac.uk/efo/EFO_0008398	T wave morphology measurement	5
http://www.ebi.ac.uk/efo/EFO_0008399	mean fractional anisotropy measurement	1
http://www.ebi.ac.uk/efo/EFO_0008400	susceptibility to chickenpox measurement	1
http://www.ebi.ac.uk/efo/EFO_0008401	susceptibility to shingles measurement	5
http://www.ebi.ac.uk/efo/EFO_0008402	susceptibility to cold sores measurement	1
http://www.ebi.ac.uk/efo/EFO_0008403	susceptibility to mononucleosis measurement	1
http://www.ebi.ac.uk/efo/EFO_0008404	susceptibility to mumps measurement	1
http://www.ebi.ac.uk/efo/EFO_0008405	susceptibility to hepatitis B infection measurement	2
http://www.ebi.ac.uk/efo/EFO_0008406	susceptibility to plantar warts measurement	1
http://www.ebi.ac.uk/efo/EFO_0008407	susceptibility to Mycobacterium tuberculosis infection measurement	2
http://www.ebi.ac.uk/efo/EFO_0008408	susceptibility to strep throat measurement	1
http://www.ebi.ac.uk/efo/EFO_0008409	susceptibility to scarlet fever measurement	1
http://www.ebi.ac.uk/efo/EFO_0008410	susceptibility to pneumonia measurement	1
http://www.ebi.ac.uk/efo/EFO_0008411	susceptibility to bacterial meningitis measurement	1
http://www.ebi.ac.uk/efo/EFO_0008412	susceptibility to vaginal yeast infection measurement	1
http://www.ebi.ac.uk/efo/EFO_0008413	susceptibility to urinary tract infection measurement	1
http://www.ebi.ac.uk/efo/EFO_0008414	susceptibility to measles measurement	1
http://www.ebi.ac.uk/efo/EFO_0008415	susceptibility to hepatitis A infection measurement	1
http://www.ebi.ac.uk/efo/EFO_0008416	susceptibility to rheumatic fever measurement	3
http://www.ebi.ac.uk/efo/EFO_0008417	susceptibility to common cold measurement	1
http://www.ebi.ac.uk/efo/EFO_0008418	susceptibility to rubella infection measurement	1
http://www.ebi.ac.uk/efo/EFO_0008419	susceptibility to chronic sinus infection measurement	1
http://www.ebi.ac.uk/efo/EFO_0008420	parietal cortex measurement	2
http://www.ebi.ac.uk/efo/EFO_0008421	non-alcoholic fatty liver disease severity measurement	7
http://www.ebi.ac.uk/efo/EFO_0008422	susceptibility to infectious disease measurement	2
http://www.ebi.ac.uk/efo/EFO_0008423	IgG monogalactosylation measurement	1
http://www.ebi.ac.uk/efo/EFO_0008424	IgG digalactosylation measurement	1
http://www.ebi.ac.uk/efo/EFO_0008425	IgG galactosylation measurement	2
http://www.ebi.ac.uk/efo/EFO_0008426	IgG bisecting N-acetyl glucosamine measurement	2
http://www.ebi.ac.uk/efo/EFO_0008427	IgG fucosylation measurement	2
http://www.ebi.ac.uk/efo/EFO_0008428	IgG sialylation measurement	2
http://www.ebi.ac.uk/efo/EFO_0008429	IgG disialylation measurement	1
http://www.ebi.ac.uk/efo/EFO_0008430	IgG monosialylation measurement	1
http://www.ebi.ac.uk/efo/EFO_0008431	maximal voluntary ventilation	1
http://www.ebi.ac.uk/efo/EFO_0008432	lipoprotein-associated phospholipase A(2) change measurement	2
http://www.ebi.ac.uk/efo/EFO_0008433	pursuit maintenance gain measurement	2
http://www.ebi.ac.uk/efo/EFO_0008434	initial pursuit acceleration	2
http://www.ebi.ac.uk/efo/EFO_0008435	gestational weight gain measurement	2
http://www.ebi.ac.uk/efo/EFO_0008436	late gestational weight gain	2
http://www.ebi.ac.uk/efo/EFO_0008437	early gestational weight gain	2
http://www.ebi.ac.uk/efo/EFO_0008438	growth hormone measurement	2
http://www.ebi.ac.uk/efo/EFO_0008446	platelet-to-lymphocyte ratio	1
http://www.ebi.ac.uk/efo/EFO_0008447	neutrophil-to-lymphocyte ratio	1
http://www.ebi.ac.uk/efo/EFO_0008449	magnesium:creatinine ratio measurement	1
http://www.ebi.ac.uk/efo/EFO_0008450	fractional excretion of magnesium measurement	1
http://www.ebi.ac.uk/efo/EFO_0008451	activities of daily living score measurement	3
http://www.ebi.ac.uk/efo/EFO_0008452	mid-arm muscle circumference measurement	1
http://www.ebi.ac.uk/efo/EFO_0008453	calf circumference measurement	1
http://www.ebi.ac.uk/efo/EFO_0008454	short physical performance battery score measurement	1
http://www.ebi.ac.uk/efo/EFO_0008455	sleep apnea measurement during REM sleep	1
http://www.ebi.ac.uk/efo/EFO_0008456	sleep apnea measurement during non-REM sleep	1
http://www.ebi.ac.uk/efo/EFO_0008457	cannabis dependence measurement	10
http://www.ebi.ac.uk/efo/EFO_0008458	tacrolimus measurement	3
http://www.ebi.ac.uk/efo/EFO_0008459	response to mepolizumab	6
http://www.ebi.ac.uk/efo/EFO_0008460	colorectal health	1
http://www.ebi.ac.uk/efo/EFO_0008462	pregnancy induced alloimmunization	4
http://www.ebi.ac.uk/efo/EFO_0008463	glucagon measurement	7
http://www.ebi.ac.uk/efo/EFO_0008464	glucose-dependent insulinotropic peptide measurement	2
http://www.ebi.ac.uk/efo/EFO_0008465	glucagon-like peptide-1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0008466	matrix metalloproteinase 8 measurement	1
http://www.ebi.ac.uk/efo/EFO_0008467	behavioural inhibitory control measurement	3
http://www.ebi.ac.uk/efo/EFO_0008468	midregional pro atrial natriuretic peptide measurement	1
http://www.ebi.ac.uk/efo/EFO_0008469	B-type natriuretic peptide to N-terminal pro B-type natriuretic peptide ratio	1
http://www.ebi.ac.uk/efo/EFO_0008470	dietary potassium intake measurement	4
http://www.ebi.ac.uk/efo/EFO_0008473	insulin response measurement	6
http://www.ebi.ac.uk/efo/EFO_0008474	spine bone mineral density change measurement	1
http://www.ebi.ac.uk/efo/EFO_0008475	mood instability measurement	8
http://www.ebi.ac.uk/efo/EFO_0008476	delayed reward discounting measurement	2
http://www.ebi.ac.uk/efo/EFO_0008483	response to trauma exposure	12
http://www.ebi.ac.uk/efo/EFO_0008484	response to carbamazepine	9
http://www.ebi.ac.uk/efo/EFO_0008486	male homosexuality	1
http://www.ebi.ac.uk/efo/EFO_0008487	lateral ventricle volume measurement	3
http://www.ebi.ac.uk/efo/EFO_0008505	hepatitis virus-related hepatocellular carcinoma	2
http://www.ebi.ac.uk/efo/EFO_0008506	hyperparathyroidism	4
http://www.ebi.ac.uk/efo/EFO_0008511	metopic craniosynostosis	1
http://www.ebi.ac.uk/efo/EFO_0008518	polymyalgia rheumatica	8
http://www.ebi.ac.uk/efo/EFO_0008521	rhinitis	2
http://www.ebi.ac.uk/efo/EFO_0008529	kynurenine measurement	3
http://www.ebi.ac.uk/efo/EFO_0008530	kynurenine:tryptophan ratio	1
http://www.ebi.ac.uk/efo/EFO_0008531	GLP-1-stimulated insulin response	1
http://www.ebi.ac.uk/efo/EFO_0008532	clinically amyopathic dermatomyositis	1
http://www.ebi.ac.uk/efo/EFO_0008533	dyspepsia	9
http://www.ebi.ac.uk/efo/EFO_0008534	tryptophan measurement	2
http://www.ebi.ac.uk/efo/EFO_0008535	post-traumatic stress disorder symptom measurement	3
http://www.ebi.ac.uk/efo/EFO_0008536	anti-centromere-antibody-positive systemic scleroderma	2
http://www.ebi.ac.uk/efo/EFO_0008537	anti-topoisomerase-I-antibody-positive systemic scleroderma	2
http://www.ebi.ac.uk/efo/EFO_0008538	helping behavior measurement	1
http://www.ebi.ac.uk/efo/EFO_0008539	vitamin D dietary intake measurement	1
http://www.ebi.ac.uk/efo/EFO_0008541	response to opioid	5
http://www.ebi.ac.uk/efo/EFO_0008543	c3d:C3 ratio	1
http://www.ebi.ac.uk/efo/EFO_0008544	analgesia requirement measurement	1
http://www.ebi.ac.uk/efo/EFO_0008546	poisoning	26
http://www.ebi.ac.uk/efo/EFO_0008553	femur fracture	2
http://www.ebi.ac.uk/efo/EFO_0008560	female infertility	6
http://www.ebi.ac.uk/efo/EFO_0008561	diaphragmatic hernia	4
http://www.ebi.ac.uk/efo/EFO_0008568	Sleep Disorder	18
http://www.ebi.ac.uk/efo/EFO_0008573	alcoholic liver disease	6
http://www.ebi.ac.uk/efo/EFO_0008574	gangrene	2
http://www.ebi.ac.uk/efo/EFO_0008578	sperm motility measurement	1
http://www.ebi.ac.uk/efo/EFO_0008579	risk-taking behaviour	8
http://www.ebi.ac.uk/efo/EFO_0008580	response to taxane	3
http://www.ebi.ac.uk/efo/EFO_0008581	salivary gland disease	2
http://www.ebi.ac.uk/efo/EFO_0008582	thrombin activatable fibrinolysis inhibitor activation peptide measurement	1
http://www.ebi.ac.uk/efo/EFO_0008583	acute myocardial infarction	4
http://www.ebi.ac.uk/efo/EFO_0008584	Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction	2
http://www.ebi.ac.uk/efo/EFO_0008585	ST Elevation Myocardial Infarction	4
http://www.ebi.ac.uk/efo/EFO_0008586	Non-ST Elevation Myocardial Infarction	2
http://www.ebi.ac.uk/efo/EFO_0008588	peritonitis	8
http://www.ebi.ac.uk/efo/EFO_0008589	esterified cholesterol measurement	9
http://www.ebi.ac.uk/efo/EFO_0008591	free cholesterol measurement	8
http://www.ebi.ac.uk/efo/EFO_0008592	high density lipoprotein particle size measurement	1
http://www.ebi.ac.uk/efo/EFO_0008593	low density lipoprotein particle size measurement	1
http://www.ebi.ac.uk/efo/EFO_0008594	very low density lipoprotein particle size measurement	1
http://www.ebi.ac.uk/efo/EFO_0008595	intermediate density lipoprotein measurement	5
http://www.ebi.ac.uk/efo/EFO_0008596	chylomicron measurement	2
http://www.ebi.ac.uk/efo/EFO_0008601	pemphigus foliaceus	2
http://www.ebi.ac.uk/efo/EFO_0008615	Cystic Kidney Disease	2
http://www.ebi.ac.uk/efo/EFO_0008620	Polycystic Kidney Disease	2
http://www.ebi.ac.uk/efo/EFO_0008622	female genital tract polyp	2
http://www.ebi.ac.uk/efo/EFO_0008624	vitreous body disease	4
http://www.ebi.ac.uk/efo/EFO_0008626	vitreous hemorrhage	2
http://www.ebi.ac.uk/efo/EFO_0009001	Mastocytosis	2
http://www.ebi.ac.uk/efo/EFO_0009002	splenic disease	2
http://www.ebi.ac.uk/efo/EFO_0009003	ovarian dysfunction	2
http://www.ebi.ac.uk/efo/EFO_0009010	HSV2 virologic severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0009029	Central precocious puberty	1
http://www.ebi.ac.uk/efo/EFO_0009087	non-typhoidal Salmonella bacteremia	1
http://www.ebi.ac.uk/efo/EFO_0009092	breast milk measurement	29
http://www.ebi.ac.uk/efo/EFO_0009093	choroidal melanoma	1
http://www.ebi.ac.uk/efo/EFO_0009094	idiopathic dilated cardiomyopathy	1
http://www.ebi.ac.uk/efo/EFO_0009096	negative domain measurement	1
http://www.ebi.ac.uk/efo/EFO_0009097	positive domain measurement	1
http://www.ebi.ac.uk/efo/EFO_0009098	cognitive domain measurement	1
http://www.ebi.ac.uk/efo/EFO_0009099	arousal domain measurement	1
http://www.ebi.ac.uk/efo/EFO_0009100	social domain measurement	1
http://www.ebi.ac.uk/efo/EFO_0009101	age at first birth measurement	12
http://www.ebi.ac.uk/efo/EFO_0009102	number of children ever born measurement	5
http://www.ebi.ac.uk/efo/EFO_0009103	theory of mind measurement	1
http://www.ebi.ac.uk/efo/EFO_0009104	hyperuricemia	4
http://www.ebi.ac.uk/efo/EFO_0009105	high altitude adaptation	1
http://www.ebi.ac.uk/efo/EFO_0009113	alcohol exposure measurement	44
http://www.ebi.ac.uk/efo/EFO_0009115	tobacco smoke exposure measurement	4
http://www.ebi.ac.uk/efo/EFO_0009116	vitamin supplement exposure measurement	18
http://www.ebi.ac.uk/efo/EFO_0009130	clostridium difficile infection	6
http://www.ebi.ac.uk/efo/EFO_0009131	response to polyunsaturated fatty acid supplementation	3
http://www.ebi.ac.uk/efo/EFO_0009132	cholesterol efflux capacity measurement	5
http://www.ebi.ac.uk/efo/EFO_0009133	cholesteryl ester transfer protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0009134	trimethyllysine measurement	1
http://www.ebi.ac.uk/efo/EFO_0009168	response to prednisolone	1
http://www.ebi.ac.uk/efo/EFO_0009170	response to tyrosine kinase inhibitor	15
http://www.ebi.ac.uk/efo/EFO_0009175	response to synacthen	2
http://www.ebi.ac.uk/efo/EFO_0009176	adrenal suppression measurement	2
http://www.ebi.ac.uk/efo/EFO_0009177	myopic maculopathy severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0009178	neurofilament light chain measurement	3
http://www.ebi.ac.uk/efo/EFO_0009179	beta-secretase 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0009180	rosacea severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0009181	growth differentiation factor 15 measurement	4
http://www.ebi.ac.uk/efo/EFO_0009182	psychotic symptom measurement	29
http://www.ebi.ac.uk/efo/EFO_0009183	empathy measurement	2
http://www.ebi.ac.uk/efo/EFO_0009184	heart rate response to exercise	4
http://www.ebi.ac.uk/efo/EFO_0009185	heart rate response to recovery post exercise	6
http://www.ebi.ac.uk/efo/EFO_0009188	Red cell distribution width	2
http://www.ebi.ac.uk/efo/EFO_0009189	Hyperthyroidism	8
http://www.ebi.ac.uk/efo/EFO_0009190	Thyrotoxicosis	12
http://www.ebi.ac.uk/efo/EFO_0009253	Immature Reticulocyte Fraction Measurement	1
http://www.ebi.ac.uk/efo/EFO_0009255	cecal neoplasm	2
http://www.ebi.ac.uk/efo/EFO_0009260	non-melanoma skin carcinoma	4
http://www.ebi.ac.uk/efo/EFO_0009261	response to aripiprazole	1
http://www.ebi.ac.uk/efo/EFO_0009262	nicotine dependence symptom count	4
http://www.ebi.ac.uk/efo/EFO_0009263	nicotine withdrawal symptom count	1
http://www.ebi.ac.uk/efo/EFO_0009264	maximum cigarettes per day measurement	1
http://www.ebi.ac.uk/efo/EFO_0009265	nausea and vomiting of pregnancy severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0009266	refractory celiac disease	1
http://www.ebi.ac.uk/efo/EFO_0009267	delirium	3
http://www.ebi.ac.uk/efo/EFO_0009268	family history of Alzheimer’s disease	14
http://www.ebi.ac.uk/efo/EFO_0009270	heel bone mineral density	23
http://www.ebi.ac.uk/efo/EFO_0009271	Epstein Barr virus nuclear antigen-1 seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0009272	Epstein Barr viral capsid antigen seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0009273	anti-Epstein Barr virus antibody measurement	5
http://www.ebi.ac.uk/efo/EFO_0009274	Epstein Barr viral capsid antigen IgG measurement	3
http://www.ebi.ac.uk/efo/EFO_0009275	premature cardiac contractions	1
http://www.ebi.ac.uk/efo/EFO_0009276	ventricular ectopy	2
http://www.ebi.ac.uk/efo/EFO_0009277	supraventricular ectopy	2
http://www.ebi.ac.uk/efo/EFO_0009278	cranial vault morphology measurement	3
http://www.ebi.ac.uk/efo/EFO_0009279	response to tenofovir	8
http://www.ebi.ac.uk/efo/EFO_0009281	choroidal thickness measurement	1
http://www.ebi.ac.uk/efo/EFO_0009282	sodium measurement	20
http://www.ebi.ac.uk/efo/EFO_0009283	potassium measurement	7
http://www.ebi.ac.uk/efo/EFO_0009284	chloride measurement	3
http://www.ebi.ac.uk/efo/EFO_0009285	fractional shortening	1
http://www.ebi.ac.uk/efo/EFO_0009286	heart relative wall thickness	2
http://www.ebi.ac.uk/efo/EFO_0009287	interventricular septum thickness	1
http://www.ebi.ac.uk/efo/EFO_0009288	posterior wall thickness	1
http://www.ebi.ac.uk/efo/EFO_0009289	left ventricular mass	5
http://www.ebi.ac.uk/efo/EFO_0009290	left ventricular mass index	1
http://www.ebi.ac.uk/efo/EFO_0009291	E/A ratio	1
http://www.ebi.ac.uk/efo/EFO_0009303	fructosamine measurement	1
http://www.ebi.ac.uk/efo/EFO_0009304	percent glycated albumin	1
http://www.ebi.ac.uk/efo/EFO_0009305	total glycated albumin	1
http://www.ebi.ac.uk/efo/EFO_0009306	atazanavir measurement	1
http://www.ebi.ac.uk/efo/EFO_0009308	response to long-chain n-3 PUFA dietary supplementation	1
http://www.ebi.ac.uk/efo/EFO_0009314	blood coagulation disease	2
http://www.ebi.ac.uk/efo/EFO_0009321	diabetic macular edema	1
http://www.ebi.ac.uk/efo/EFO_0009322	proliferative diabetic retinopathy	4
http://www.ebi.ac.uk/efo/EFO_0009323	alpha synuclein measurement	3
http://www.ebi.ac.uk/efo/EFO_0009324	APOL1 risk genotype carrier status	2
http://www.ebi.ac.uk/efo/EFO_0009325	basal ganglia growth measurement	1
http://www.ebi.ac.uk/efo/EFO_0009327	cerebellum growth measurement	1
http://www.ebi.ac.uk/efo/EFO_0009328	cerebral cortex growth measurement	1
http://www.ebi.ac.uk/efo/EFO_0009330	Chlamydia trachomatis seropositivity	4
http://www.ebi.ac.uk/efo/EFO_0009331	erosive tooth wear measurement	2
http://www.ebi.ac.uk/efo/EFO_0009332	executive function measurement	14
http://www.ebi.ac.uk/efo/EFO_0009334	prefrontal cortex growth measurement	1
http://www.ebi.ac.uk/efo/EFO_0009335	white matter growth measurement	1
http://www.ebi.ac.uk/efo/EFO_0009336	velopharyngeal dysfunction	1
http://www.ebi.ac.uk/efo/EFO_0009338	Epstein-Barr virus early antigen seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0009339	Herpes simplex virus 2 seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0009340	Varicella zoster virus seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0009341	Helicobacter pylori seropositivity	7
http://www.ebi.ac.uk/efo/EFO_0009342	Measles virus seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0009343	Mumps virus seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0009344	Rubella virus seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0009345	Hepatitis B virus surface antigen seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0009346	Hepatitis B virus core antigen seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0009347	Anti-cytomegalovirus IgG measurement	4
http://www.ebi.ac.uk/efo/EFO_0009348	Anti-Epstein-Barr virus early antigen IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0009349	Anti-herpes simplex virus 1 IgG measurement	2
http://www.ebi.ac.uk/efo/EFO_0009350	Anti-herpes simplex virus 2 IgG measurement	2
http://www.ebi.ac.uk/efo/EFO_0009351	Anti-varicella zoster virus IgG measurement	2
http://www.ebi.ac.uk/efo/EFO_0009352	Anti-Helicobacter pylori IgG measurement	6
http://www.ebi.ac.uk/efo/EFO_0009353	Anti-Toxoplasma gondii IgG measurement	3
http://www.ebi.ac.uk/efo/EFO_0009354	Anti-influenza A virus IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0009355	Anti-measles virus IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0009356	Anti-mumps virus IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0009357	Anti-rubella virus IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0009358	Anti-hepatitis B virus surface antigen IgG measurement	2
http://www.ebi.ac.uk/efo/EFO_0009359	Anti-hepatitis B virus core antigen IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0009360	eyelid sagging measurement	2
http://www.ebi.ac.uk/efo/EFO_0009361	colorectal mucinous adenocarcinoma	1
http://www.ebi.ac.uk/efo/EFO_0009362	nicotine withdrawal measurement	1
http://www.ebi.ac.uk/efo/EFO_0009363	chronic central serous retinopathy	2
http://www.ebi.ac.uk/efo/EFO_0009364	non-allergic rhinitis	1
http://www.ebi.ac.uk/efo/EFO_0009365	vaginal discharge	2
http://www.ebi.ac.uk/efo/EFO_0009366	quality of life during menstruation measurement	17
http://www.ebi.ac.uk/efo/EFO_0009367	glucose metabolism measurement	1
http://www.ebi.ac.uk/efo/EFO_0009368	factor VII activating protease measurement	1
http://www.ebi.ac.uk/efo/EFO_0009369	diffusing capacity of the lung for carbon monoxide	2
http://www.ebi.ac.uk/efo/EFO_0009370	radon exposure measurement	1
http://www.ebi.ac.uk/efo/EFO_0009372	response to ketogenic diet	1
http://www.ebi.ac.uk/efo/EFO_0009373	edema	5
http://www.ebi.ac.uk/efo/EFO_0009374	energy intake measurement	3
http://www.ebi.ac.uk/efo/EFO_0009381	fibroblast growth factor 23 measurement	4
http://www.ebi.ac.uk/efo/EFO_0009382	metabolically healthy obesity	1
http://www.ebi.ac.uk/efo/EFO_0009388	sum of basophil and neutrophil counts	1
http://www.ebi.ac.uk/efo/EFO_0009389	sum of eosinophil and basophil counts	1
http://www.ebi.ac.uk/efo/EFO_0009390	sum of neutrophil and eosinophil counts	1
http://www.ebi.ac.uk/efo/EFO_0009391	response to tamoxifen	3
http://www.ebi.ac.uk/efo/EFO_0009392	glucose metabolism decline measurement	6
http://www.ebi.ac.uk/efo/EFO_0009393	breast pressure measurement	1
http://www.ebi.ac.uk/efo/EFO_0009394	hippocampal CA1 volume	2
http://www.ebi.ac.uk/efo/EFO_0009395	hippocampal CA3 volume	2
http://www.ebi.ac.uk/efo/EFO_0009396	hippocampal CA4 volume	2
http://www.ebi.ac.uk/efo/EFO_0009397	hippocampus molecular layer volume	2
http://www.ebi.ac.uk/efo/EFO_0009398	hippocampal tail volume	2
http://www.ebi.ac.uk/efo/EFO_0009399	subiculum volume	2
http://www.ebi.ac.uk/efo/EFO_0009400	presubiculum volume	2
http://www.ebi.ac.uk/efo/EFO_0009401	hippocampal amigdala transition area volume	2
http://www.ebi.ac.uk/efo/EFO_0009402	hippocampus fimbria volume	2
http://www.ebi.ac.uk/efo/EFO_0009403	granule cell layer dentate gyrus volume	2
http://www.ebi.ac.uk/efo/EFO_0009404	hippocampal fissure volume	2
http://www.ebi.ac.uk/efo/EFO_0009405	parasubiculum volume	2
http://www.ebi.ac.uk/efo/EFO_0009408	abnormal vaginal discharge smell	1
http://www.ebi.ac.uk/efo/EFO_0009409	abnormal vaginal discharge itching	1
http://www.ebi.ac.uk/efo/EFO_0009410	uterine fibroid measurement	3
http://www.ebi.ac.uk/efo/EFO_0009412	interleukin 1 alpha measurement	1
http://www.ebi.ac.uk/efo/EFO_0009414	CCL17 measurement	1
http://www.ebi.ac.uk/efo/EFO_0009415	CCL19 measurement	2
http://www.ebi.ac.uk/efo/EFO_0009417	CCL23 measurement	1
http://www.ebi.ac.uk/efo/EFO_0009418	CCL24 measurement	1
http://www.ebi.ac.uk/efo/EFO_0009419	CX3CL1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0009422	CXCL5 measurement	2
http://www.ebi.ac.uk/efo/EFO_0009423	CXCL6 measurement	1
http://www.ebi.ac.uk/efo/EFO_0009429	Mycobacterium infection	2
http://www.ebi.ac.uk/efo/EFO_0009431	intestinal disease	18
http://www.ebi.ac.uk/efo/EFO_0009432	fibroblastic disorder	2
http://www.ebi.ac.uk/efo/EFO_0009435	arthritis disease activity score measurement	1
http://www.ebi.ac.uk/efo/EFO_0009436	offspring survival measurement	12
http://www.ebi.ac.uk/efo/EFO_0009437	offspring mortality measurement	20
http://www.ebi.ac.uk/efo/EFO_0009438	number of pregnancies measurement	2
http://www.ebi.ac.uk/efo/EFO_0009439	multiple births measurement	3
http://www.ebi.ac.uk/efo/EFO_0009440	age at last pregnancy measurement	4
http://www.ebi.ac.uk/efo/EFO_0009441	Waldenstrom macroglobulinemia	1
http://www.ebi.ac.uk/efo/EFO_0009443	BRCAX breast cancer	1
http://www.ebi.ac.uk/efo/EFO_0009448	pulmonary fibrosis	2
http://www.ebi.ac.uk/efo/EFO_0009449	keratitis	2
http://www.ebi.ac.uk/efo/EFO_0009450	conjunctivitis	6
http://www.ebi.ac.uk/efo/EFO_0009453	hemiplegia	4
http://www.ebi.ac.uk/efo/EFO_0009454	gastric ulcer	9
http://www.ebi.ac.uk/efo/EFO_0009455	lacrimal apparatus disease	4
http://www.ebi.ac.uk/efo/EFO_0009458	alcohol use disorder measurement	51
http://www.ebi.ac.uk/efo/EFO_0009459	ACPA-positive rheumatoid arthritis	2
http://www.ebi.ac.uk/efo/EFO_0009460	ACPA-negative rheumatoid arthritis	2
http://www.ebi.ac.uk/efo/EFO_0009464	corneal disease	2
http://www.ebi.ac.uk/efo/EFO_0009466	Löfgren’s syndrome	1
http://www.ebi.ac.uk/efo/EFO_0009467	response to anti-vascular endothelial growth factor drug	2
http://www.ebi.ac.uk/efo/EFO_0009468	jaw disease	2
http://www.ebi.ac.uk/efo/EFO_0009469	Bartholin gland disease	2
http://www.ebi.ac.uk/efo/EFO_0009470	soft tissue disease	7
http://www.ebi.ac.uk/efo/EFO_0009472	tympanic membrane perforation	4
http://www.ebi.ac.uk/efo/EFO_0009473	hemolysis	10
http://www.ebi.ac.uk/efo/EFO_0009476	neck injury	3
http://www.ebi.ac.uk/efo/EFO_0009477	vertebral joint disease	4
http://www.ebi.ac.uk/efo/EFO_0009479	throat disease	1
http://www.ebi.ac.uk/efo/EFO_0009480	coping behaviour measurement	7
http://www.ebi.ac.uk/efo/EFO_0009481	paranasal sinus disease	5
http://www.ebi.ac.uk/efo/EFO_0009482	drug allergy	9
http://www.ebi.ac.uk/efo/EFO_0009484	uterine polyp	4
http://www.ebi.ac.uk/efo/EFO_0009485	eye injury	4
http://www.ebi.ac.uk/efo/EFO_0009486	diabetic eye disease	9
http://www.ebi.ac.uk/efo/EFO_0009487	nerve compression syndrome	4
http://www.ebi.ac.uk/efo/EFO_0009490	nervous system injury	1
http://www.ebi.ac.uk/efo/EFO_0009493	paroxysmal tachycardia	2
http://www.ebi.ac.uk/efo/EFO_0009505	head injury	14
http://www.ebi.ac.uk/efo/EFO_0009507	knee injury	2
http://www.ebi.ac.uk/efo/EFO_0009509	limb injury	4
http://www.ebi.ac.uk/efo/EFO_0009511	abnormal PAP smear	4
http://www.ebi.ac.uk/efo/EFO_0009512	lower extremity fracture	7
http://www.ebi.ac.uk/efo/EFO_0009513	multiple bone fractures	2
http://www.ebi.ac.uk/efo/EFO_0009514	upper extremity fracture	13
http://www.ebi.ac.uk/efo/EFO_0009515	wrist fracture	2
http://www.ebi.ac.uk/efo/EFO_0009520	contraception	6
http://www.ebi.ac.uk/efo/EFO_0009521	dislocation	6
http://www.ebi.ac.uk/efo/EFO_0009522	disturbance of skin sensation	5
http://www.ebi.ac.uk/efo/EFO_0009523	fecal incontinence	3
http://www.ebi.ac.uk/efo/EFO_0009531	aortic valve disease	2
http://www.ebi.ac.uk/efo/EFO_0009534	biliary tract disease	6
http://www.ebi.ac.uk/efo/EFO_0009536	blepharitis	8
http://www.ebi.ac.uk/efo/EFO_0009540	dental pulp disease	2
http://www.ebi.ac.uk/efo/EFO_0009541	disease of peritoneum	2
http://www.ebi.ac.uk/efo/EFO_0009544	esophageal disease	3
http://www.ebi.ac.uk/efo/EFO_0009545	esophageal varices	8
http://www.ebi.ac.uk/efo/EFO_0009547	eyelid disease	6
http://www.ebi.ac.uk/efo/EFO_0009549	female reproductive system disease	13
http://www.ebi.ac.uk/efo/EFO_0009550	headache disorder	2
http://www.ebi.ac.uk/efo/EFO_0009551	heart valve disease	6
http://www.ebi.ac.uk/efo/EFO_0009552	hemorrhoid	11
http://www.ebi.ac.uk/efo/EFO_0009555	male reproductive system disease	2
http://www.ebi.ac.uk/efo/EFO_0009556	mineral metabolism disease	4
http://www.ebi.ac.uk/efo/EFO_0009557	mitral valve disease	4
http://www.ebi.ac.uk/efo/EFO_0009558	mononeuropathy	4
http://www.ebi.ac.uk/efo/EFO_0009559	nerve plexus disease	8
http://www.ebi.ac.uk/efo/EFO_0009560	otitis externa	6
http://www.ebi.ac.uk/efo/EFO_0009562	polyneuropathy	6
http://www.ebi.ac.uk/efo/EFO_0009569	trigeminal nerve disease	2
http://www.ebi.ac.uk/efo/EFO_0009570	tympanic membrane disease	2
http://www.ebi.ac.uk/efo/EFO_0009579	postpartum hemorrhage	4
http://www.ebi.ac.uk/efo/EFO_0009580	prophylactic surgery	4
http://www.ebi.ac.uk/efo/EFO_0009582	sprain	8
http://www.ebi.ac.uk/efo/EFO_0009583	place of residence measurement	2
http://www.ebi.ac.uk/efo/EFO_0009584	AQP4-IgG-positive neuromyelitis optica	1
http://www.ebi.ac.uk/efo/EFO_0009585	AQP4-IgG-negative neuromyelitis optica	1
http://www.ebi.ac.uk/efo/EFO_0009586	skin hydration measurement	1
http://www.ebi.ac.uk/efo/EFO_0009587	anhedonia measurement	4
http://www.ebi.ac.uk/efo/EFO_0009588	"feeling ""fed-up"" measurement"	3
http://www.ebi.ac.uk/efo/EFO_0009589	worry measurement	31
http://www.ebi.ac.uk/efo/EFO_0009590	visual memory measurement	1
http://www.ebi.ac.uk/efo/EFO_0009591	verbal memory measurement	1
http://www.ebi.ac.uk/efo/EFO_0009592	social interaction measurement	20
http://www.ebi.ac.uk/efo/EFO_0009594	irritability measurement	3
http://www.ebi.ac.uk/efo/EFO_0009595	guilt measurement	1
http://www.ebi.ac.uk/efo/EFO_0009596	feeling tense measurement	3
http://www.ebi.ac.uk/efo/EFO_0009597	feeling nervous measurement	5
http://www.ebi.ac.uk/efo/EFO_0009598	feeling miserable measurement	3
http://www.ebi.ac.uk/efo/EFO_0009599	feeling emotionally hurt measurement	1
http://www.ebi.ac.uk/efo/EFO_0009601	testicular disease	8
http://www.ebi.ac.uk/efo/EFO_0009602	prostate disease	4
http://www.ebi.ac.uk/efo/EFO_0009603	stroke outcome severity measurement	6
http://www.ebi.ac.uk/efo/EFO_0009604	labyrinthitis	2
http://www.ebi.ac.uk/efo/EFO_0009605	pancreas disease	10
http://www.ebi.ac.uk/efo/EFO_0009606	macular degeneration	6
http://www.ebi.ac.uk/efo/EFO_0009607	pituitary gland disease	2
http://www.ebi.ac.uk/efo/EFO_0009608	stomach disease	7
http://www.ebi.ac.uk/efo/EFO_0009609	myocarditis	3
http://www.ebi.ac.uk/efo/EFO_0009610	cervical spondylosis	5
http://www.ebi.ac.uk/efo/EFO_0009613	fibula fracture	4
http://www.ebi.ac.uk/efo/EFO_0009614	clavicle fracture	6
http://www.ebi.ac.uk/efo/EFO_0009616	finger fracture	4
http://www.ebi.ac.uk/efo/EFO_0009618	foot fracture	2
http://www.ebi.ac.uk/efo/EFO_0009620	rib fracture	10
http://www.ebi.ac.uk/efo/EFO_0009623	nose injury	6
http://www.ebi.ac.uk/efo/EFO_0009628	abnormal result of function studies	8
http://www.ebi.ac.uk/efo/EFO_0009631	fall	4
http://www.ebi.ac.uk/efo/EFO_0009632	amputation	2
http://www.ebi.ac.uk/efo/EFO_0009636	cesarean section	7
http://www.ebi.ac.uk/efo/EFO_0009637	pleural effusion	2
http://www.ebi.ac.uk/efo/EFO_0009639	Braxton-Hicks contractions	2
http://www.ebi.ac.uk/efo/EFO_0009640	family history of cancer	30
http://www.ebi.ac.uk/efo/EFO_0009641	malaise	4
http://www.ebi.ac.uk/efo/EFO_0009657	acute pharyngitis	4
http://www.ebi.ac.uk/efo/EFO_0009658	adverse effect	60
http://www.ebi.ac.uk/efo/EFO_0009660	anus disease	2
http://www.ebi.ac.uk/efo/EFO_0009661	bronchitis	5
http://www.ebi.ac.uk/efo/EFO_0009662	common wart	2
http://www.ebi.ac.uk/efo/EFO_0009663	disease of genitourinary system	2
http://www.ebi.ac.uk/efo/EFO_0009665	disorder of patella	2
http://www.ebi.ac.uk/efo/EFO_0009666	enthesopathy	4
http://www.ebi.ac.uk/efo/EFO_0009668	external ear disease	2
http://www.ebi.ac.uk/efo/EFO_0009669	flatulence	4
http://www.ebi.ac.uk/efo/EFO_0009672	inner ear disease	2
http://www.ebi.ac.uk/efo/EFO_0009673	laryngeal disease	3
http://www.ebi.ac.uk/efo/EFO_0009675	melanocytic nevus	10
http://www.ebi.ac.uk/efo/EFO_0009676	musculoskeletal system disease	1
http://www.ebi.ac.uk/efo/EFO_0009677	occlusion precerebral artery	2
http://www.ebi.ac.uk/efo/EFO_0009682	pregnancy disorder	6
http://www.ebi.ac.uk/efo/EFO_0009685	rectal disease	2
http://www.ebi.ac.uk/efo/EFO_0009686	respiratory failure	4
http://www.ebi.ac.uk/efo/EFO_0009687	somatoform disorder	2
http://www.ebi.ac.uk/efo/EFO_0009688	stomatitis	10
http://www.ebi.ac.uk/efo/EFO_0009689	urethral disease	6
http://www.ebi.ac.uk/efo/EFO_0009690	urinary system disease	7
http://www.ebi.ac.uk/efo/EFO_0009691	vestibular disease	6
http://www.ebi.ac.uk/efo/EFO_0009693	thiopurine metabolite measurement	4
http://www.ebi.ac.uk/efo/EFO_0009694	beta-lactam allergy measurement	1
http://www.ebi.ac.uk/efo/EFO_0009695	household income	5
http://www.ebi.ac.uk/efo/EFO_0009696	social deprivation	1
http://www.ebi.ac.uk/efo/EFO_0009698	gestational blood glucose measurement	11
http://www.ebi.ac.uk/efo/EFO_0009699	foot muscle strength measurement	4
http://www.ebi.ac.uk/efo/EFO_0009700	visual perception measurement	6
http://www.ebi.ac.uk/efo/EFO_0009701	visceral:total adipose tissue ratio	1
http://www.ebi.ac.uk/efo/EFO_0009702	intra-individual reaction time variability measurement	2
http://www.ebi.ac.uk/efo/EFO_0009703	red blood cell folate measurement	2
http://www.ebi.ac.uk/efo/EFO_0009704	radiation-induced brain injury	1
http://www.ebi.ac.uk/efo/EFO_0009705	small intestine enteropathy	1
http://www.ebi.ac.uk/efo/EFO_0009706	latent autoimmune diabetes in adults	3
http://www.ebi.ac.uk/efo/EFO_0009707	fractures, ununited	3
http://www.ebi.ac.uk/efo/EFO_0009711	Townsend deprivation index	4
http://www.ebi.ac.uk/efo/EFO_0009714	chronic disease	2
http://www.ebi.ac.uk/efo/EFO_0009715	wheezing	4
http://www.ebi.ac.uk/efo/EFO_0009716	age at first facial hair	6
http://www.ebi.ac.uk/efo/EFO_0009717	bilateral oophorectomy	2
http://www.ebi.ac.uk/efo/EFO_0009718	peak expiratory flow	4
http://www.ebi.ac.uk/efo/EFO_0009719	artificial cardiac pacemaker	4
http://www.ebi.ac.uk/efo/EFO_0009720	able to hear with hearing aids	2
http://www.ebi.ac.uk/efo/EFO_0009723	job satisfaction measurement	14
http://www.ebi.ac.uk/efo/EFO_0009724	health satisfaction measurement	156
http://www.ebi.ac.uk/efo/EFO_0009725	friendship satisfaction measurement	10
http://www.ebi.ac.uk/efo/EFO_0009726	financial situation satisfaction measurement	12
http://www.ebi.ac.uk/efo/EFO_0009727	shortness of breath	2
http://www.ebi.ac.uk/efo/EFO_0009729	surgery on leg artery	2
http://www.ebi.ac.uk/efo/EFO_0009748	response to ketamine	5
http://www.ebi.ac.uk/efo/EFO_0009749	age at first sexual intercourse measurement	4
http://www.ebi.ac.uk/efo/EFO_0009750	dissociation measurement	1
http://www.ebi.ac.uk/efo/EFO_0009751	facial asymmetry measurement	3
http://www.ebi.ac.uk/efo/EFO_0009752	visuospatial impairment	1
http://www.ebi.ac.uk/efo/EFO_0009759	Chronic Obstructive Asthma	2
http://www.ebi.ac.uk/efo/EFO_0009761	periprosthetic osteolysis	2
http://www.ebi.ac.uk/efo/EFO_0009762	healthspan	2
http://www.ebi.ac.uk/efo/EFO_0009764	eye colour measurement	9
http://www.ebi.ac.uk/efo/EFO_0009765	alanine measurement	3
http://www.ebi.ac.uk/efo/EFO_0009766	asparagine measurement	3
http://www.ebi.ac.uk/efo/EFO_0009767	glycine measurement	9
http://www.ebi.ac.uk/efo/EFO_0009768	glutamine measurement	3
http://www.ebi.ac.uk/efo/EFO_0009769	histidine measurement	2
http://www.ebi.ac.uk/efo/EFO_0009770	leucine measurement	3
http://www.ebi.ac.uk/efo/EFO_0009771	methionine measurement	1
http://www.ebi.ac.uk/efo/EFO_0009773	proline measurement	3
http://www.ebi.ac.uk/efo/EFO_0009774	serine measurement	1
http://www.ebi.ac.uk/efo/EFO_0009775	threonine measurement	1
http://www.ebi.ac.uk/efo/EFO_0009776	ornithine measurement	2
http://www.ebi.ac.uk/efo/EFO_0009777	citrulline measurement	2
http://www.ebi.ac.uk/efo/EFO_0009779	tri-iodothyronine/thyroxine ratio measurement	1
http://www.ebi.ac.uk/efo/EFO_0009780	HER2 negative breast carcinoma	6
http://www.ebi.ac.uk/efo/EFO_0009781	progesterone-receptor negative breast cancer	3
http://www.ebi.ac.uk/efo/EFO_0009782	progesterone-receptor positive breast cancer	6
http://www.ebi.ac.uk/efo/EFO_0009783	carotid atherosclerosis	2
http://www.ebi.ac.uk/efo/EFO_0009784	central serous retinopathy	1
http://www.ebi.ac.uk/efo/EFO_0009785	remission	11
http://www.ebi.ac.uk/efo/EFO_0009786	encounter with health service	8
http://www.ebi.ac.uk/efo/EFO_0009790	asparaginase activity measurement	1
http://www.ebi.ac.uk/efo/EFO_0009791	fatty acid desaturase enzyme activity measurement	2
http://www.ebi.ac.uk/efo/EFO_0009792	valine measurement	3
http://www.ebi.ac.uk/efo/EFO_0009793	isoleucine measurement	3
http://www.ebi.ac.uk/efo/EFO_0009794	NRF2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0009795	serum urea measurement	6
http://www.ebi.ac.uk/efo/EFO_0009796	response to supplemental oxygen	1
http://www.ebi.ac.uk/efo/EFO_0009797	lung disease associated with cystic fibrosis	1
http://www.ebi.ac.uk/efo/EFO_0009804	pulse wave reflection index measurement	2
http://www.ebi.ac.uk/efo/EFO_0009805	whole body water mass	2
http://www.ebi.ac.uk/efo/EFO_0009806	total hip arthroplasty	3
http://www.ebi.ac.uk/efo/EFO_0009812	secondary malignant neoplasm	18
http://www.ebi.ac.uk/efo/EFO_0009816	perineal laceration during delivery	6
http://www.ebi.ac.uk/efo/EFO_0009817	ease of getting up in the morning, self-reported	8
http://www.ebi.ac.uk/efo/EFO_0009819	comparative body size at age 10, self-reported	7
http://www.ebi.ac.uk/efo/EFO_0009822	ability to walk or cycle unaided for 10 minutes, self-reported	2
http://www.ebi.ac.uk/efo/EFO_0009823	achievement of target heart rate, self-reported	2
http://www.ebi.ac.uk/efo/EFO_0009824	bringing up phlegm, sputum or mucus on most days, self-reported	2
http://www.ebi.ac.uk/efo/EFO_0009825	sign or symptom concerning food and fluid intake	2
http://www.ebi.ac.uk/efo/EFO_0009826	abnormality of serum enzyme levels	4
http://www.ebi.ac.uk/efo/EFO_0009827	abnormal result of diagnostic imaging	8
http://www.ebi.ac.uk/efo/EFO_0009833	kidney injury	1
http://www.ebi.ac.uk/efo/EFO_0009841	irregular respiration	2
http://www.ebi.ac.uk/efo/EFO_0009854	treatment resistant depression	2
http://www.ebi.ac.uk/efo/EFO_0009855	frontal fibrosing alopecia	1
http://www.ebi.ac.uk/efo/EFO_0009857	ruminative stress response	1
http://www.ebi.ac.uk/efo/EFO_0009858	brooding stress response	1
http://www.ebi.ac.uk/efo/EFO_0009859	reflective stress response	1
http://www.ebi.ac.uk/efo/EFO_0009860	chromosomal aberration frequency	7
http://www.ebi.ac.uk/efo/EFO_0009861	chromosome-type aberration frequency	7
http://www.ebi.ac.uk/efo/EFO_0009862	chromatid-type aberration frequency	7
http://www.ebi.ac.uk/efo/EFO_0009863	anxiety measurement	17
http://www.ebi.ac.uk/efo/EFO_0009864	metabolic network measurement	1
http://www.ebi.ac.uk/efo/EFO_0009865	transcriptome measurement	1
http://www.ebi.ac.uk/efo/EFO_0009881	nonischemic cardiomyopathy	1
http://www.ebi.ac.uk/efo/EFO_0009882	urinary potassium to creatinine ratio	1
http://www.ebi.ac.uk/efo/EFO_0009883	urinary sodium to creatinine ratio	1
http://www.ebi.ac.uk/efo/EFO_0009884	urinary sodium to potassium ratio	1
http://www.ebi.ac.uk/efo/EFO_0009885	frailty measurement	2
http://www.ebi.ac.uk/efo/EFO_0009890	lean mass-adjusted fat body mass	4
http://www.ebi.ac.uk/efo/EFO_0009891	carbamazepine metabolite measurement	1
http://www.ebi.ac.uk/efo/EFO_0009892	facial attractiveness measurement	7
http://www.ebi.ac.uk/efo/EFO_0009893	response to oxcarbazepine	4
http://www.ebi.ac.uk/efo/EFO_0009894	carbamazepine-induced hyponatremia	3
http://www.ebi.ac.uk/efo/EFO_0009895	oxcarbazepine-induced hyponatremia	3
http://www.ebi.ac.uk/efo/EFO_0009896	anti-thyroglobulin antibody measurement	5
http://www.ebi.ac.uk/efo/EFO_0009902	handedness	14
http://www.ebi.ac.uk/efo/EFO_0009903	inflammatory disease	2
http://www.ebi.ac.uk/efo/EFO_0009923	Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement	4
http://www.ebi.ac.uk/efo/EFO_0009924	Drugs used in diabetes use measurement	7
http://www.ebi.ac.uk/efo/EFO_0009925	Antithrombotic agent use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009926	Vasodilators used in cardiac diseases use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009927	Antihypertensive use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009928	Diuretic use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009929	Beta blocking agent use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009930	Calcium channel blocker use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009931	Agents acting on the renin-angiotensin system use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009932	HMG CoA reductase inhibitor use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009933	Thyroid preparation use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009934	Immunosuppressant use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009935	Non-steroidal anti-inflammatory and antirheumatic product use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009936	Drugs affecting bone structure and mineralization use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009937	Opioid use measurement	5
http://www.ebi.ac.uk/efo/EFO_0009938	Anilide use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009939	Antimigraine preparation use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009940	Antidepressant use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009941	Inhalant adrenergic use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009942	Glucocorticoid use measurement	4
http://www.ebi.ac.uk/efo/EFO_0009943	Antihistamine use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009944	Antiglaucoma preparations and miotics use measurement	3
http://www.ebi.ac.uk/efo/EFO_0009945	psychological resilience measurement	3
http://www.ebi.ac.uk/efo/EFO_0009946	low density lipoprotein triglyceride measurement	2
http://www.ebi.ac.uk/efo/EFO_0009947	nucleoside diphosphate kinase A measurement	1
http://www.ebi.ac.uk/efo/EFO_0009948	chorioamnionitis	1
http://www.ebi.ac.uk/efo/EFO_0009949	KANNO antigen measurement	1
http://www.ebi.ac.uk/efo/EFO_0009951	response to surgery	9
http://www.ebi.ac.uk/efo/EFO_0009952	post-operative atrial fibrillation	1
http://www.ebi.ac.uk/efo/EFO_0009953	post-operative myocardial infarction	1
http://www.ebi.ac.uk/efo/EFO_0009954	post-operative delirium	1
http://www.ebi.ac.uk/efo/EFO_0009955	post-operative acute kidney injury	1
http://www.ebi.ac.uk/efo/EFO_0009956	post-operative stroke	1
http://www.ebi.ac.uk/efo/EFO_0009958	response to bisphosphonate	5
http://www.ebi.ac.uk/efo/EFO_0009959	diverticular disease	8
http://www.ebi.ac.uk/efo/EFO_0009960	atypical femoral fracture	2
http://www.ebi.ac.uk/efo/EFO_0009961	Insulinogenic index measurement	1
http://www.ebi.ac.uk/efo/EFO_0009962	response to radioiodine	1
http://www.ebi.ac.uk/efo/EFO_0009963	bipolar I disorder	3
http://www.ebi.ac.uk/efo/EFO_0009964	bipolar II disorder	2
http://www.ebi.ac.uk/efo/EFO_0009965	Schizoaffective disorder-bipolar type	1
http://www.ebi.ac.uk/efo/EFO_0010049	asthma symptoms measurement	3
http://www.ebi.ac.uk/efo/EFO_0010050	thyroglobulin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010052	response to tacrolimus	1
http://www.ebi.ac.uk/efo/EFO_0010053	response to cyclosporine	1
http://www.ebi.ac.uk/efo/EFO_0010054	response to mycophenolic acid	2
http://www.ebi.ac.uk/efo/EFO_0010055	response to calcineurin inhibitor	1
http://www.ebi.ac.uk/efo/EFO_0010056	liver iron measurement	2
http://www.ebi.ac.uk/efo/EFO_0010057	vascular cell adhesion molecule-1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010059	cerebral microbleeds	5
http://www.ebi.ac.uk/efo/EFO_0010060	chronic human papillomavirus infection	1
http://www.ebi.ac.uk/efo/EFO_0010062	response to salmeterol	3
http://www.ebi.ac.uk/efo/EFO_0010065	response to intravenous immunoglobulin therapy	1
http://www.ebi.ac.uk/efo/EFO_0010066	corneal hysteresis	7
http://www.ebi.ac.uk/efo/EFO_0010067	corneal resistance factor	7
http://www.ebi.ac.uk/efo/EFO_0010068	respiratory symptom change measurement	2
http://www.ebi.ac.uk/efo/EFO_0010069	nerve conduction velocity	1
http://www.ebi.ac.uk/efo/EFO_0010070	nerve conduction amplitude	1
http://www.ebi.ac.uk/efo/EFO_0010071	cardiac troponin I measurement	2
http://www.ebi.ac.uk/efo/EFO_0010072	toothache	3
http://www.ebi.ac.uk/efo/EFO_0010073	number of teeth measurement	2
http://www.ebi.ac.uk/efo/EFO_0010074	trochanter size	1
http://www.ebi.ac.uk/efo/EFO_0010075	intertrochanteric region size	1
http://www.ebi.ac.uk/efo/EFO_0010076	femoral neck size	1
http://www.ebi.ac.uk/efo/EFO_0010077	response to belimumab	1
http://www.ebi.ac.uk/efo/EFO_0010078	dentures	4
http://www.ebi.ac.uk/efo/EFO_0010079	corneal endothelial cell measurement	3
http://www.ebi.ac.uk/efo/EFO_0010080	geographic atrophy lesion growth	1
http://www.ebi.ac.uk/efo/EFO_0010083	dentate gyrus volume measurement	2
http://www.ebi.ac.uk/efo/EFO_0010084	anti-meningococcal C IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0010085	anti-tetanus toxoid IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0010086	anti-Haemophilus influenzae type b polyribosylribitol phosphate IgG measurement	1
http://www.ebi.ac.uk/efo/EFO_0010087	anti-meningococcal C serum bactericidal antibody measurement	1
http://www.ebi.ac.uk/efo/EFO_0010089	bitter beverage consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010090	sweet beverage consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010091	tea consumption measurement	9
http://www.ebi.ac.uk/efo/EFO_0010092	bitter alcoholic beverage consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010093	bitter non-alcoholic beverage consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010094	grapefruit juice consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010095	non-grapefruit juice consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010096	artificially sweetened beverage consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010097	sugar sweetened beverage consumption measurement	1
http://www.ebi.ac.uk/efo/EFO_0010098	stress-related disorder	10
http://www.ebi.ac.uk/efo/EFO_0010099	chronic widespread pain	3
http://www.ebi.ac.uk/efo/EFO_0010100	multisite chronic pain	4
http://www.ebi.ac.uk/efo/EFO_0010101	decreased susceptibility to hepatitis C infection	1
http://www.ebi.ac.uk/efo/EFO_0010103	response to peginterferon alfa-2a	1
http://www.ebi.ac.uk/efo/EFO_0010104	health literacy measurement	1
http://www.ebi.ac.uk/efo/EFO_0010105	CD4-positive T-lymphocyte count	2
http://www.ebi.ac.uk/efo/EFO_0010106	CD3-positive T-lymphocyte count	1
http://www.ebi.ac.uk/efo/EFO_0010107	CD8-positive T-lymphocyte count	1
http://www.ebi.ac.uk/efo/EFO_0010108	CD19-positive B-lymphocyte count	1
http://www.ebi.ac.uk/efo/EFO_0010109	CD56-positive NK-lymphocyte cell count	1
http://www.ebi.ac.uk/efo/EFO_0010110	ketone body measurement	1
http://www.ebi.ac.uk/efo/EFO_0010111	acetoacetate measurement	2
http://www.ebi.ac.uk/efo/EFO_0010112	acetate measurement	2
http://www.ebi.ac.uk/efo/EFO_0010113	3-hydroxybutyric acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0010114	citrate measurement	2
http://www.ebi.ac.uk/efo/EFO_0010117	pyruvate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010118	sphingomyelin measurement	144
http://www.ebi.ac.uk/efo/EFO_0010119	omega-3 polyunsaturated fatty acid measurement	5
http://www.ebi.ac.uk/efo/EFO_0010120	fasting blood glucose change measurement	4
http://www.ebi.ac.uk/efo/EFO_0010123	response to antiviral drug	2
http://www.ebi.ac.uk/efo/EFO_0010124	response to atorvastatin	1
http://www.ebi.ac.uk/efo/EFO_0010125	viral load	3
http://www.ebi.ac.uk/efo/EFO_0010126	time to first cigarette measurement	3
http://www.ebi.ac.uk/efo/EFO_0010127	serum immunoglobulin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010128	immunoglobulin isotype switching measurement	5
http://www.ebi.ac.uk/efo/EFO_0010129	breakfast skipping measurement	2
http://www.ebi.ac.uk/efo/EFO_0010130	health study participation	7
http://www.ebi.ac.uk/efo/EFO_0010131	decreased walking ability	1
http://www.ebi.ac.uk/efo/EFO_0010132	decreased fine motor function	2
http://www.ebi.ac.uk/efo/EFO_0010133	diabetic maculopathy	2
http://www.ebi.ac.uk/efo/EFO_0010135	urine specific gravity measurement	1
http://www.ebi.ac.uk/efo/EFO_0010136	urinary pH measurement	2
http://www.ebi.ac.uk/efo/EFO_0010137	leukocyte esterase measurement	1
http://www.ebi.ac.uk/efo/EFO_0010138	nitrite measurement	1
http://www.ebi.ac.uk/efo/EFO_0010139	fish consumption measurement	4
http://www.ebi.ac.uk/efo/EFO_0010140	opioid overdose severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0010142	same-sex sexual behavior	9
http://www.ebi.ac.uk/efo/EFO_0010143	chronic mountain sickness	1
http://www.ebi.ac.uk/efo/EFO_0010144	frontal lobe volume measurement	2
http://www.ebi.ac.uk/efo/EFO_0010145	occipital lobe volume measurement	2
http://www.ebi.ac.uk/efo/EFO_0010146	parietal lobe volume measurement	2
http://www.ebi.ac.uk/efo/EFO_0010147	temporal lobe volume measurement	3
http://www.ebi.ac.uk/efo/EFO_0010148	pepsinogen-I measurement	1
http://www.ebi.ac.uk/efo/EFO_0010149	pepsinogen I/II ratio	1
http://www.ebi.ac.uk/efo/EFO_0010150	anti-anoctamin 2 antibody measurement	1
http://www.ebi.ac.uk/efo/EFO_0010151	soluble triggering receptor expressed on myeloid cells 2 measurement	3
http://www.ebi.ac.uk/efo/EFO_0010152	response to phenylephrine	4
http://www.ebi.ac.uk/efo/EFO_0010154	platinum measurement	1
http://www.ebi.ac.uk/efo/EFO_0010156	sweet liking measurement	1
http://www.ebi.ac.uk/efo/EFO_0010157	sucrose liking measurement	1
http://www.ebi.ac.uk/efo/EFO_0010158	sugar consumption measurement	3
http://www.ebi.ac.uk/efo/EFO_0010176	keratinocyte carcinoma	3
http://www.ebi.ac.uk/efo/EFO_0010177	lobar intracerebral hemorrhage	2
http://www.ebi.ac.uk/efo/EFO_0010178	non-lobar intracerebral hemorrhage	2
http://www.ebi.ac.uk/efo/EFO_0010219	aldosterone measurement	1
http://www.ebi.ac.uk/efo/EFO_0010220	17-hydroxyprogesterone measurement	1
http://www.ebi.ac.uk/efo/EFO_0010221	systemising measurement	3
http://www.ebi.ac.uk/efo/EFO_0010222	ceramide measurement	29
http://www.ebi.ac.uk/efo/EFO_0010223	diglyceride measurement	37
http://www.ebi.ac.uk/efo/EFO_0010224	lysophosphatidylcholine measurement	35
http://www.ebi.ac.uk/efo/EFO_0010225	lysophosphatidylethanolamine measurement	10
http://www.ebi.ac.uk/efo/EFO_0010226	phosphatidylcholine measurement	307
http://www.ebi.ac.uk/efo/EFO_0010227	phosphatidylcholine ether measurement	1
http://www.ebi.ac.uk/efo/EFO_0010228	phosphatidylethanolamine measurement	81
http://www.ebi.ac.uk/efo/EFO_0010229	phosphatidylethanolamine ether measurement	1
http://www.ebi.ac.uk/efo/EFO_0010230	phosphatidylinositol measurement	56
http://www.ebi.ac.uk/efo/EFO_0010231	sterol measurement	7
http://www.ebi.ac.uk/efo/EFO_0010234	viral subtype carrier status	1
http://www.ebi.ac.uk/efo/EFO_0010235	response to proton-pump inhibitor	1
http://www.ebi.ac.uk/efo/EFO_0010241	galectin-3-binding protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0010243	inorganic ion measurement	1
http://www.ebi.ac.uk/efo/EFO_0010244	uveal melanoma disease severity	1
http://www.ebi.ac.uk/efo/EFO_0010245	oxytocin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010269	amenorrhea	1
http://www.ebi.ac.uk/efo/EFO_0010271	bacterial pathogen genotype measurement	2
http://www.ebi.ac.uk/efo/EFO_0010272	abdominal aortic calcification measurement	1
http://www.ebi.ac.uk/efo/EFO_0010273	thoracic aortic calcification measurement	1
http://www.ebi.ac.uk/efo/EFO_0010282	gastrointestinal disease	2
http://www.ebi.ac.uk/efo/EFO_0010286	banks of the superior temporal sulcus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010287	brain cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010289	caudal anterior cingulate cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010290	caudal middle frontal gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010291	cerebellum cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010293	choroid plexus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010295	corpus callosum anterior volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010296	corpus callosum central volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010297	corpus callosum mid-anterior volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010298	corpus callosum posterior volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010300	corpus collosum mid-posterior volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010301	cuneus cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010303	fourth ventricle volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010304	frontal pole volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010305	fusiform gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010306	Grey matter density measurement	1
http://www.ebi.ac.uk/efo/EFO_0010307	inferior parietal cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010308	inferior temporal gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010309	insular cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010310	isthmus cingulate cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010311	lateral occipital cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010312	lateral orbital frontal cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010314	lingual gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010315	medial orbital frontal cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010316	middle temporal gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010317	paracentral lobule volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010318	parahippocampal gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010319	pars opercularis volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010320	pars orbitalis volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010321	pars triangularis volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010322	pericalcarine cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010323	postcentral gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010324	posterior cingulate cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010325	precentral gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010326	precuneus cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010327	rostral anterior cingulate cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010328	rostral middle frontal gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010329	superior frontal gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010330	superior parietal cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010331	superior temporal gyrus volume measurement	4
http://www.ebi.ac.uk/efo/EFO_0010332	supramarginal gyrus volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010333	temporal horn of lateral ventricle volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010334	temporal pole volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010335	third ventricle volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010336	transverse temporal cortex volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010337	ventral diencephalon volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010339	FVC change measurement	1
http://www.ebi.ac.uk/efo/EFO_0010340	cholesteryl ester 14:0 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010341	cholesteryl ester 16:0 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010342	cholesteryl ester 16:1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010343	cholesteryl ester 18:0 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010344	cholesteryl ester 18:1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010345	cholesteryl ester 18:2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010346	cholesteryl ester 18:3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010347	cholesteryl ester 20:3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010348	cholesteryl ester 20:4 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010349	cholesteryl ester 20:5 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010350	cholesteryl ester 22:6 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010351	cholesteryl ester measurement	6
http://www.ebi.ac.uk/efo/EFO_0010352	diacylglycerol 34:1 measurement	4
http://www.ebi.ac.uk/efo/EFO_0010353	diacylglycerol 34:2 measurement	4
http://www.ebi.ac.uk/efo/EFO_0010354	diacylglycerol 36:1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010355	diacylglycerol 36:2 measurement	5
http://www.ebi.ac.uk/efo/EFO_0010359	lysophosphatidylcholine 18:0 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010360	lysophosphatidylcholine 18:1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010361	lysophosphatidylcholine 18:2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010362	lysophosphatidylcholine 20:3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010363	lysophosphatidylcholine 20:4 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010366	lysophosphatidylethanolamine 16:0 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010367	lysophosphatidylethanolamine 18:0 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010368	lysophosphatidylethanolamine 18:1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010369	lysophosphatidylethanolamine 18:2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010370	lysophosphatidylethanolamine 20:4 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010371	lysophosphatidylethanolamine 22:6 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010372	phosphatidylcholine 32:0 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010399	triacylglycerol 44:1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010400	triacylglycerol 46:0 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010401	triacylglycerol 46:1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010402	triacylglycerol 46:2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010403	triacylglycerol 48:0 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010404	triacylglycerol 48:1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010405	triacylglycerol 48:2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010406	triacylglycerol 48:3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010407	triacylglycerol 48:4 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010408	triacylglycerol 50:1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010409	triacylglycerol 50:2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010410	triacylglycerol 50:3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010411	triacylglycerol 50:4 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010412	triacylglycerol 50:5 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010413	triacylglycerol 52:1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010414	triacylglycerol 52:2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010415	triacylglycerol 52:3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010416	triacylglycerol 52:4 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010417	triacylglycerol 52:5 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010418	triacylglycerol 52:6 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010419	triacylglycerol 54:1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010420	triacylglycerol 54:2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010421	triacylglycerol 54:3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010422	triacylglycerol 54:4 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010423	triacylglycerol 54:5 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010424	triacylglycerol 54:6 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010425	triacylglycerol 54:7 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010429	triacylglycerol 56:2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010430	triacylglycerol 56:3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010431	triacylglycerol 56:4 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010432	triacylglycerol 56:5 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010433	triacylglycerol 56:6 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010434	triacylglycerol 56:7 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010435	triacylglycerol 56:8 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010437	triacylglycerol 58:10 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010441	triacylglycerol 58:7 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010442	triacylglycerol 58:8 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010443	triacylglycerol 58:9 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010445	cocaine use disorder	6
http://www.ebi.ac.uk/efo/EFO_0010456	allantoin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010457	Alpha ketoglutarate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010459	aminoadipic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0010462	aspartate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010469	carnitine measurement	23
http://www.ebi.ac.uk/efo/EFO_0010472	creatine measurement	7
http://www.ebi.ac.uk/efo/EFO_0010476	dimethylglycine measurement	1
http://www.ebi.ac.uk/efo/EFO_0010486	glucuronate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010487	glutamate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010488	glycerol-3-phosphate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010500	hypoxanthine mesurement	1
http://www.ebi.ac.uk/efo/EFO_0010502	indoxyl sulfate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010503	inosine measurement	1
http://www.ebi.ac.uk/efo/EFO_0010508	malate measurement	2
http://www.ebi.ac.uk/efo/EFO_0010511	niacinamide measurement	1
http://www.ebi.ac.uk/efo/EFO_0010519	pantothenic acid mesurement	1
http://www.ebi.ac.uk/efo/EFO_0010535	sucrose measurement	1
http://www.ebi.ac.uk/efo/EFO_0010536	taurine measurement	3
http://www.ebi.ac.uk/efo/EFO_0010546	uridine measurement	2
http://www.ebi.ac.uk/efo/EFO_0010548	xanthine measurement	2
http://www.ebi.ac.uk/efo/EFO_0010552	social environment measurement	4
http://www.ebi.ac.uk/efo/EFO_0010553	cocaine use measurement	1
http://www.ebi.ac.uk/efo/EFO_0010554	retinal vasculature measurement	9
http://www.ebi.ac.uk/efo/EFO_0010555	left ventricular stroke volume measurement	3
http://www.ebi.ac.uk/efo/EFO_0010556	Left ventricular mass to end-diastolic volume ratio	3
http://www.ebi.ac.uk/efo/EFO_0010557	lactose tolerance test	1
http://www.ebi.ac.uk/efo/EFO_0010559	anti-drug antibody measurement	19
http://www.ebi.ac.uk/efo/EFO_0010570	ventricular enlargement measurement	1
http://www.ebi.ac.uk/efo/EFO_0010572	growth rate measurement	5
http://www.ebi.ac.uk/efo/EFO_0010573	kallikrein-11 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010574	epithelial cell adhesion molecule measurement	1
http://www.ebi.ac.uk/efo/EFO_0010575	vascular endothelial growth factor D measurement	2
http://www.ebi.ac.uk/efo/EFO_0010576	liver fibrosis measurement	8
http://www.ebi.ac.uk/efo/EFO_0010577	response to dimethyl fumarate	2
http://www.ebi.ac.uk/efo/EFO_0010578	complex trait	7
http://www.ebi.ac.uk/efo/EFO_0010583	alpha fetoprotein measurement	1
http://www.ebi.ac.uk/efo/EFO_0010584	cancer antigen 19.9 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010585	cancer antigen 15.3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010586	CD40 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010587	interleukin-2 receptor subunit alpha measurement	1
http://www.ebi.ac.uk/efo/EFO_0010588	matrix metalloproteinase 1 measurement	3
http://www.ebi.ac.uk/efo/EFO_0010589	matrix metalloproteinase 10 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010590	matrix metalloproteinase 12 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010591	matrix metalloproteinase 7 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010593	cystatin B measurement	1
http://www.ebi.ac.uk/efo/EFO_0010596	monocyte chemotactic protein 1 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010597	NF-kappa-B essential modulator measurement	1
http://www.ebi.ac.uk/efo/EFO_0010598	platelet endothelial cell adhesion molecule measurement	1
http://www.ebi.ac.uk/efo/EFO_0010599	ST2 protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0010600	angiopoietin-1 receptor measurement	1
http://www.ebi.ac.uk/efo/EFO_0010602	brain age measurement	2
http://www.ebi.ac.uk/efo/EFO_0010603	cancer antigen 125 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010604	urine volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010605	brain stem volume measurement	1
http://www.ebi.ac.uk/efo/EFO_0010606	sclerostin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010607	tumor necrosis factor, receptor superfamily, member 5 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010610	tumor necrosis factor receptor superfamily member 6 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010611	cathepsin D measurement	1
http://www.ebi.ac.uk/efo/EFO_0010613	tumor necrosis factor ligand superfamily member 14 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010614	follistatin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010615	galanin peptides measurement	1
http://www.ebi.ac.uk/efo/EFO_0010616	renin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010617	tumor necrosis factor ligand superfamily member 11 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010618	pappalysin‐1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010619	cathepsin L1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010620	dickkopf‐related protein 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010622	kallikrein‐6 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010623	tissue factor measurement	1
http://www.ebi.ac.uk/efo/EFO_0010626	placenta growth factor measurement	2
http://www.ebi.ac.uk/efo/EFO_0010629	pro‐interleukin‐16 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010637	salivary metabolite measurement	1
http://www.ebi.ac.uk/efo/EFO_0010638	atopic asthma	3
http://www.ebi.ac.uk/efo/EFO_0010639	pain measurement	55
http://www.ebi.ac.uk/efo/EFO_0010640	chronic post-operative pain measurement	1
http://www.ebi.ac.uk/efo/EFO_0010648	response to vitamin B3	5
http://www.ebi.ac.uk/efo/EFO_0010650	creativity measurement	1
http://www.ebi.ac.uk/efo/EFO_0010683	localized superficial swelling, mass, or lump	8
http://www.ebi.ac.uk/efo/EFO_0010696	soluble gp130 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010698	retinal break	4
http://www.ebi.ac.uk/efo/EFO_0010699	diffuse plaque measurement	2
http://www.ebi.ac.uk/efo/EFO_0010700	reticulocyte measurement	9
http://www.ebi.ac.uk/efo/EFO_0010701	mean reticulocyte volume	4
http://www.ebi.ac.uk/efo/EFO_0010702	opioid use disorder	4
http://www.ebi.ac.uk/efo/EFO_0010703	trauma exposure measurement	3
http://www.ebi.ac.uk/efo/EFO_0010707	trans-3-hydroxycotinine measurement	1
http://www.ebi.ac.uk/efo/EFO_0010718	response to amisulpride	1
http://www.ebi.ac.uk/efo/EFO_0010721	lung transplantation	2
http://www.ebi.ac.uk/efo/EFO_0010722	ophthalmic procedure	10
http://www.ebi.ac.uk/efo/EFO_0010723	ocular sarcoidosis	4
http://www.ebi.ac.uk/efo/EFO_0010724	lifestyle measurement	11
http://www.ebi.ac.uk/efo/EFO_0010725	aseptic loosening	2
http://www.ebi.ac.uk/efo/EFO_0010726	osteoarthritis, knee, total joint arthroplasty	6
http://www.ebi.ac.uk/efo/EFO_0010729	sun exposure measurement	12
http://www.ebi.ac.uk/efo/EFO_0010730	response to bezlotoxumab	1
http://www.ebi.ac.uk/efo/EFO_0010731	response to low calorie diet	1
http://www.ebi.ac.uk/efo/EFO_0010732	omega-6:omega-3 polyunsaturated fatty acid ratio	1
http://www.ebi.ac.uk/efo/EFO_0010733	polyunsaturated fatty acid measurement	4
http://www.ebi.ac.uk/efo/EFO_0010735	response to angiotensin receptor blocker	3
http://www.ebi.ac.uk/efo/EFO_0010736	cortical surface area measurement	4
http://www.ebi.ac.uk/efo/EFO_0010742	protein binding measurement	2
http://www.ebi.ac.uk/efo/EFO_0010743	sperm measurement	1
http://www.ebi.ac.uk/efo/EFO_0010744	testis size	1
http://www.ebi.ac.uk/efo/EFO_0010745	semen measurement	1
http://www.ebi.ac.uk/efo/EFO_0010746	Inhibin B measurement	1
http://www.ebi.ac.uk/efo/EFO_0010747	response to levodopa	4
http://www.ebi.ac.uk/efo/EFO_0010748	response to zonisamide	2
http://www.ebi.ac.uk/efo/EFO_0010749	motor function measurement	4
http://www.ebi.ac.uk/efo/EFO_0010750	PHF-tau measurement	1
http://www.ebi.ac.uk/efo/EFO_0010758	anti-Kaposi's sarcoma-associated herpesvirus antibody measurement	3
http://www.ebi.ac.uk/efo/EFO_0010760	4E-BP1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010761	adenosine deaminase measurement	1
http://www.ebi.ac.uk/efo/EFO_0010762	advanced glycosylation end product-specific receptor ligand measurement	2
http://www.ebi.ac.uk/efo/EFO_0010763	axin-1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010764	caspase-8 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010766	CCL20 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010768	CCL25 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010769	CCL28 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010770	CCL3 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010772	CD244 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010773	CD5 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010774	CD6 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010775	colony stimulating factor 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010776	CUB domain containing protein 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010777	CXCL1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010778	CXCL10 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010780	CXCL9 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010781	delta/notch like EGF Repeat Containing protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0010782	fibroblast growth factor 19 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010783	fibroblast growth factor 21 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010784	fibroblast growth factor 5 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010785	fms related receptor tyrosine kinase-3 ligand measurement	1
http://www.ebi.ac.uk/efo/EFO_0010786	interleukin-10 receptor B measurement	1
http://www.ebi.ac.uk/efo/EFO_0010788	leukemia inhibitory factor receptor measurement	1
http://www.ebi.ac.uk/efo/EFO_0010789	monocyte chemotactic protein-2 measurement	2
http://www.ebi.ac.uk/efo/EFO_0010790	monocyte chemotactic protein-4 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010791	neurotrophin-3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010792	oncostatin-M measurement	1
http://www.ebi.ac.uk/efo/EFO_0010793	programmed death-ligand 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010796	STAM binding protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0010797	sulfotrasferase 1A1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010798	transforming growth factor-alpha measurement	1
http://www.ebi.ac.uk/efo/EFO_0010800	tumor necrosis factor ligand superfamily member 10 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010801	tumor necrosis factor ligand superfamily member 12 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010802	tumor necrosis factor receptor superfamily member 9 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010803	urokinase-type plasminogen activator measurement	1
http://www.ebi.ac.uk/efo/EFO_0010804	vascular endothelial growth factor A measurement	2
http://www.ebi.ac.uk/efo/EFO_0010808	response to tafenoquine	3
http://www.ebi.ac.uk/efo/EFO_0010809	fat intake measurement	1
http://www.ebi.ac.uk/efo/EFO_0010810	protein intake measurement	3
http://www.ebi.ac.uk/efo/EFO_0010811	carbohydrate intake measurement	3
http://www.ebi.ac.uk/efo/EFO_0010812	T-cell immunoglobulin and mucin domain 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010816	dietary fat liking measurement	2
http://www.ebi.ac.uk/efo/EFO_0010817	self-injurious ideation	7
http://www.ebi.ac.uk/efo/EFO_0010819	clonal hematopoiesis	1
http://www.ebi.ac.uk/efo/EFO_0010820	spontaneous coronary artery dissection	3
http://www.ebi.ac.uk/efo/EFO_0010821	liver fat measurement	5
http://www.ebi.ac.uk/efo/EFO_0010822	stenosing tenosynovitis	1
http://www.ebi.ac.uk/efo/EFO_0010824	response to rhododendrol	1
http://www.ebi.ac.uk/efo/EFO_0010825	response to fluoropyrimidines	4
http://www.ebi.ac.uk/efo/EFO_0010834	tumor necrosis factor measurement	1
http://www.ebi.ac.uk/efo/EFO_0010899	anti-merkel cell virus antibody measurement	2
http://www.ebi.ac.uk/efo/EFO_0010900	anti-polyomavirus 2 antibody measurement	2
http://www.ebi.ac.uk/efo/EFO_0010903	anti-chlamydia trachomatis antibody measurement	6
http://www.ebi.ac.uk/efo/EFO_0010904	anti-BK polyomavirus antibody measurement	2
http://www.ebi.ac.uk/efo/EFO_0010905	BK polyomavirus seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0010906	merkel cell virus seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0010907	polyomavirus 2 seropositivity	2
http://www.ebi.ac.uk/efo/EFO_0010908	Epstein-Barr virus seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0010909	adrenomedullin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010910	C-C motif chemokine 20 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010911	C-X-C motif chemokine 16 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010912	endothelial cell-specific molecule 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010913	eosinophil cationic protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0010914	fatty acid-binding protein, adipocyte measurement	1
http://www.ebi.ac.uk/efo/EFO_0010915	heat shock 27 kDa protein measurement	1
http://www.ebi.ac.uk/efo/EFO_0010916	interleukin-27 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010917	kidney injury molecule 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010918	lectin-like oxidized LDL receptor 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010919	melusin measurement	1
http://www.ebi.ac.uk/efo/EFO_0010920	membrane-bound aminopeptidase P measurement	1
http://www.ebi.ac.uk/efo/EFO_0010921	N-terminal prohormone brain natriuretic peptide measurement	1
http://www.ebi.ac.uk/efo/EFO_0010922	P-selectin glycoprotein ligand 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010923	pentraxin-related protein PTX3 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010924	proheparin-binding EGF-like growth factor measurement	1
http://www.ebi.ac.uk/efo/EFO_0010925	protein S100-A12 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010926	proteinase-activated receptor 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010927	proto-oncogene tyrosine-protein kinase Src measurement	1
http://www.ebi.ac.uk/efo/EFO_0010928	SIR2-like protein 2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010929	TNF-related activation-induced cytokine measurement	1
http://www.ebi.ac.uk/efo/EFO_0010930	TNF-related apoptosis-inducing ligand receptor 2 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010931	tumor necrosis factor receptor 1 measurement	1
http://www.ebi.ac.uk/efo/EFO_0010932	urokinase plasminogen activator surface receptor measurement	1
http://www.ebi.ac.uk/efo/EFO_0010933	response to dexamethasone	1
http://www.ebi.ac.uk/efo/EFO_0010934	aspartate aminotransferase to alanine aminotransferase ratio	2
http://www.ebi.ac.uk/efo/EFO_0010940	microglial activation measurement	2
http://www.ebi.ac.uk/efo/EFO_0010947	epidermal growth factor measurement	1
http://www.ebi.ac.uk/efo/EFO_0010948	lower face morphology measurement	247
http://www.ebi.ac.uk/efo/EFO_0010949	upper face morphology measurement	322
http://www.ebi.ac.uk/efo/EFO_0010950	response to cranial radiation therapy	3
http://www.ebi.ac.uk/efo/EFO_0010952	urinary potassium measurement	2
http://www.ebi.ac.uk/efo/EFO_0010966	pneumonia severity measurement	1
http://www.ebi.ac.uk/efo/EFO_0010967	urinary microalbumin measurement	3
http://www.ebi.ac.uk/efo/EFO_0010968	phosphate measurement	6
http://www.ebi.ac.uk/efo/EFO_0010969	response to growth hormone	1
http://www.ebi.ac.uk/efo/EFO_0010970	severe malarial anemia	1
http://www.ebi.ac.uk/efo/EFO_0010971	response to metamizole	2
http://www.ebi.ac.uk/efo/EFO_0010972	blood phosphate measurement	2
http://www.ebi.ac.uk/efo/EFO_0010977	macrovascular complications of diabetes	1
http://www.ebi.ac.uk/efo/EFO_0010978	chemotherapy-induced cytotoxicity measurement	69
http://www.ebi.ac.uk/efo/EFO_0010979	2-hydroxyisobutyrate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010980	3-aminoisobutyrate measurement	2
http://www.ebi.ac.uk/efo/EFO_0010983	3-hydroxyisobutyrate measurement	3
http://www.ebi.ac.uk/efo/EFO_0010984	3-hydroxyisovalerate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010985	3-Indoxylsulfate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010986	4-deoxyerythronic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0010987	4-deoxythreonic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0010988	5-oxoproline measurement	2
http://www.ebi.ac.uk/efo/EFO_0010989	acetone measurement	1
http://www.ebi.ac.uk/efo/EFO_0010990	dimethylamine measurement	1
http://www.ebi.ac.uk/efo/EFO_0010991	formate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010992	hippurate measurement	1
http://www.ebi.ac.uk/efo/EFO_0010993	n-acetyl neuraminic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0010994	n-methyl-2-pyridone-5-carboxamide measurement	1
http://www.ebi.ac.uk/efo/EFO_0010995	n-methylnicotinic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0010996	n-methylpicolinic acid measurement	1
http://www.ebi.ac.uk/efo/EFO_0010997	n1-methyl-nicotinamide measurement	1
http://www.ebi.ac.uk/efo/EFO_0010998	p-cresol sulfate measurement	2
http://www.ebi.ac.uk/efo/EFO_0010999	p-hydroxyphenylacetate measurement	1
http://www.ebi.ac.uk/efo/EFO_0011000	proline betaine measurement	1
http://www.ebi.ac.uk/efo/EFO_0011001	scyllo-inositol measurement	1
http://www.ebi.ac.uk/efo/EFO_0011002	succinate measurement	1
http://www.ebi.ac.uk/efo/EFO_0011003	trimethylamine measurement	1
http://www.ebi.ac.uk/efo/EFO_0011004	trimethylamine oxide measurement	1
http://www.ebi.ac.uk/efo/EFO_0011005	urea measurement	4
http://www.ebi.ac.uk/efo/EFO_0011007	estrogen measurement	1
http://www.ebi.ac.uk/efo/EFO_0011008	sex hormone measurement	1
http://www.ebi.ac.uk/efo/EFO_0011009	glycochenodeoxycholate 3-O-glucuronide measurement	1
http://www.ebi.ac.uk/efo/EFO_0011010	glycodeoxycholate 3-O-glucuronide measurement	1
http://www.ebi.ac.uk/efo/EFO_0011011	sitting height measurement	5
http://www.ebi.ac.uk/efo/EFO_0011012	blood bicarbonate measurement	1
http://www.ebi.ac.uk/efo/EFO_0011013	vaginal microbiome measurement	5
http://www.ebi.ac.uk/efo/EFO_0011014	health-related quality of life measurement	2
http://www.ebi.ac.uk/efo/EFO_0011015	educational attainment	11
http://www.ebi.ac.uk/efo/EFO_0011023	concussion	1
http://www.ebi.ac.uk/efo/EFO_0011031	intestinal permeability measurement	1
http://www.ebi.ac.uk/efo/EFO_0011033	ST segment duration	1
http://www.ebi.ac.uk/efo/EFO_0011034	T wave duration	1
http://www.ebi.ac.uk/efo/EFO_0011035	TP segment duration	1
http://www.ebi.ac.uk/efo/EFO_0011036	matrix metalloproteinase–degraded type I collagen measurement	1
http://www.ebi.ac.uk/efo/EFO_0011037	anti-human herpes virus 6 antibody measurement	3
http://www.ebi.ac.uk/efo/EFO_0011038	anti-human herpes virus 7 antibody measurement	1
http://www.ebi.ac.uk/efo/EFO_0011039	myeloperoxidase (MPO)-DNA complex measurement	1
http://www.ebi.ac.uk/efo/EFO_0011041	response to BCG intravesical immunotherapy	1
http://www.ebi.ac.uk/efo/EFO_0011043	neck circumference	3
http://www.ebi.ac.uk/efo/EFO_0011044	BMI-adjusted neck circumference	3
http://www.ebi.ac.uk/efo/EFO_0011045	fetal weight	1
http://www.ebi.ac.uk/efo/EFO_0011053	immune system toxicity	1
http://www.ebi.ac.uk/efo/EFO_0600000	sortilin measurement	4
http://www.ebi.ac.uk/efo/EFO_0600001	ghrelin measurement	1
http://www.ebi.ac.uk/efo/EFO_0600002	retinal layer thickness measurement	1
http://www.ebi.ac.uk/efo/EFO_0600003	vitamin C measurement	1
http://www.ebi.ac.uk/efo/EFO_0600004	retinal nerve fibre layer thickness measurement	1
http://www.ebi.ac.uk/efo/EFO_0600005	ganglion cell inner plexiform layer thickness measurement	1
http://www.ebi.ac.uk/efo/EFO_0600006	human herpesvirus 7 seropositivity	1
http://www.ebi.ac.uk/efo/EFO_0600007	fish oil supplement exposure measurement	8
http://www.ebi.ac.uk/efo/EFO_0600008	mitochondrial heteroplasmy measurement	1
http://www.ebi.ac.uk/efo/EFO_0600009	cardiac ablation	1
http://www.ebi.ac.uk/efo/EFO_0600010	emodin glucuronidation measurement	1
http://www.ebi.ac.uk/efo/EFO_0600011	Parkinson's disease symptom measurement	1
http://www.ebi.ac.uk/efo/EFO_0600012	S100 calcium-binding protein B measurement	1
http://www.ebi.ac.uk/efo/EFO_0600013	response to ropeginterferon alfa-2b	1
http://www.ebi.ac.uk/efo/EFO_0600016	plasma beta-amyloid 1-40:1-42 ratio measurement	1
http://www.ebi.ac.uk/efo/EFO_0600017	response to dolutegravir	1
http://www.ebi.ac.uk/efo/EFO_0600018	trabecular bone score	1
http://www.ebi.ac.uk/efo/EFO_0600020	time to remission of COVID-19 symptoms	2
http://www.ebi.ac.uk/efo/EFO_0600021	response to dietary selenium supplementation	1
http://www.ebi.ac.uk/efo/EFO_0600022	response to gamma-aminobutyric acid receptor agonists	1
http://www.ebi.ac.uk/efo/EFO_0600023	response to immune checkpoint inhibitor	1
http://www.ebi.ac.uk/efo/EFO_0600024	response to tofacitinib	6
http://www.ebi.ac.uk/efo/EFO_0600027	hemoglobin change measurement	1
http://www.ebi.ac.uk/efo/EFO_0600028	N-acylethanolamine measurement	1
http://www.ebi.ac.uk/efo/EFO_0600031	response to benznidazole	1
http://www.ebi.ac.uk/efo/EFO_0600032	congenital right-sided heart lesions	1
http://www.ebi.ac.uk/efo/EFO_1000014	acidosis	2
http://www.ebi.ac.uk/efo/EFO_1000018	bladder disease	11
http://www.ebi.ac.uk/efo/EFO_1000023	chronic cystitis	2
http://www.ebi.ac.uk/efo/EFO_1000024	chronic rhinosinusitis	4
http://www.ebi.ac.uk/efo/EFO_1000025	cystitis	12
http://www.ebi.ac.uk/efo/EFO_1000042	ovarian clear cell adenocarcinoma	1
http://www.ebi.ac.uk/efo/EFO_1000045	pancreatic neuroendocrine tumor	1
http://www.ebi.ac.uk/efo/EFO_1000049	pulmonary tuberculosis	5
http://www.ebi.ac.uk/efo/EFO_1000059	cervical artery dissection	1
http://www.ebi.ac.uk/efo/EFO_1000166	Cervical Intraepithelial Neoplasia Grade 2/3	2
http://www.ebi.ac.uk/efo/EFO_1000203	Conjunctival Disorder	2
http://www.ebi.ac.uk/efo/EFO_1000221	Ductal Breast Carcinoma In Situ and Lobular Carcinoma In Situ	2
http://www.ebi.ac.uk/efo/EFO_1000244	Epithelioid Cell Uveal Melanoma	2
http://www.ebi.ac.uk/efo/EFO_1000294	HER2 Positive Breast Carcinoma	3
http://www.ebi.ac.uk/efo/EFO_1000363	Malignant Urinary System Neoplasm	2
http://www.ebi.ac.uk/efo/EFO_1000391	Nasal Cavity Polyp	15
http://www.ebi.ac.uk/efo/EFO_1000418	Ovarian Endometriosis	2
http://www.ebi.ac.uk/efo/EFO_1000438	Palmar Fibromatosis	4
http://www.ebi.ac.uk/efo/EFO_1000478	Pituitary Gland Adenoma	1
http://www.ebi.ac.uk/efo/EFO_1000481	Plantar Fibromatosis	1
http://www.ebi.ac.uk/efo/EFO_1000566	Testicular Germ Cell Tumor	5
http://www.ebi.ac.uk/efo/EFO_1000616	Uveal Melanoma	6
http://www.ebi.ac.uk/efo/EFO_1000627	thyroid disease	5
http://www.ebi.ac.uk/efo/EFO_1000630	marginal zone B-cell lymphoma	4
http://www.ebi.ac.uk/efo/EFO_1000633	adenomatous colon polyp	4
http://www.ebi.ac.uk/efo/EFO_1000635	hemangioma	4
http://www.ebi.ac.uk/efo/EFO_1000636	inflammatory skin disease	1
http://www.ebi.ac.uk/efo/EFO_1000637	acute respiratory distress syndrome	3
http://www.ebi.ac.uk/efo/EFO_1000648	developmental dysplasia of the hip	3
http://www.ebi.ac.uk/efo/EFO_1000649	estrogen-receptor positive breast cancer	15
http://www.ebi.ac.uk/efo/EFO_1000650	estrogen-receptor negative breast cancer	11
http://www.ebi.ac.uk/efo/EFO_1000651	recalcitrant atopic dermatitis	1
http://www.ebi.ac.uk/efo/EFO_1000652	acute pancreatitis	4
http://www.ebi.ac.uk/efo/EFO_1000653	sarcopenia	1
http://www.ebi.ac.uk/efo/EFO_1000656	sporadic Creutzfeld Jacob disease	2
http://www.ebi.ac.uk/efo/EFO_1000657	rectum cancer	8
http://www.ebi.ac.uk/efo/EFO_1000678	cholesteatoma of middle ear	2
http://www.ebi.ac.uk/efo/EFO_1000697	exanthem	3
http://www.ebi.ac.uk/efo/EFO_1000705	granulomatous dermatitis	2
http://www.ebi.ac.uk/efo/EFO_1000714	impetigo	2
http://www.ebi.ac.uk/efo/EFO_1000726	lichen planus	5
http://www.ebi.ac.uk/efo/EFO_1000749	pemphigus	1
http://www.ebi.ac.uk/efo/EFO_1000755	pigmentation disease	2
http://www.ebi.ac.uk/efo/EFO_1000760	rosacea	6
http://www.ebi.ac.uk/efo/EFO_1000764	seborrheic dermatitis	3
http://www.ebi.ac.uk/efo/EFO_1000766	skin atrophy	2
http://www.ebi.ac.uk/efo/EFO_1000782	altitude sickness	1
http://www.ebi.ac.uk/efo/EFO_1000783	diabetic neuropathy	1
http://www.ebi.ac.uk/efo/EFO_1000786	osteoarthritis, hip	27
http://www.ebi.ac.uk/efo/EFO_1000787	osteoarthritis, spine	3
http://www.ebi.ac.uk/efo/EFO_1000789	osteoarthritis, hand	13
http://www.ebi.ac.uk/efo/EFO_1000800	alcohol withdrawal delirium	2
http://www.ebi.ac.uk/efo/EFO_1000802	alcoholic liver cirrhosis	4
http://www.ebi.ac.uk/efo/EFO_1000811	anterior uveitis	3
http://www.ebi.ac.uk/efo/EFO_1000825	atrial heart septal defect	2
http://www.ebi.ac.uk/efo/EFO_1000826	atrophic gastritis	2
http://www.ebi.ac.uk/efo/EFO_1000830	bacterial endocarditis	1
http://www.ebi.ac.uk/efo/EFO_1000831	bacterial meningitis	3
http://www.ebi.ac.uk/efo/EFO_1000833	balanitis	2
http://www.ebi.ac.uk/efo/EFO_1000839	bladder calculus	2
http://www.ebi.ac.uk/efo/EFO_1000840	bladder neck obstruction	2
http://www.ebi.ac.uk/efo/EFO_1000848	breast cyst	4
http://www.ebi.ac.uk/efo/EFO_1000881	coronary aneurysm	6
http://www.ebi.ac.uk/efo/EFO_1000882	coronary stenosis	3
http://www.ebi.ac.uk/efo/EFO_1000883	coronary thrombosis	1
http://www.ebi.ac.uk/efo/EFO_1000886	cutaneous mastocytosis	3
http://www.ebi.ac.uk/efo/EFO_1000904	drug-Induced dyskinesia	1
http://www.ebi.ac.uk/efo/EFO_1000906	dry eye syndrome	4
http://www.ebi.ac.uk/efo/EFO_1000910	dysplasia of cervix	6
http://www.ebi.ac.uk/efo/EFO_1000941	frozen shoulder	2
http://www.ebi.ac.uk/efo/EFO_1000965	Henoch-Schoenlein purpura	2
http://www.ebi.ac.uk/efo/EFO_1000971	hyperemesis gravidarum	1
http://www.ebi.ac.uk/efo/EFO_1000987	intestinal perforation	2
http://www.ebi.ac.uk/efo/EFO_1000997	iritis	2
http://www.ebi.ac.uk/efo/EFO_1000999	joint disease	16
http://www.ebi.ac.uk/efo/EFO_1001017	limited scleroderma	3
http://www.ebi.ac.uk/efo/EFO_1001022	low tension glaucoma	2
http://www.ebi.ac.uk/efo/EFO_1001047	mouth disease	6
http://www.ebi.ac.uk/efo/EFO_1001050	multiple system atrophy	3
http://www.ebi.ac.uk/efo/EFO_1001055	myxedema	4
http://www.ebi.ac.uk/efo/EFO_1001095	peptic esophagitis	1
http://www.ebi.ac.uk/efo/EFO_1001114	pneumococcal meningitis	4
http://www.ebi.ac.uk/efo/EFO_1001132	pseudotumor cerebri	1
http://www.ebi.ac.uk/efo/EFO_1001134	pulmonary edema	2
http://www.ebi.ac.uk/efo/EFO_1001141	pyelonephritis	2
http://www.ebi.ac.uk/efo/EFO_1001145	Raynaud disease	6
http://www.ebi.ac.uk/efo/EFO_1001157	retinal vein occlusion	4
http://www.ebi.ac.uk/efo/EFO_1001160	rheumatic fever	4
http://www.ebi.ac.uk/efo/EFO_1001161	rheumatic heart disease	5
http://www.ebi.ac.uk/efo/EFO_1001164	SAPHO syndrome	1
http://www.ebi.ac.uk/efo/EFO_1001176	sensorineural hearing loss	2
http://www.ebi.ac.uk/efo/EFO_1001178	shoulder impingement syndrome	5
http://www.ebi.ac.uk/efo/EFO_1001181	sigmoid neoplasm	4
http://www.ebi.ac.uk/efo/EFO_1001209	temporal arteritis	2
http://www.ebi.ac.uk/efo/EFO_1001216	tooth disease	4
http://www.ebi.ac.uk/efo/EFO_1001219	trigeminal neuralgia	2
http://www.ebi.ac.uk/efo/EFO_1001231	uveitis	4
http://www.ebi.ac.uk/efo/EFO_1001243	wheat allergic reaction	1
http://www.ebi.ac.uk/efo/EFO_1001249	non-alcoholic steatohepatitis	3
http://www.ebi.ac.uk/efo/EFO_1001250	rotator cuff tear	6
http://www.ebi.ac.uk/efo/EFO_1001252	gastric cardia carcinoma	1
http://www.ebi.ac.uk/efo/EFO_1001253	maculopapular eruption	6
http://www.ebi.ac.uk/efo/EFO_1001254	noise-induced hearing loss	4
http://www.ebi.ac.uk/efo/EFO_1001255	spontaneous abortion	6
http://www.ebi.ac.uk/efo/EFO_1001267	Aortic Coarctation	1
http://www.ebi.ac.uk/efo/EFO_1001272	bacterial pneumonia	2
http://www.ebi.ac.uk/efo/EFO_1001281	Buruli Ulcer	2
http://www.ebi.ac.uk/efo/EFO_1001282	Candidemia	2
http://www.ebi.ac.uk/efo/EFO_1001289	Cholecystitis, Acute	3
http://www.ebi.ac.uk/efo/EFO_1001293	collagenous colitis	1
http://www.ebi.ac.uk/efo/EFO_1001295	microscopic colitis	2
http://www.ebi.ac.uk/efo/EFO_1001322	eye foreign body	4
http://www.ebi.ac.uk/efo/EFO_1001329	Follicular Cyst	2
http://www.ebi.ac.uk/efo/EFO_1001336	Hammer Toe Syndrome	2
http://www.ebi.ac.uk/efo/EFO_1001345	Hepatitis, Alcoholic	1
http://www.ebi.ac.uk/efo/EFO_1001354	Kleine-Levin Syndrome	1
http://www.ebi.ac.uk/efo/EFO_1001370	Metatarsalgia	2
http://www.ebi.ac.uk/efo/EFO_1001375	Myocardial Ischemia	1
http://www.ebi.ac.uk/efo/EFO_1001388	Pelvic Inflammatory Disease	2
http://www.ebi.ac.uk/efo/EFO_1001395	Phlebitis	4
http://www.ebi.ac.uk/efo/EFO_1001425	Skull Fractures	2
http://www.ebi.ac.uk/efo/EFO_1001434	Tendinopathy	4
http://www.ebi.ac.uk/efo/EFO_1001435	tenosynovitis	2
http://www.ebi.ac.uk/efo/EFO_1001436	thyroid nodule	3
http://www.ebi.ac.uk/efo/EFO_1001454	amnesia	2
http://www.ebi.ac.uk/efo/EFO_1001455	auditory system disease	10
http://www.ebi.ac.uk/efo/EFO_1001459	diabetic foot	2
http://www.ebi.ac.uk/efo/EFO_1001460	diverticulitis	3
http://www.ebi.ac.uk/efo/EFO_1001466	Graves ophthalmopathy	1
http://www.ebi.ac.uk/efo/EFO_1001480	metastatic colorectal cancer	3
http://www.ebi.ac.uk/efo/EFO_1001482	cardiotoxicity	3
http://www.ebi.ac.uk/efo/EFO_1001483	non-obstructive coronary artery disease	1
http://www.ebi.ac.uk/efo/EFO_1001486	primary biliary cirrhosis	7
http://www.ebi.ac.uk/efo/EFO_1001488	influenza A (H1N1)	3
http://www.ebi.ac.uk/efo/EFO_1001489	skin and soft tissue Staphylococcus aureus infection	2
http://www.ebi.ac.uk/efo/EFO_1001490	late-onset myasthenia gravis	1
http://www.ebi.ac.uk/efo/EFO_1001491	abortion	2
http://www.ebi.ac.uk/efo/EFO_1001492	atrophic macular degeneration	6
http://www.ebi.ac.uk/efo/EFO_1001493	cardiac embolism	3
http://www.ebi.ac.uk/efo/EFO_1001494	psoriasis vulgaris	4
http://www.ebi.ac.uk/efo/EFO_1001495	small artery occlusion	1
http://www.ebi.ac.uk/efo/EFO_1001504	small vessel stroke	13
http://www.ebi.ac.uk/efo/EFO_1001506	primary angle closure glaucoma	3
http://www.ebi.ac.uk/efo/EFO_1001507	asparaginase-induced acute pancreatitis	2
http://www.ebi.ac.uk/efo/EFO_1001510	specific language impairment	5
http://www.ebi.ac.uk/efo/EFO_1001512	endometrial carcinoma	13
http://www.ebi.ac.uk/efo/EFO_1001513	liver neoplasm	4
http://www.ebi.ac.uk/efo/EFO_1001514	endometrial endometrioid carcinoma	1
http://www.ebi.ac.uk/efo/EFO_1001515	ovarian endometrioid carcinoma	3
http://www.ebi.ac.uk/efo/EFO_1001516	ovarian serous carcinoma	12
http://www.ebi.ac.uk/efo/EFO_1001754	Abruptio Placentae	1
http://www.ebi.ac.uk/efo/EFO_1001791	femoral hernia	4
http://www.ebi.ac.uk/efo/EFO_1001799	incomplete abortion	2
http://www.ebi.ac.uk/efo/EFO_1001825	pleurisy	8
http://www.ebi.ac.uk/efo/EFO_1001837	rectocele	2
http://www.ebi.ac.uk/efo/EFO_1001857	Takayasu arteritis	9
http://www.ebi.ac.uk/efo/EFO_1001858	Tarlov Cysts	2
http://www.ebi.ac.uk/efo/EFO_1001864	uterine prolapse	2
http://www.ebi.ac.uk/efo/EFO_1001866	ventral hernia	4
http://www.ebi.ac.uk/efo/EFO_1001869	dysentery	2
http://www.ebi.ac.uk/efo/EFO_1001870	late-onset Alzheimers disease	8
http://www.ebi.ac.uk/efo/EFO_1001872	agoraphobia	2
http://www.ebi.ac.uk/efo/EFO_1001890	food allergy	5
http://www.ebi.ac.uk/efo/EFO_1001892	generalized anxiety disorder	4
http://www.ebi.ac.uk/efo/EFO_1001893	Hand-foot syndrome	5
http://www.ebi.ac.uk/efo/EFO_1001896	lateral epicondylitis	2
http://www.ebi.ac.uk/efo/EFO_1001901	neuroendocrine neoplasm	1
http://www.ebi.ac.uk/efo/EFO_1001904	oral mucositis	1
http://www.ebi.ac.uk/efo/EFO_1001908	phobic disorder	4
http://www.ebi.ac.uk/efo/EFO_1001909	Plantar Fasciitis	1
http://www.ebi.ac.uk/efo/EFO_1001917	social anxiety disorder	2
http://www.ebi.ac.uk/efo/EFO_1001918	specific phobia	2
http://www.ebi.ac.uk/efo/EFO_1001919	Spinal cord injury	4
http://www.ebi.ac.uk/efo/EFO_1001925	pneumococcal bacteremia	3
http://www.ebi.ac.uk/efo/EFO_1001926	pathological gambling	1
http://www.ebi.ac.uk/efo/EFO_1001927	cutaneous squamous cell carcinoma	2
http://www.ebi.ac.uk/efo/EFO_1001928	small intestine neuroendocrine tumor	1
http://www.ebi.ac.uk/efo/EFO_1001929	selective IgA deficiency disease	1
http://www.ebi.ac.uk/efo/EFO_1001930	idiopathic osteonecrosis of the femoral head	4
http://www.ebi.ac.uk/efo/EFO_1001931	oropharynx cancer	6
http://www.ebi.ac.uk/efo/EFO_1001947	childhood T acute lymphoblastic leukemia	1
http://www.ebi.ac.uk/efo/EFO_1001950	colon carcinoma	9
http://www.ebi.ac.uk/efo/EFO_1001951	colorectal carcinoma	2
http://www.ebi.ac.uk/efo/EFO_1001976	cardioembolic stroke	10
http://www.ebi.ac.uk/efo/EFO_1001986	connective tissue disease	1
http://www.ebi.ac.uk/efo/EFO_1001998	complex regional pain syndrome	1
http://www.ebi.ac.uk/efo/EFO_1001999	systemic juvenile idiopathic arthritis	2
http://www.ebi.ac.uk/efo/EFO_1002000	Takotsubo cardiomyopathy	1
http://www.ebi.ac.uk/efo/EFO_1002002	high altitude pulmonary edema	2
http://www.ebi.ac.uk/efo/EFO_1002003	hypersensitivity reaction disease	1
http://www.ebi.ac.uk/efo/EFO_1002004	drug hypersensitivity syndrome	2
http://www.ebi.ac.uk/efo/EFO_1002005	lumbar disc herniation	1
http://www.ebi.ac.uk/efo/EFO_1002006	treatment-resistant hypertension	9
http://www.ebi.ac.uk/efo/EFO_1002009	macular telangiectasia type 2	3
http://www.ebi.ac.uk/efo/EFO_1002010	TP53 Positive Breast Carcinoma	1
http://www.ebi.ac.uk/efo/EFO_1002011	adult onset asthma	12
http://www.ebi.ac.uk/efo/EFO_1002012	ligament rupture	1
http://www.ebi.ac.uk/efo/EFO_1002013	alcoholic pancreatitis	3
http://www.ebi.ac.uk/efo/EFO_1002017	differentiated thyroid carcinoma	4
http://www.ebi.ac.uk/efo/EFO_1002018	bronchial disease	4
http://www.ebi.ac.uk/efo/EFO_1002019	oligoarticular juvenile idiopathic arthritis	2
http://www.ebi.ac.uk/efo/EFO_1002020	systemic juvenile idiopathic arthritis, polyarticular juvenile idiopathic arthritis, rheumatoid factor negative, oligoarticular juvenile idiopathic arthritis	1
http://www.ebi.ac.uk/efo/EFO_1002021	ankle injury	1
http://www.ebi.ac.uk/efo/EFO_1002022	Herpes simplex infection	2
http://www.ebi.ac.uk/efo/EFO_1002025	measles	4
http://www.ebi.ac.uk/efo/EFO_1002026	rubella	4
http://www.ebi.ac.uk/efo/EFO_1002029	chronic rhinosinusitis with nasal polyps	1
http://www.ebi.ac.uk/efo/EFO_1002031	Hodgkins lymphoma, mixed cellularity	1
http://www.ebi.ac.uk/efo/EFO_1002032	primary hypertension	8
http://www.ebi.ac.uk/efo/EFO_1002034	secondary hypertension	2
http://www.ebi.ac.uk/efo/EFO_1002040	Corneal astigmatism	23
http://www.ebi.ac.uk/efo/EFO_1002048	kidney failure	2
http://www.ebi.ac.uk/efo/EFO_1002051	facial nerve disease	2
http://www.orpha.net/ORDO/Orphanet_101953	Rare dyslipidemia	1
http://www.orpha.net/ORDO/Orphanet_101997	Primary immunodeficiency	1
http://www.orpha.net/ORDO/Orphanet_130	Brugada syndrome	2
http://www.orpha.net/ORDO/Orphanet_139039	Orofacial clefting syndrome	3
http://www.orpha.net/ORDO/Orphanet_139390	Isolated craniosynostosis	1
http://www.orpha.net/ORDO/Orphanet_141136	Hemifacial microsomia	1
http://www.orpha.net/ORDO/Orphanet_156071	Keratoconus	4
http://www.orpha.net/ORDO/Orphanet_1572	Common variable immunodeficiency	2
http://www.orpha.net/ORDO/Orphanet_166282	Familial sick sinus syndrome	2
http://www.orpha.net/ORDO/Orphanet_179	Birdshot chorioretinopathy	1
http://www.orpha.net/ORDO/Orphanet_182098	pneumoconiosis	3
http://www.orpha.net/ORDO/Orphanet_1941	Juvenile absence epilepsy	1
http://www.orpha.net/ORDO/Orphanet_1945	Rolandic epilepsy	1
http://www.orpha.net/ORDO/Orphanet_199315	Familial clubfoot with or without associated lower limb anomalies	1
http://www.orpha.net/ORDO/Orphanet_2133	Hemoglobin E disease	1
http://www.orpha.net/ORDO/Orphanet_232	Sickle cell anemia	2
http://www.orpha.net/ORDO/Orphanet_2445	Conotruncal heart malformations	6
http://www.orpha.net/ORDO/Orphanet_2495	Meningioma	2
http://www.orpha.net/ORDO/Orphanet_2573	Moyamoya disease	2
http://www.orpha.net/ORDO/Orphanet_278	Corticobasal degeneration	3
http://www.orpha.net/ORDO/Orphanet_282	Frontotemporal dementia	12
http://www.orpha.net/ORDO/Orphanet_2828	Young adult-onset Parkinsonism	1
http://www.orpha.net/ORDO/Orphanet_30391	Biliary atresia	2
http://www.orpha.net/ORDO/Orphanet_307	Juvenile myoclonic epilepsy	1
http://www.orpha.net/ORDO/Orphanet_309824	Disorder of metabolite absorption and transport	4
http://www.orpha.net/ORDO/Orphanet_309833	Disorder of other vitamins and cofactors metabolism and transport	4
http://www.orpha.net/ORDO/Orphanet_3389	Tuberculosis	25
http://www.orpha.net/ORDO/Orphanet_3437	Vogt-Koyanagi-Harada disease	1
http://www.orpha.net/ORDO/Orphanet_35093	Isolated scaphocephaly	1
http://www.orpha.net/ORDO/Orphanet_355	Gaucher disease	1
http://www.orpha.net/ORDO/Orphanet_388	Hirschsprung disease	7
http://www.orpha.net/ORDO/Orphanet_391311	Susceptibility to viral and mycobacterial infections	3
http://www.orpha.net/ORDO/Orphanet_398934	Malignant epithelial tumor of ovary	5
http://www.orpha.net/ORDO/Orphanet_399	Huntington disease	2
http://www.orpha.net/ORDO/Orphanet_440	Familial hypospadias	1
http://www.orpha.net/ORDO/Orphanet_46724	Cerebral arteriovenous malformation	1
http://www.orpha.net/ORDO/Orphanet_53351	X-linked dystonia-parkinsonism	1
http://www.orpha.net/ORDO/Orphanet_538	Lymphangioleiomyomatosis	1
http://www.orpha.net/ORDO/Orphanet_54247	Posterior cortical atrophy	1
http://www.orpha.net/ORDO/Orphanet_586	Cystic fibrosis	3
http://www.orpha.net/ORDO/Orphanet_64280	Childhood absence epilepsy	1
http://www.orpha.net/ORDO/Orphanet_654	Nephroblastoma	1
http://www.orpha.net/ORDO/Orphanet_683	Progressive supranuclear palsy	8
http://www.orpha.net/ORDO/Orphanet_70589	Bronchopulmonary dysplasia	5
http://www.orpha.net/ORDO/Orphanet_768	Familial long QT syndrome	1
http://www.orpha.net/ORDO/Orphanet_79062	Disorder of amino acid and other organic acid metabolism	2
http://www.orpha.net/ORDO/Orphanet_791	Retinitis pigmentosa	5
http://www.orpha.net/ORDO/Orphanet_79102	Thyrotoxic periodic paralysis	6
http://www.orpha.net/ORDO/Orphanet_79364	Alopecia	5
http://www.orpha.net/ORDO/Orphanet_797	Sarcoidosis	21
http://www.orpha.net/ORDO/Orphanet_85443	AL amyloidosis	10
http://www.orpha.net/ORDO/Orphanet_908	Fragile X syndrome	1
http://www.orpha.net/ORDO/Orphanet_93930	Bladder exstrophy	1
http://www.orpha.net/ORDO/Orphanet_93957	Limb dystonia	1
http://www.orpha.net/ORDO/Orphanet_96346	Anorectal malformation	1
http://www.orpha.net/ORDO/Orphanet_98896	Duchenne muscular dystrophy	1
http://www.orpha.net/ORDO/Orphanet_98974	Fuchs endothelial corneal dystrophy	2
http://www.orpha.net/ORDO/Orphanet_99701	Mesial temporal lobe epilepsy with hippocampal sclerosis	1